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At present, the main diagnostic for catheter related bloodstream infection is the presence of 
fever, often coupled with rigors, which is highly unspecific, unreliable and relies heavily on 
subjective decision on behalf of the patient or clinical staff to raise an alert. It is clearly 
imperative therefore to develop readily integratable in situ sensors which could monitor the 
condition of the catheter line and warn the patient/clinical professionals of the early onset 
of biofilm formation. The ability to eradicate pathogen contamination would also be an ideal 
prerequisite for such systems in order to fully minimise the risk of infection, undoubtedly 
reducing mortality and morbidity rates caused by the infection.  
 
This research project has focused on the use of pH as an indirect method in detecting line 
contamination. Various carbon-based materials (carbon fibre mesh, carbon-loaded 
polyethylene film and carbon screen printed electrodes) were used as electrode substrates 
due to their versatility, mass manufacturability, scalability as well as relatively low 
production cost – a prerequisite given the emphasis on cost reductions within healthcare 
systems.  
 
Surface modifications through electrochemical anodisation, electropolymerisation of a 
custom flavin-phenol derivative as well as adsorption of riboflavin were investigated and 
their purpose in enhancing the proposed sensor’s electroanalytical performance towards pH 
detection were critically assessed. A microbial reactor, total parenteral nutrition (TPN) and 
laked horse blood – all of which present complex media containing a range of potential 
interferences, were employed to examine the sensitivity, selectivity and repeatability of the 
various sensor designs. The design and development of a flavin-modified polymer was found 
to exhibit Nernstian behaviour (55 mV/pH) over pH 2.55 to pH 8.12. This approach was 
further updated to exploit physisorbed riboflavin (vitamin B2) with similar characteristics (61 
mV/pH) but which was intrinsically biocompatible.  The riboflavin system was employed with 
authentic TPN formulations and found to exhibit reversible pH monitoring capabilities 
(repeated cycling in over 20 scans) with minimal drift (4 mV). 
 
The dual capability of riboflavin in detecting pH as well as electro-generating reactive oxygen 
species was also exploited and studied. Through the generation of the reactive oxygen 





feasible. Ultimately, a riboflavin-based smart catheter system is proposed as a suitable 
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SPE Screen Printed Electrode 
SQWV Square Wave Voltammogram 
TC Taurolidine-Citrate 
TCH Taurolidine-Citrate-Heparin 
TLS Taurolidine Lock Solution 
TPN Total Parenteral Nutrition 
TSC Trisodium Citrate 
UK United Kingdom 







VAP Ventilator Associated Pneumonia 
WE Working Electrode 
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There is a pressing need for a smart sensor system that can identify and monitor catheter 
contamination and ultimately the onset of catheter-related bloodstream infection. Efficient 
and timely intervention could lead to a significant reduction in morbidity and mortality rates 
relating to this ubiquitous nosocomial infection. This chapter introduces the research 











Nosocomial infection, or healthcare-associated infection (HCAI), is described by the World 
Health Organisation (WHO) as an infection that was absent during admission and which 
occurred while the patient is under the care of a hospital or other similar facility (1). It is 
highlighted as the leading adverse event in healthcare. Although it is difficult to obtain 
reliable global data to determine the significance or severity of HCAI due to the lack of 
surveillance as well as the complexity and absence of standards for determining nosocomial 
infections, studies suggest that hundreds of millions of patients around the world are 
affected by HCAI annually (1). Despite several efforts and precautions to reduce the risk of 
HCAI, there is still no solution to the problem.  
 
Hospital-acquired infections can be caused by a myriad of factors. Clinical determinants 
include: immunosuppression, extended and unnecessary use of antibiotics and invasive 
devices, as well as going through complex and high-risk procedures (1). Other socioeconomic 
factors are due to resource-limited settings which are common in developing countries. 
Some examples of these are overcrowding, limited knowledge and application of basic 
antiseptic and aseptic techniques, inadequate equipment and the lack of knowledge in 
proper hygienic conditions and correct waste disposal (1). 
 
It is inevitable that the longer patients stay in the hospital, the higher the risk of acquiring a 
HCAI. Hospital-acquired infection leads to a multitude of problems including but not limited 
to: increased duration of hospital stays, augmented hospital bills for patients and their 
guardians,  higher risk of antimicrobial resistance, additional cost for health care systems, 
and more importantly, it causes unnecessary deaths (1).  
 
Patients who have had invasive devices inserted, such as catheters, have a higher risk of 
acquiring a HCAI (1). Although catheters and other indwelling devices are integral to modern 
medical procedures, they proffer perfect conditions for biofilm-forming bacterial 
colonisation which increases the risk to not only antibiotic resistance but also for catheter-
related blood stream infections (CRBSI). There are two types of CRBSI: central line-associated 
bloodstream infection (CLABSI) and non-CLABSI (i.e. catheter associated urinary tract 
infection). Central lines are described by the United States Centers for Disease Control and 






infusion or haemodynamic monitoring and which concludes at or near the heart or in one of 
the following major vessels: umbilical artery/vein in neonates, internal jugular veins, 
subclavian veins, aorta, superior/inferior vena cava, pulmonary artery, common/external 
iliac veins, brachiocephalic veins and/or femoral veins (2). Intravenous catheters vary 
depending on its entry site into the vein. This includes tunnelled and non-tunnelled 
catheters, totally implantable catheters and peripherally inserted central catheters (PICC). In 
comparison to other medical devices, central venous catheters (CVC) lead to more device-
related infections, are one of the leading causes of mortality, morbidity as well as the major 
source of septicaemia in hospitalised patients (3). In addition, CVCs are said to have up to 64-
fold greater relative risk when compared to peripheral venous catheters (3). It is important to 
note that there are two major types of catheters: urinary and intravenous (IV) catheters. The 
primary focus of this thesis will be on the latter. 
 
Each year in the United States (US) alone, an estimate of 250,000 cases of CLABSI are 
reported, making this one of the most prevalent cause of nosocomial infection (4,5). Among 
those affected, the mortality rate is approximately 24% (5) which results to around 28,000 
patient deaths in intensive care units (ICUs) in the US annually (6). With an attributable 
average cost of around $45,000 per patient, CRBSI costs up to $2.3 billion each year in 
addition to these life-threatening complications (6,7). Moreover, studies (7,8) have shown that 
there is an increased hospital length of stay of up to 22 days and up to 20 day extended ICU 
admission. Hence, CRBSI is the most expensive and lethal complication arising from central 
venous catheterisation (3). 
 
At present, the main diagnostic method for CRBSI are CVC patients with fever which can be 
accompanied by rigors. Other symptoms include nausea, inexplicable hypotension,  malaise 
and vomiting (3). The appearance of swelling, erythema and oozing drainage around the 
catheter exit site are also indicators of CRBSI (3) but these are largely subjective and 
unreliable. As such, several clinical/laboratory tests are completed to exclude alternative 
sources of infection. In addition to the aforementioned clinical indicators, at least one 
positive peripheral blood culture with a definitive proof that there is no other possible source 
of infection apart from the catheter must be obtained (3). Furthermore, for a patient to be 
diagnosed with CRBSI, they need to have a positive quantitative or semi-quantitative culture 
from the catheter tip, which is contaminated with the same pathogen as that in culture 






tests take up time and other clinical/laboratory resources which adds to the economic 
healthcare burden and could increase risk of patient morbidity.   
 
Currently, the most effective solution to catheter-related infection, especially to 
immunocompromised patients or those who have any local or systemic infection, is the 
removal of the catheter. There is a higher probability of recurring infection if the catheter is 
kept than if it is removed (3). However, this is costly and may not always be feasible due to 
limited insertion sites. For catheter salvage, the intake of systemic antibiotics in conjunction 
with lock therapy, specifically antibiotic lock therapy (ALT), is a common method. This 
involves saturating the catheter lumen with supra-therapeutic concentrations of antibiotic(s) 
such as vancomycin and gentamycin. This increases the chances of eradicating pathogens 
growing in biofilms. Nevertheless, antibiotic lock therapy also has its downfalls. Firstly, it 
increases the risk of antibiotic resistance and secondly, the likelihood of success varies. 
Microorganisms such as Staphylococcus aureus (S. aureus) are infamously unsusceptible to 
ALT (3,10,11). Other lock therapies which exploits the antimicrobial properties of substances 
such as ethanol and citrate have also been discovered and used (12–19). Similar to ALT 
however, their efficacy can be contentious and some studies have indicated that they do not 
fully eradicate all pathogens, may affect the catheter material integrity and can lead to 
additional physiological complications.  
  
Numerous preventative measures for reducing the incidence of CRBSI have been 
implemented and include: choice of catheter material, antimicrobial impregnation of 
catheters and improved training in the use of aseptic techniques. However it is evident that 
there is no permanent solution at present. Additionally, current diagnostic methods are 
costly, unreliable and highly subjective. The existence of various internal and external 
pathological pathways can also often lead to challenges in providing a suitable method in 
eradicating CRBSI-causing pathogens.   
 
The most ubiquitous source of CRBSI is the catheter hub. This is due its frequent 
manipulation by healthcare workers, carers as well as patients themselves thus increasing 
the risk of catheter contamination.  There are many hub designs in use and an example is 
shown in Figure 1.1.1. In this case, the hub is composed of an outer cap with internal female 
thread where a needleless syringe is inserted.  A blunt cannula pierces through the silicone 






Although aseptic techniques are performed, microbial colonisation still occurs. If the hub is 
compromised, the injection of solution through it allows the free movement of sessile 
microorganisms along the catheter line thus increasing the risk of CRBSI. As such, there is a 
pressing need for the development of a novel ‘smart’ hub which can detect contamination 
and enable swift replacement minimising the onset of biofilm formation. It could also be 
envisaged that the hub could be integrated into a more holistic connected health network 
where it could serve as an early warning alert to the patient/caregiver/clinicians enabling 
more timely interventions that lead to more positive outcomes and reduce likelihood of 
further, systemic complications. This thesis lays the foundations for an electrochemical 
monitoring system that can address some of these needs and showcases the development 
pathway and how new approaches to the design of a smart catheter hub could be 
implemented in practice.  
 
 
Figure 1.1.1 An example of a catheter needle free hub (ICU Medical Clave™ connector) and CT scan of its 
internal components. 
 
1.2 Project Aims and Objectives 
 
The aim of this project was to investigate the design and development of a ‘smart’ carbon-
based sensor that could not only monitor the line condition but which could, ultimately, act 
autonomously to counter an emerging infection threat via the generation of reactive oxygen 
species. It was envisaged that this would eventually be amalgamated into already existing 
catheter systems thereby providing a quick and effective method of alerting relevant 
clinicians about the onset of biofilm formation. The present investigation sought to develop 
the technology for a radical approach to preserve line integrity, improving patient’s quality 







The objectives of this project were: 
 
• To develop and employ a modified carbon-based electrode capable of feedback 
control through monitoring pH as indirect markers of biofouling; 
• To design and develop a catheter hub extension case that can easily be integrated 
into existing catheter systems; 
• To characterise the surface morphologies of the electrically conductive material and 
optimise their electrochemical properties using conventional methods; 
• To assess the modified system’s ability to generate reactive oxygen species ‘on 
demand’; 
• To ensure robustness of the sensor through repetitive scanning; 
• To demonstrate the electrode’s ability to monitor pH within a more complex setting.  
 
1.3 Chapter Summaries 
 
In attempting to fulfil the project objectives, the thesis documents the approaches taken, the 
corresponding outcomes of the various investigations and provides a critical analysis of the 
practical applicability of the resulting technological advances. The thesis consists of 8 
chapters and a summary of each is given in turn: 
 
Chapter 2 details an overview of the relevant literature and emerging research trends 
necessary for considering the development of new tools for addressing catheter-related 
bloodstream infection. Existing approaches (technical and clinical) and the challenges faced 
in attempting to minimise the onset of CRBSI and subsequent treatments are discussed. 
Developments in smart materials and new clinical procedures are critically considered. 
 
Chapter 3 outlines the experimental methods and the underlying principles utilised 
throughout this research project. It should be noted that the peculiarities of the various 
experiments are detailed in each individual chapter. 
 
Chapter 4 discusses carbon fibre as a versatile, scalable material often used as a sensor 
substrate. It is relatively common to employ electrochemical anodisation to improve the 






suitable foundation in developing a smart catheter probe. This chapter examines the effect 
of anodisation along with ultrasonic forces in exfoliating carbon fibre surfaces. 
Electrochemical measurements and surface characterisation were completed wherein the 
efficacy of the technique in enhancing the conductive electrode’s sensing capabilities was 
examined. 
 
Chapter 5 focuses on the addition of an electrode modifier which was used to enhance the 
sensor’s ability to detect the required variable which, in this project, is pH – exploited as a 
method in detecting the presence of microorganisms. Although there is a variety of pH 
sensitive modifiers, their application in real matrices often comes as a challenge. This chapter 
describes the use of a customised flavin-modified carbon mesh and its ability to indirectly 
detect pH changes using potentiometric techniques. Its function was then challenged in a 
more complex, relevant in situ setting of a microbial bioreactor.  
 
Chapter 6 details the employment of flavin-phenol polymer on a carbon-polyethylene film. 
The developed sensor is mechanically flexible and electrochemically active which are both 
suitable requisites to pH-sensitive smart systems.  
 
Chapter 7 employs screen printed electrode as a cheaper, more readily mass reproducible 
and disposable alternative to carbon fibre mesh. This chapter examines the functionality of 
carbon-based screen printed electrode modified with riboflavin, vitamin B2, in detecting pH 
changes. A 3D printed catheter hub was created, used as an extension and its purpose was 
evaluated. Additionally, this chapter highlights the use of a revised catheter hub system using 
carbon fibre mesh as the working, counter and reference electrode. Preliminary work on the 
generation of hydrogen peroxide using amperometric techniques was also discussed.  
 
Chapter 8 summarises and concludes the research conducted within this project. 


















There is undoubtedly a pressing need to identify as well as inhibit the onset of catheter 
contamination to provide valuable information for clinicians when consulting a catheterised, 
febrile patient. This would enable more rapid and efficient clinical interventions to eliminate 
catheter related bloodstream infection and improve patient outcomes. The introduction of 
a smart system that could readily be integrated into existing intravenous lines and which 
could detect as well as eradicate pathogens would be an ideal response to the need. The 
primary aim of this literature review is to concisely provide a critical assessment of the pivotal 
and emerging research pathway leading to the underpinning principles and eventually, the 









Aspects of the work detailed in this chapter is published as the cover article in: 
Casimero C, Ruddock T, Hegarty C, Barber R, Devine A, Davis J. Minimising Blood Stream 






2.1 History of Intravenous Therapy 
 
Intravenous (IV) therapy is one of the most ubiquitous, standard medical procedures in 
modern medicine. A walk through any hospital setting will reveal patients with some form of 
intravascular access device and, as they form the basis of most treatments, such systems will 
be among the first medical interventions upon being admitted to hospital. Within the media 
(print or screen), an image of a patient connected to an intravenous drip bag is almost 
inevitably used to depict hospitals. Yet only a few are aware of the climactic events that belie 
its evolution from antiquity to the present day.  In simple terms, IV therapy is a treatment 
that delivers and/or extracts fluid directly from a vein. The most common device is the 
peripheral venous catheter (PVC) which employs a small, hollow and flexible tube (cannula), 
which is inserted through the skin into the vein and is typically placed at the back of the hand 
or in the arm and it has been estimated that some 330 million are inserted in US hospitals 
each year (20,21). A conventional PVC device is highlighted in Figure 2.1.1 and comprises of a 
removable needle which guides the catheter into the vein. Such intravascular devices are 
typically used to deliver fluids straight into the bloodstream and can also be used to extract 
blood for sampling. 
 
Figure 2.1.1 Typical components common to a peripheral venous catheter. 
 
Derived from the ancient Greek word ‘kathiénai’, translating to ‘to send down’, catheters 
were first used as treatment for male urinary retention (22). The evolutionary pathway of IV 
therapy is punctuated with revolutionary changes in medical practice. While IV therapy has 
been known from antiquity, it has been suggested that the first recorded application can be 
found in Greek mythology involving Jason and the golden fleece (23). In short, after retrieving 
the golden fleece, Jason was met by his ailing father Aeson who was too unwell and weak to 






mixed it with some herbs and returned it into his veins which reinvigorated him (23). This 
procedure has hints of the modern blood transfusion we now know and use today. A brief 
summary of the significant, real-life scientific events that led to current intravenous therapy 
methods are exhibited in Table 2.1.1. 
 
Table 2.1.1 A summarised version of significant events leading to current intravenous therapy. Information 
acquired from (23–28). 
Year Event 
1492 First attempt at blood transfusion to Pope Innocent VII who fell into a stroke-induced coma. However, blood could have 
actually been given orally as per custom of the time. 
1615 Andreas Libavius of Saxony first provides the description of blood transfusion. 
1628 William Harvey discovers blood circulation. 
1654 Francis Folly completes the first successful animal to animal transfusion. 
1656 First intravenous injection from animal to animal. Sir Christopher Wren famously used a quill and a pig’s bladder to 
intoxicate a dog. 
1662 First IV injection to a human is described by Johann D. Major. 
1665 Richard Lower accomplished the first animal to human transfusion. In the same year, Lower transfused sheep blood to a 
man suffering from a case of insanity. 
1818 First recorded successful human to human blood transfusion by William Blundell. 
1827 Cholera epidemic ensues from India and reached England in 1831. 
1831 William Brooke O’Shaughnessy coined the term ‘black blood’ and first describes the primary pathology of cholera. 
1833 With the help of O’Shaughnessy, Thomas Latta was the first to successfully infuse saline solution which formed the basis 
of current solutions. 
1844 Francis Rynd develops the first hollow metal needle and subsequently performed the first subcutaneous injection. In the 
same year, Claude Bernard employed the early modern application of cardiac catheterisation and which formed the 
basis of current methods used by surgeons today. 
1853 Charles Gabriel Pravaz and Alexander Wood independently produced the first designs of metal hypodermic syringe. 
1857 Louis Pasteur defines the relationship between germs and disease. 
1867 Joseph Lister used and applied Pasteur’s theory of disease and developed of the use of antiseptic surgical methods. 
1894 Sir Almroth Wright first discovered citrate as an anticoagulant. 
1901 Karl Landsteiner identified 3 out of 4 of the now known blood groups and final AB blood group was discovered a year 
later. 
1914 Citrated blood was first used for transfusion. 
1932 The first blood bank was founded in Leningrad.  
1939 Discovery of the Rh system. 
1940s David Sheridan pioneered the modern disposable catheter upon the second world war advent. 
1945 Introduction of plastic IV catheters in hospitals. 
1950 David Masa developed the Rochester plastic needle, creating the first modern disposable IV catheter system and 
inadvertently exploded the use of intravenous fluids. 
1950 William Murphy and Carl Walter replaced the problematic glass bottles and introduced the use of plastic bags for blood 
collection and IV transfusion. 
1969 Development and introduction of current total parenteral nutrition solution. 
1970 Beldig H. Scribner and Wayne Everett Quinton invented the first designs of the Scribner-Quinton central venous 
catheter. 
1973 The Broviac catheter was originally developed by Robert C. Atkins but was more famously use for catheterisation by 
John Walter Broviac. 
1975 Verne L. Hoshal Jr., Tommy Thompson, the Thompson and Baxter company, and Millie Lawson of the MD Anderson 
Cancer centre all contributed to the development and popularity of modern peripherally inserted central catheters.  
1979 Both Robert O Hickman and James Sisley were responsible for creating and commercialising the Hickman catheter.  
1988 Due to the increasing cases of catheter-related bloodstream infection, particularly in home parenteral patients, Dr. 
Bernard Messing and his team were the first to report the use of antibiotic lock therapy. 
1997 Silver loaded catheter was first employed by Nina Gatter and her team as a preventative method and an alternative to 
antibiotic use. 
2009 The Infectious Diseases Society of America recommended antibiotic lock therapy as a standard for certain central 







From this, it evident that the curiosity coupled with dedication of scientists have allowed the 
establishment of IV therapy – a method that is considered to be one of the most vital and 
ubiquitous prerequisites in modern healthcare settings.   
 
2.2 Central Venous Catheters 
 
The estimated global central venous catheters (CVC) market was around US$ 647 million in 
2015 (29) with up to an estimate of 5 million CVCs inserted annually in the US alone (21,30). 
Central venous catheters are samples of lifesaving indwelling devices that are usually used 
for monitoring, therapeutic and/or diagnostic purposes. There are four different types of 
central intravenous catheters: totally implantable catheters, peripherally inserted catheters, 
tunnelled and non-tunnelled catheters, as detailed in Table 2.2.1. Central venous access is 
usually through the dexter (left side) of the patient as this provides a shorter, easier and a 
more direct route to the superior vena cava (31). Figure 2.2.1 displays common access sites 
for CVC placement. Typically, CVCs are used for long term-access to administer parenteral 
nutrition, fluids and various medications, especially those that are harmful to the peripheral 
veins, through the bloodstream. Additionally, CVCs are inserted for patients who require 
frequent blood tests, haemodialysis, chemotherapy and long-term antibiotics. The 
measuring and monitoring of central venous pressure are also completed through CVCs (30,32).  
 
The choice of central venous catheter type is dependent on the frequency and severity of 
complications as well as risk of failure that may arise with each type (33). The associated risks 
and ease of access with individual insertion sites must also be considered.  Mechanical 
difficulties, thrombosis, local haematoma, vessel laceration as well as catheter related 
bloodstream infection are common adverse effects of catheter placement. Further 













Table 2.2.1 Details of the four types of central intravenous catheters (5,31,34). 




Months to years 
Delivery of chemotherapy 
and other irritant drugs as 
well as long-term 
intermittent access. 
Less interference with daily 
activities; minimal flushing; lower 
risk of infection. 
PICC-line 
6 weeks to 6 
months 
Administration of irritant 
drugs, antibiotics and total 
parenteral nutrition; blood 
sampling. 
Low complication rate; easier to 
insert and lower insertion hazard – 
important especially to more 





Months to years 
Long term infusion of 
chemotherapy and other 
irritant drugs. 
Reduced risk of infection due to 
distance between vein entrance site 
and skin exit site. 
Non-tunnelled 
Less than 3 
weeks 
Short term administration of 
TPN; delivery of irritant 
drugs, vasopressors and 
inotropes. 
Multi lumen access; can be replaced 
in non-surgical setting through 












The recommended approach to catheter placement typically involves the employment of 
ultrasound guidance. Some emergency situations however prohibit the use of ultrasound. 
This includes the absence of equipment as well as difficulty in placing the ultrasound probe 
due to the lack of space, primarily while inserting the needle through the subclavian access 
site (36). In these cases, anatomical surface landmarks are professionally detected and used 
to orient the cannulating needle and thus catheter placement (36). Clinicians also consider 
contraindications such as the presence of thrombus in the chosen vein, existing infection 
along the access route and trauma in the anatomic surrounding (36). Understandably, 
catheter placement is completed in sterile, aseptic conditions. 
 
Depending on the line type, there are different techniques used to insert a catheter: 
Seldinger and cut-down approach. Initially established in the 1950s, the modified Seldinger 
technique is used in most cases of catheter placement (21). It was first used as an innovative 
approach for arteriography and, in spite of its advantages over previous catheter placement 
methods (i.e. through the needle and needle alone technique), it was the early 1980s before 
its use became routine (37). The method involves inserting a flexible guidewire into a 
punctured vein through the needle, threading the catheter and removal of the guidewire 
(Figure 2.2.2). Its primary advantage is that it allows a catheter to be introduced into a vessel 
through an aperture that is only the size of the catheter itself which reduces the injury caused 
to the patient (37). 
 






2.3 Healthcare Associated Infections 
 
As the name suggests, healthcare associated infections (HCAI) are infections that weren’t 
present during initial patient diagnosis and which patients attain while receiving care for 
other health issues in a hospital or other healthcare institutions. The United States Center 
for Disease Control and Prevention (CDC) states that around 1.7 million hospitalised patients 
are affected by a HCAI with mortality rate of 1 in 17 (1,2,39). Nosocomial infections are 
described as the common adverse effect of healthcare and belongs to the top 10 leading 
causes of fatality in the US (1,39). It is also estimated that up to 15% of hospitalised patients in 
developed countries obtain a HCAI, affecting up to 37% of those in intensive care units (ICUs) 
(39). The risk of acquiring a HCAI is even greater in lower income countries with up to 20 times 
higher risk than developed countries (39). Patients in intensive care are more susceptible to 
infection as they are critically ill and are commonly immunocompromised. It is estimated 
that around half a million cases of HCAIs are diagnosed annually in ICUs alone (39–41). 
Nosocomial infections predictably increase morbidity, mortality as well as costs. 
Approximately 90,000 deaths in the US are due to HCAIs and annually costs up to US$45 
billion in the US alone (39). As such, HCAIs are a major concern not only for the patients but 
also on the healthcare industry.  
 
Nosocomial infections affect patients in both developed and developing countries. In the US, 
the CDC reported an estimated morbidity rate of 4.5% (1). According to a surveillance report 
by the European Centre for Disease Prevention and Control (ECDC) in 2013, HCAI has an 
average prevalence of 5.7% (1 in 18 patients), translating to an estimated 80,000 patients in 
European countries (42,43). The World Health Organisation (WHO) also reported that up to 
51% of European ICU patients are infected and around 30% will be affected by at least one 
episode of nosocomial infections (1). 
 
In developing countries, the average prevalence of hospital-acquired infection varies 
between 5.7% and 19.1% (1). It is also estimated that an overall frequency of 42.7 episodes 
per 1000 patients days occur in ICU patients which is nearly three times more than those in 
developed countries (1).  Additionally, it is reported that in some low- and middle-income 
countries, patients using ventilators, central lines and other invasive devices, have a higher 
risk - up to 19-fold increase than patients in the US and Germany (1). In countries with 






up to 67% of patients have been found to be affected and an incidence rate of up to 9 times 
greater than in higher income countries (1). Noteworthily, nosocomial infections are said to 
be the cause of up to 56% death in neonatal period among babies born in resource-limited 
hospitals, which increases to up to 75% in South-East Asian countries and Sub-Saharan Africa 
(1).   
 
Apart from infections attributable to surgical intervention and the common spread of 
infection between patients and health care workers, most HCAIs are due to invasive, 
indwelling devices. These are categorised into catheter-related bloodstream infection 
(CRBSI), catheter-associated urinary tract infections (CAUTIs) and ventilator-associated 
pneumonia (VAP). For the purpose of this literature review, CRBSIs will be the primary topic 
in discussion, focusing mainly on central venous catheters.  
 
2.4 Catheter-Related Bloodstream Infection 
 
Although catheter use is advantageous, it is not without its complications. Catheter related 
bloodstream infection, also known as catheter-related sepsis, is defined as the presence of 
bacteraemia and/or fungaemia as a direct result of intravenous catheterisation. It is the most 
common, expensive and fatal complication caused by central venous catheters and has been 
estimated to account for a mortality rate approaching 25%  (3,44). Additionally, it is the most 
common source of nosocomial infection, accounting for up to 20% in the United Kingdom 
(UK) (3). Though there is a reduced incidence rate of 46% between 2008 and 2013 in the US, 
over thirty thousand cases of central-line associated bloodstream infection are still reported 
annually in intensive care units and facilities wards in the US alone (44).  
 
The main difference between CRBSI and CLABSI definitions are simply the settings where 
they were developed. The former is typically used in research settings where it is imperative 
that an objective and unambiguous information regarding the risk factors and pathogenesis 
of bloodstream infection as a result of vascular catheters are obtained (45). In contrast, CLABSI 
is used in a non-research environment, usually for surveillance purposes of healthcare-
associated bloodstream infection, where standardised, clear and definite results can’t be 
determined due to different diagnostic laboratory investigations completed in individual 
healthcare establishments (45). As such, CLABSI is essentially employed as a surrogate 







The use of intravascular devices such as CVCs have significantly increased over the past 
couple of decades which has led to an increased rate of indwelling device-related 
bloodstream infection.  Of this, catheter related blood stream infection affects up to 250,000 
patients and cause up to 15 million CVC days in the US alone yearly (1,32). The infection leads 
to up to 28,000 deaths and costs up to approximately $2.3 billion annually (4,6), with each 
patient roughly costing an additional $45,000 (6,7), in the US alone. The majority of patients 
with CRBSI are chronically catheterised i.e. those who are in clinical care, with cancer and 
those who undergo haemodialysis (47). Around 22,000 – 100,000 of these CRBSI cases are in 
the haemodialysis population and costs over US$500 million annually (47). 
 
In the UK, CRBSI leads to an additional cost of up to £6,200 per episode with an annual cost 
of up to £36.2 million for the healthcare system (48). This infection can also lead to up to 14 
days additional length of stay with up to 33,600 ICU days recorded per year (48). In a 2011 UK 
survey, around 40% of primary bloodstream infection was related to CVC (34). More than half 
of ICU patients already have at least one central line and generally around 20% - 30% of these 
are eventually colonized by microorganisms (49). In a study by Tacconelli et al. (2009), an 
associated cost of between €36 million and €164 million are annually spent in each of four 
European countries namely the UK, France, Italy and Germany (48). The same study estimates 
14,400 CRBSI cases causing up to over 201,000 ICU days and an upper approximate of 1,584 
deaths per annum (48). According to the report by the National Nosocomial Infections 
Surveillance system published in 2004, the median rate of bloodstream infection (BSI) caused 
by central lines varied from 0.38 to 0.79 per 1000 catheter in different ICU types (50). Although 
the attributable mortality rate of CRBSI can vary (12-25%) (5), the morbidity caused by the 
infection is well studied including thrombophlebitis, sepsis and septic shock. The variance in 
numbers between each research can be explained by the diversified quantity and quality of 
individual epidemiological studies  as well as discrepancies between clinical practices 
worldwide (48).  
 
2.4.1 Pathology and Risk Factors of Catheter-Related Bloodstream 
Infection 
 
There are four major pathogenic pathways of CRBSI as displayed in Figure 2.4.1. First, the 






colonisation of the catheter tip and cutaneous tract can readily occur (3). This is the most 
common extraluminal infection pathway for short-term catheters (21). Central venous 
catheters are readily coated with plasma proteins after insertion and skin flora can promptly 
embed in the protein as they move along the catheter and down it’s lumen, hence colonizing 
the catheter (51).  
 
 
Figure 2.4.1 Potential pathogenic routes of catheter-related blood stream infection. 
 
A study of 2,595 patients by Lorente et al. (2005) found that femoral access correlated to a 
higher incidence than both jugular and subclavian venous access (52). This is further supported 
by a randomised control trial of 289 adult patients within intensive care units completed by 
Merrer et al. (2001) where it was concluded that subclavian catheterisation was associated 
with lower risk of complications in comparison to femoral catheterisation (53).  Similarly, 
central venous insertion through the femoral or jugular vein is not advised for adult patients, 
especially for non-tunnelled CVCs (21,52–57). It is stated that a subclavian access would 
significantly reduce the risk of CRBSI (9,52,58) however, the risk of mechanical complications 
can sometimes outweigh the benefits of using this site, particularly evident in haemodialysis 
patients (56). For instance, in a comparative study by Trerotola et al. (2000), of 279 catheters 
placed, no significant difference in infection rates between subclavian and internal jugular 
access was found yet 13% of patients with catheterisation through the former suffered from 
symptomatic venous thrombosis in comparison to 3% with the latter (59). Furthermore, post 






preferred internal jugular route (56,60,61). As such, deciding for the correct and suitable 
catheter placement must consider the risk and benefits of each insertion site. 
 
Catheter related bloodstream infection could also originate from catheter lumen 
contamination prior to insertion or through a hematogenous route from a separate infection 
site. Similarly, the introduction of infusate, such as total parenteral nutrition (TPN) and 
dialysate, leads to an increase risk of CRBSI.  In fact, the major cause is the frequent 
manipulation of the line allowing the internal migration of the colonising microorganisms 
along the catheter lumen. Previously thought to subsequently cause CRBSI exclusively in 
long-term catheters, hub colonisation and migration has been acknowledged to be  the most 
common source of infection for both short- and long-term catheters (45). Chernecky and 
Waller (2011) state that fifty percent of CRBSI cases are caused by intraluminal migration of 
microorganisms through the catheter connector and hub, which can be easily colonised 
within 24 hours of insertion (62). Similarly, a review by Moureau and Flynn (2015) state that 
needle free connectors (NFC) are the greatest risk for contamination of the catheter, after 
insertion, with up to 45% of NFCs contaminated (63).  
 
System manipulation usually occurs through the needle free connector and, as such, is the 
most common nidus in the catheter system leading to CRBSI. Though there are a variety of 
commercially available NFCs, most share common access port design.  Commonly the hub 
has an outer cap that allows a male luer needleless syringe/connector to be inserted which 
leads to the compression of a silicone septum which then allows the solution to flow into the 
catheter lumen (64,65) (Figure 2.4.2). While there are differences in internal mechanism, most 
designs rely on a split septum which acts as a physical barrier to pathogen entry when 
disconnected. Another septum design involves the use of solid sealed silicone surfaces (BD 
Max Zero™) which potentially minimises the number of surface crevices through which 
contaminants can adhere to. However, this still relies on the luer activated deformation of 
the silicone cap within the device to enable fluid flow. If planktonic microorganisms are 
already present in the hub, these are then able to freely migrate through the catheter line, 











Figure 2.4.2 Needle free connectors based on A) simple split septum, B) mechanical spring compression and C) 
blunt cannula. CT scans of the internal components of an ICU Medical Clave™ connector D) before and E) after 
connection to a giving set with a luer connector. 
 
In a study by Chernecky and Waller (2011), wherein a comparison between commercially 
available antimicrobial and non-antimicrobial connectors was completed, an antimicrobial 
connector produced up to 8.8 times more colony forming units (CFU) than the latter type (62). 
It is suggested that this could be due to the variation in design, with there being three types 
of fluid displacement in conventional needleless intravenous connectors: zero/neutral, 
positive and negative. Positive displacement refers to the forced movement of a minute 
solution volume into the end of the catheter after disconnection, as a safety precaution to 
prevent occlusion due to blood (66). Negative pressure luer access refers to the opposite i.e. 
there is blood reflux to the catheter, and where a neutral valve type is supposedly designed 
to prevent any backflow of fluid into the catheter (66). Additionally, there is a variety of 
antimicrobial components that could be used to impregnate connectors and hubs, hence 
adding to the discrepancy between antimicrobial properties. It is known that the presence 
of blood (as minute as 4-30 µL) within the needle-free catheter hub would lead to haemolysis 






Moreover, blood is also a significant source of nutrients that would enhance bacterial growth 
and their interaction with fibrin further leads to adhesion and biofilm formation thus 
ultimately leading to CRBSI (67). It is the complex external surface designs and intricate 
interiors of catheter hubs and other needleless connectors that causes complications in 
flushing and disinfection which, in turn, increases susceptibility to contamination. 
Furthermore, the presence of gaps, such as those in between septum and solution pathway, 
as well as dead spaces inside the hub proffers the perfect nidus for pathogen invasion and 
thus a major source of CRBSI (62,66). There is a need therefore to design a hub where less is 
better.  
 
Independent from the insertion site, another risk factor is the number of lumens present in 
the catheter system. Multi-lumens are used to administer multiple, usually incompatible, 
intravenous fluids such as medicines and TPN simultaneously. An observational study by 
Khanna et al. (2013) found that in comparison to single lumen, double and triple lumen 
catheters are associated to higher CRBSI incidence (23.1% vs 37% vs 39.8%, respectively) (68). 
Additionally, Frasca et al. (2010) described five randomised studies where it was concluded 
that, although a significant increase in contamination was observed in both single- and multi-
lumen catheters, a higher risk of infection was associated with multiple lumen catheters (21). 
For patients with indwelling catheters who require TPN, 13.1% of patients with bloodstream 
infection had multiple lumens which is significantly greater than only 2.6% of single-lumen 
catheterised patients affected (21). Likewise, a surveillance study of 1,369 CVCs showed that 
each additional lumen increased the risk of infection (57). Therefore, the use of multi-lumen 
catheters should, where possible, be limited. Lipid-containing solutions should be 
administered through a specific lumen, and unnecessary lumens should be permanently 
closed in cases where a catheter can’t be removed (57). For catheters with triple- or double-
lumen, CLABSI will be missed if more than one lumen is not tested for blood culture up to 
15.8% and 27.2% of the time, respectively (69). 
 
Unsurprisingly, the increased duration of catheter use is associated with an increased risk of 
catheter related bloodstream infection. Studies completed in the 1990s have shown that 
catheter use between 5-7 days corresponds to higher risk of infection but a study in 2013 
has revealed that only after 12 days of catheter use was there a significant risk (68). It states 
that patients with in situ catheterisation greater than 12 days have 2.21 times more chance 






more recent surveillance by Pandit et al. (2019) supports this study as they observed that of 
107 patients, 65 of them did not attain CRBSI with an average catheterisation period of only 
8.43 ± 1.28 days while the other 42 patients was affected by CRBSI with average 
catheterisation duration of 12.19 ± 1.89 days (70). The difference may be explained by various 
variables in individual studies including the number of patients involved and choice of 
characteristic inclusions. 
 
Certain patient characteristics, such as low serum albumin levels can also predispose a 
patient to CRBSI. For instance, studies show that patients with lower albumin levels, 
compared to those that are in normal range, had a greater risk of nosocomial infection (71,72). 
This is said to be due to albumin having an anti-adhesive property against the attachment of 
bacteria, like Staphylococcus aureus, to cells in vitro (72). Thus, a low albumin level leads to an 
increase in bacterial colonization which, in turn, increases the risk of CRBSI. Additional risk 
factors include, but are not limited to: age, poor personal hygiene, moisture around insertion 
site and other morbidities like diabetes mellitus, low haemoglobin level and peripheral 
atherosclerosis (3). 
 
Additionally, patients who receive total parenteral nutrition have been found to have a 
higher risk of developing CRBSI compared to those who don’t (60.7% vs 34.4%) (73). Patients 
with morbidities like intestinal failure rely heavily on the administration of TPN and other 
intravenous fluids through the catheter in order to receive the required fluids and nutrition 
(74,75). Although necessary, this leads to an increased risk of catheter-related bloodstream 
infection and catheter malfunction since the line is used more frequently and for over a long 
period each time. Dibb et al. (2016) identified 588 patients administered with home 
parenteral nutrition and, of these, 137 patients acquired 297 cases of CRBSI (76). This 
correlation is unsurprising as TPN contains various components such as amino acids, 
dextrose and lipids that proffer an idyllic environment for the proliferation of CRBSI-causing 




Catheter contamination readily leads to the formation of biofilm – bacterial or fungal. 
Biofilm-forming microorganisms commonly isolated from CVCs are described in Table 2.4.1. 






they recorded 1129 episodes of CRBSI (78). However, it is important to note that the 
prevalence of organisms vary from each study and are dependent on various factors 
including the chosen application i.e. haemodialysis and chemotherapy (3,45,79–81). Upon the 
insertion of a catheter, the device is instantaneously enveloped with a conditioning film 
composed of organic macromolecules such as fibrinogen, pyruvate and glucose, which, in 
turn, further aids pathogen surface adhesion (9,82). Pathogens will more readily adhere to this 
film than to the bare catheter material itself and, once attached to the luminal surface, will 
rapidly establish a biofilm (9). As early as 24 hours after catheter placement, device 
contamination and biofilm formation onset can occur (9). 
 
Table 2.4.1 Common biofilm forming microorganisms found in catheters (72,78,79,83,84). 
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bacteria Gastrointestinal tract 3.4% 






A biofilm is an accumulation of microbial organisms that are associated to a substratum and 
releases extracellular matrix (ECM) that can shelter it from antimicrobial treatments (9,85,86). 
Around 65 - 80% of all microbial and chronic infections are caused by biofilms (87,88). Biofilm 
formation is said to occur in four main stages: surface attachment and cell division, micro 
colony formation, maturation of biofilm, and dispersion, as summarised in Figure 2.4.3. A 






mostly nucleic acid, protein and exopolysaccharides, which forms the ECM surrounding the 
cells (89). Biofilm structures are integrated with fluid-filled channels that allow the transport 
and exchange of nutrients and oxygen to the cells developing underneath. In addition, this 
encasement provides biofilms with their mechanical stability by producing glue-like 
connections between cells and to the substratum (86), improving their irreversible adhesion 
to catheter surfaces (9). This protective layer can also limit the diffusion of antimicrobial 
agents, by creating a barrier or simply binding directly to the agents, towards cells in the 
deeper layer which inadvertently reduce the effect of antibiotics thus ultimately leading to 
antibiotic resistance (87,90). This hallmark resistance, or at least tolerance, to antibiotic therapy 
plays a significant role in the appearance of bacteraemia (3). In comparison to antibiotic 
concentrations required to eliminate bacteria in solution, biofilm eradication demands 
minimum inhibitory concentrations of 100 to 1000 times greater (91). After maturation, the 
biofilm life cycle then continues with microorganism detachment and dispersion which is 
crucial for bacterial survival and transmission of disease. A myriad of factors including 
overpopulation (due to continuous cell division), competition, and nutrient deficiency causes 
planktonic cells to detach from the biofilm colony which can then readily disperse, form new 
biofilm colonies and cause systemic infection (87,89,90).  
 
 
Figure 2.4.3 Biofilm life cycle. Adapted from (92). 
 
Microbial properties such as the presence of fimbriae and flagella as well as surface-
associated proteins can also increase the rate of bacterial attachment (9). Repulsive forces 
found in most environmental materials, at about 10 – 20 nm from the surface, can help deter 
microbial attachment however, these appendages along with attractive van der Waals 
forces, enable the cells to remain in place prior to enforcing a more stable and permanent 
attachment mechanism (87,90). Another factor that enhances microbial attachment is the 






surface roughness (9). Lee et al. (2017) studied the development of various biofilm forming 
microbes on different types of catheter materials. They found that the smooth, less porous 
silicone-based catheters had 1.5 times less biofilm count than the corresponding latex-based 
catheters (93). This is due to rough surfaces having greater surface area than smooth surfaces 
thus enhancing surface adhesion (82,94). Additionally, the presence of grooves and trenches 
on rough surfaces could reduce the effect of shear forces on the microbe, which would 
therefore lead to better attachment (82). Adherence to the surface is a key stage in 
colonisation and it is said that hydrophobic, non-polar surfaces such as those used in 
catheters lead to more biofilm formation compared to its counterpart (82,89).   
 
2.4.3 Current Practice 
 
Currently, the most sensitive and main diagnostic in determining CRBSI is the significant 
increase of patient temperature and presence of rigors (periodic onset of cold shivering and 
sweating) which are highly unspecific, insensitive and unreliable (34). Figure 2.4.4 displays the 
diagnostic process applied when a CVC patient experiences an acute febrile episode. Local 
inflammation around the catheter site, erythema, purulent discharge and presence of 
phlebitis can also be used to determine CRBSI (5,95). However, these are reported to occur 
even without CRBSI or local infection and thus their use for indicative purposes can be 
subjective (5,95).  As such, microbiological data linking the catheter to BSI is required. There 
are various approaches to attain this data and they can be divided into two: requiring 









Figure 2.4.4 Diagnosis flowchart for patients with CVC experiencing acute febrile episode. Adapted from (5). DTP 






Table 2.4.2 Microbiological techniques to diagnose CRBSI (5,9). 
Procedure Diagnostic criteria Sensitivity Specificity Disadvantages 




Quantitative central blood 
culture results to colony 
forming unit (CFU) count of ≥ 
5-fold more than CFU count 
from simultaneously drawn 
blood from peripheral vein 
93% 97% - 100% 




Non-quantitative blood culture 
drawn from CVC becomes 
positive ≥2 h before 
simultaneously drawn blood 
culture from peripheral vein 
89% - 90% 72% - 87% 
Interpretation can be 
difficult due to blood 
culture contamination 






Quantitative blood culture 
from CVC is ≥100 CFU/mL 
 
81% - 86% 85% - 96% 
Cannot differentiate 






Bacteria presence 87% 94% 











Requiring catheter removal techniques 




≥15 CFU/mL from a 5 cm CVC 
tip 
45% - 84% 85% 
Only detects extra 
luminal and distal 
colonisation. Unable to 
detect microorganisms 







≥103 CFU from CVC tip 
 
82% - 83% 89-97% 
The cut-off points of 
≥103 CFU vs ≥102 CFU 
is not well defined. 
Microscopy of 
stained CVC: 
Gram stain and 
acridine orange 
staining 
Direct visualisation of the 
microorganisms 
84% -100% 97% - 100% 
Impractical and labour 
intensive 
 
As previously noted, CRBSI diagnosis mostly relies on the association of clinical signs and 
laboratory result synergy. It is important to note that if a positive result is obtained from the 






signifies catheter colonisation rather than CRBSI (3). Microbiological testing, with or without 
line removal, provides a much clearer analysis, however, quantitative blood cultures are not 
always readily accessible.  
 
Currently, patients with CRBSI are treated with antibiotics such as vancomycin, teicoplanin 
and cefazolin (96). However the eradication of line contamination by antibiotics can be 
unreliable and international guidelines, such as those from the Infectious Diseases Society of 
America, have highly recommended catheter removal - especially when the presence of 
Staphylococcus aureus is detected due to its association to treatment failures and further 
complications (97). The impermeable biofilm requires higher concentrations of antibiotics and 
for a longer period which in turn increases costs.  Infection relapse may also occur as an initial 
culture may find a false negative result, since biofilms can be in a dormant but viable state, 
thus allowing the microorganisms under the biofilm to regenerate and cause infection (75).  
 
A second method is the total removal of catheter. This is often the primary route for patients 
suffering from immunodeficiency, however, the build-up of scar tissue means that 
alternative insertion sites are needed which is not always viable. Additionally, patients 
suffering from comorbidities, including thrombocytopenia and coagulopathies, and those 
with clinical needs like intravenous drips and TPN, complicates the catheter removal decision 
further (98).  Moreover, this can incur a significant amount of resources both for patients and 
healthcare systems. It is therefore imperative to salvage the vascular line as much as 
possible. As such, not only is there a total absence of a suitable diagnostic approach, there is 
also a need for a better treatment method to CRBSI.  
 
2.4.4 Preventative Measures 
 
Due to an increasing prevalence of pathogen colonisation and biofilm formation in indwelling 
devices - leading to an increased number of CRBSI cases, various protocols, guidelines and 
technologies have been implemented. Examples of commonly used systems are detailed in 











In order to reduce the risk of biofilm formation and infection, organisations like the CDC and 
Healthcare Infection Control Practices Advisory Committee (HICPAC) have provided various 
guidelines and protocols. Precautions are made prior to insertion which includes skin 
cleansing preparation with an antiseptic (i.e. 70% alcohol, povidone iodine or 2% 
chlorhexidine gluconate). Continuous training for healthcare staff, having a dedicated 
infusion therapy team and routine monitoring of CRBSI rates within each institution are also 
suggested (9,58). Central venous catheters carry a more substantial risk of infection compared 
to PICC lines and more stringent, maximal sterile protective precautions are required such as 
sterile gloves, gown and drapes (9,58). Moreover, dressing choice such as placing a 
chlorhexidine gluconate-impregnated sponge (Biopatch ™) in contact with the catheter 
insertion site and covered with transparent polyurethane film helps reduce microbial 
colonisation (9,58). In order to reduce risk of infection, catheters are also typically placed and 
secured using a suture-less securement device (56). Likewise, a set of guidelines are provided 
for the catheterised patients and/or their caregivers for the maintenance of the catheters. 
This includes daily/routine skin washing with alcohol-based soap or antibacterial products, 
specifically 2% chlorhexidine for ensuring hygienic, cleansed hands which is associated to the 
reduction of CRBSI (99–101).  
 
As aforementioned, aseptic techniques including the rubbing of 70% isopropyl alcohol (IPA) 
are used to reduce the risk of contamination. Alcohol-based wipes are the most commonly 
used tools to manage and decontaminate catheter lines and needleless connectors since the 
alcohol dehydrates bacterial cell both during application and as the solution evaporates 
(102,103). The addition of a suitable antimicrobial agent such as chlorhexidine or povidone 
iodine is commonly applied to enhance the potency of this anticontamination technique as 
it prolongs the required disinfection effect, relying on the immediacy of alcohol and 
sustained action of the antimicrobial (63,64,104–106). However, this is not completely effective 
since it relies on human factors (force applied, procedure duration, etc.) and compliance. 
Device design issues also have a part to play where the presence of crevices may hinder the 
penetration of the disinfectant thus reducing the success of complete pathogen eradication. 
An in vitro study by Menyhay and Maki (2008) discovered that of 30 needleless connectors 
disinfected with the standard 70% IPA, 67% remained able to transmit the infecting 






most effective duration of alcohol rubbing with there being conflicting results from different 
studies. Some studies (107,108) found that relatively short scrubbing (3-15 seconds) was 
adequate to disinfect needleless catheter connectors. In contrast, a study by Kaler and Chinn 
(2007) has found that longer disinfection durations of 15-60 seconds was required to 
effectively do so (105). The UK EPIC3 recommendations supports the latter and, based on an 
expert panel, it is recommended to disinfect such hubs by scrubbing with 70% alcoholic-
chlorhexidine pre- and post-manipulation for at least 30 seconds (109). While ‘scrubbing the 
hub’ is internationally recognised as a critical step in attempting to reduce CRBSI cases, it 
depends heavily on compliance and there remains an issue with disinfecting the entirety of 
the needle-free connectors (NFC) where penetration to gaps may not be possible.  
 
Additionally, for patients who require frequent blood tests or administration of drug and/or 
TPN, it means that the catheter hub is frequently manipulated thus leading to a higher risk 
of contamination. The transition of TPN administration from a healthcare environment to a 
home-based setting enhances the risk of non-compliance to aseptic guidelines and 
techniques however, even in hospitals with well-trained healthcare workers, microbial 
colonisation can still occur. A study by Holroyd et al. (2017) in an intensive care unit setting, 
showed that catheter hub contamination occurred 44% of the time (69). Indwelling catheters 
are known to have a greater risk of CRBSI in comparison to short-term catheters and the 
increased hub manipulation associated with it may contribute to the reason. Studies (69,110–
113) have revealed that if a negative culture is taken from the catheter hub, then it is unlikely 
that CVC colonisation will occur. This further corroborates the pressing demand for the 
development of a novel catheter hub which can detect pathogen contamination to reduce 
the risk of CRBSI. 
 
2.4.4.2 Barrier Caps 
 
The silicone septum previously highlighted in Figure 2.4.2 is commonly the primary barrier 
between the lumen of the catheter and external contamination, therefore it plays a key role 
in preventing pathogens from entering the line. In recent years, passive NFC barrier caps 
have been developed to provide continuous disinfection whilst the catheter is not in use 
which, in turn, allows further protection and attempts to reduce CRBSI cases (114–118). Several 
design concepts, as well as various operation modes, have been used in creating such barrier 






saturated with 70% IPA (i.e. 3M CurosÔ, SwabCapÒ, Site-ScrubÒ) or an antimicrobial 
(povidone iodine or alcoholic chlorhexidine) which is then threaded onto the luer connector 
once the catheter is inactive. When the foam comes in contact with the silicone septum, the 
twisting of the cap provides a degree of friction which can aid in the removal of bacteria. In 
a revised version, Menyhay and Maki (2008) developed a two-part system where upon 
threading the antiseptic barrier cap onto the luer connector, an internal spike pierces the 
capsule containing 2% chlorhexidine gluconate in 70% IPA which only then leads to the 
saturation of the sponge (Figure 2.4.5A) (103). A critical advantage of these systems is their 
relative independence from NFC manufacturer as it simply requires a conventional luer 
connector.  
 
Buchman et al. (2009) proposed a contrasting system whereby the barrier cap encapsulates 
the entire terminal end of the NFC (Figure 2.4.5B) which is intended to remain threaded onto 
the luer connector during flush procedures (119). Supporting this method is a study by 
Mariyaselvam et al. (2015) where the team stated that syringe tip contamination is often a 
forgotten factor that leads to CRBSI and thus the retention of the antiseptic foam as a 
secondary septum could effectively aid in the disinfection of the tips prior to insertion onto 
the NFC (120). Their alternative to the barrier cap approach was to use syringes with a coated 
antiseptic tip during flushing and observed a significant eradication of contaminants in 
comparison to control, non-coated syringe (120). The combination of both strategies could 
clearly be advantageous were it not for the increased cost.  
 
Although these barrier cap designs do not directly interact with the catheter lumen, they 
allow the disinfection of the silicone septum and surrounding area, which therefore act as a 
preventative measure specifically intended for applications where frequent manipulation of 
the hub is required. In contrast to these, Brunelli et al. (2018) employed ClearGuardÒ which 
uses a chlorhexidine-impregnated rod that directly interacts with the catheter lumen and 
replaces the NFC connector (Figure 2.4.5C) (121). The antiseptic diffuses into the intraluminal 
space which has been shown to be highly effective at reducing CRBSI rates within patients 








Figure 2.4.5 Designs of NFC barrier caps based on A) a simple foam insert, B) an encapsulating split septum and 
C) the ClearGuard® terminal cap. 
 
2.4.4.3 Catheter Material 
 
A more prominent method currently used in preventing infection is the choice of catheter 
material. It has been long recognised that the development and deployment of materials 
with antimicrobial and antifouling properties is a possible pathway in eradicating catheter 
contamination, biofilm formation and essentially eliminate the risk of catheter related 
bloodstream infection. Various research strategies on viable materials are summarised in 
Figure 2.4.6. The catheter material must have properties that would reduce protein adhesion 
and, as such, the polymer’s hydrophilicity, surface energy and material coating are taken into 
consideration. Historically polyethylene glycol derivatives were tethered at the polymer-
solution interface to create a tightly bound water interface which would inevitably make it 
more arduous to adsorb protein. Catheters were then modified with a protein (albumin) coat 






deposition that would otherwise adhere and contribute to biofilm formation (122,123). 
However, this method provides only a short-term solution as prolonged and continuous 
interaction with blood eventually causes albumin detachment and removal as it is replaced 
by higher substrate affinity adhesive proteins found in blood (i.e. fibrinogen) (123).  Ideally, the 
choice of catheter material is one that doesn’t require pre-modification but can effectively 
minimise adhesion. As such, depending on the duration of use, various materials are used to 
make catheters but the most commonly used are low surface energy (<25 mN/m) polymers 
such as silicone and polytetrafluoroethylene (Teflon®) (123–125). The latter has been associated 
with a decreased infection rate compared to other materials such as polyvinyl chloride and 
polyethylene (58). However, rather than the polymer substrate’s intrinsically low surface 
energy, it has been suggested that passivation by albumin is effectively the main cause of 
inhibiting non-specific adhesion (123,125). Manipulating surface topography has also been 
suggested in that increasing surface roughness or the addition of specific patterning based 
on biological materials (i.e. Sharklet) would provide superhydrophobic layers which in turn, 
would effectively impede bacterial growth (i.e. E. coli and S. aureus) (126). Moreover, 
minimising platelet adhesion as well as inhibiting fibrin sheath formation can also be 
achieved through the introduction of biologically inspired patterning and therefore the 
translation of such technologies to catheter systems would be markedly beneficial in 
preventing extra- and intraluminal contamination. However, this approach may be more 









Figure 2.4.6 A summary highlighting various research on suitable materials to prevent catheter contamination. 
 
Furthermore, studies have shown that the use of subcutaneous and silver impregnated cuffs 
have lowered the risk of infection (127). Subcutaneous Dacron® (polyethylene terephthalate) 
cuffs are incorporated on Hickman and Broviac catheters which produces a barrier against 
skin flora invasion by allowing host tissue to grow over it (127). A systematic review by Maki et 
al. (2006) showed that cuffed and tunnelled CVCs decrease the risk of CRBSI by nearly half 
(1.6 per 1000 catheter days) compared to non-cuffed, non-tunnelled CVCs (2.7 per 1000 
catheter days) (128). Similarly, attachable silver impregnated cuffs are used for short-term 
catheters (128). The silver ions act as antiseptic agents against both bacteria and fungi 
preventing their migration through the insertion tract (127,129). Out of 234 catheters studied, 
the silver cuffs produced nearly 25% bacteria less than control catheters (1.0% vs 3.7%) (130). 
The main disadvantage of cuffs is their inability to prevent infection from other sources such 
as already existing microorganisms in the catheter hub, poor home care techniques and 











The presence of thrombus is widely associated with septic thrombophlebitis but, 
importantly, also serves as a nidus of CRBSI (51,131). Presently, catheters are prophylactically 
infused with anticoagulant agents such as heparin to decrease the occurrence of catheter 
thrombosis, however, this may also have the additional benefit of reducing CRBSI. In a meta-
analysis study of 14 randomised trials by Randolph et al. (1998), it was suggested that heparin 
bonding and heparin prophylaxis reduce the risk of microbial contamination as well as 
thrombosis caused by central venous catheters (132). However, this didn’t clearly define the 
effect of heparin in the reduction of CRBSI and CDC guidelines encourage the avoidance of 
routine employment of anticoagulant therapy (58,131). Nonetheless, prophylactic heparin is 
still employed for deep vein thrombosis and could be helpful to maintain line integrity. Other 
contradicting explanations have also been suggested to elucidate the mechanisms of heparin 
coating and how it increases resistance to non-specific protein fouling (i.e. protein specific 
interaction, inhibition of bacterial adhesion, electrostatic repulsion, etc.), however, further 
studies are needed to determine whether these suggestions perform collectively or a specific 
mode of action predominates.  
 
2.4.4.5 Antiseptic Impregnated Catheters 
 
Another preventative measure currently used is the antimicrobial coating or impregnation 
of catheters which minimises microbial colonisation. There are 3 types of 
antiseptic/antimicrobial agents currently used in catheters: chlorhexidine-silver sulfadiazine 
(ChSSD), minocycline-rifampicin (MinR) and rifampicin-miconazole (RM) (58,133). Table 2.4.3 













Table 2.4.3 Summarised information on common antiseptic/antimicrobial components used in catheter 
impregnation. 
Nomenclature Structure Mechanism of action Classification Ref. 
Chlorhexidine 
 
Initiates cell death 
through cell wall binding 
and disruption of 
cytoplasmic membrane 










The slow release of silver 
ions, triggered by the 
interaction with sodium 
chloride-containing 
fluids, initiates disulphide 
bond formation causing 
changes to protein 
structure and 
inactivation of certain 
enzymes. It also disrupts 
DNA syntheses through 









Beneficial effect via 
calcium chelation, 
antioxidant 
functionalities as well as 
tissue penetration 







Binds to RNA polymerase 
which physically blocks 
RNA synthesis therefore 
inhibiting transcription 







Initiates an internal 
release of reactive 
oxygen species within 
the fungal specimen, 
causing oxidative stress 














In a clinical trial comparing 403 catheters, those externally coated with ChSSD against bare 
catheters, showed a decrease in colonisation rate when the former was used (13.5 vs 24.1 
per 100 catheters) (143). The same study stated that the use of ChSSD-impregnated catheters 
resulted in nearly a fivefold reduction in producing CRBSI with 1.6 incident per 1000 
catheters compared to 7.6 (143). Comparing the first generation of catheters impregnated 
with ChSSD with that of MinR-impregnated catheters, the latter was found to be associated 
with a lower infection rate. In a study of 738 catheters, there was a 14.9% decrease in 
colonisation of catheters impregnated with MinR compared to ChSSD. The difference 
remained roughly constant when the duration of catheter use was also compared (6.0% vs 
21.4% with catheters placed for less than 7 days; 10.8% vs 24.4% for those placed for more 
than 7 days). The difference in efficacy between the two could be due to the fact that 
catheters are coated with MinR both internally and externally whilst those with ChSSD are 
only externally coated. Similarly, in a study conducted by Lorente et al. (2016), RM-
impregnated catheters also resulted in a significant decrease in CRBSI rate. Of the 227 
patients with RM-coated catheters, corresponding to 2,009 CVC days, no cases of CRBSI was 
reported whilst 18 reports were registered in 245 patients using standard catheters (144). 
 
A multivariate cost-effectiveness analysis by Veenstra et al. (1999) stated that an antiseptic-
impregnated catheter is expected to save approximately US $196 in direct medical costs (i.e. 
additional costs for medical interventions attributable to CRSBI including specialist and 
nursing care) per catheter, with an upper limit estimate of US $391 saving compared to a 
standard catheter (145). Additionally, CRBSI incidence is predicted to decrease by 2.2% 
(relative decrease of 42%) and local infection incidence to decrease from 12.4% to 7.5%, 
when an impregnated catheter is used in comparison to a bare catheter (145). Although  
antiseptic impregnation of catheters is an efficient and beneficial method in minimising the 
risk of CRBSI, impregnated catheters are said to lose their function after around 14 days and 
as such are only suitable for short term use (9,58).  The use of antibiotics can also add to the 
ever-increasing resistance to antibiotics. Attributable to the ever-increasing antimicrobial 
resistance, the urge to find novel alternative methods to tackle infection caused by biofilm-










2.4.4.6 Lock Solutions 
 
Lock solutions have also been widely practiced as a preventative measure of CRBSI and which 
also increase the chance of salvaging the venous access line for long-term CVC patients. 
During periods in which the line is dormant, the European Society for Clinical Nutrition and 
Metabolism (ESPEN) recommend solutions containing saline to be flushed and locked after 
TPN administration (146,147). This not only prevents blood reflux back to the line, but it also 
maintains catheter patency. Depending on guidelines generated by catheter manufacturer, 
heparin lock solutions may be required which reduces blood clot formation. Although 
heparin is known for its anticoagulant as well as antimicrobial properties, a contradicting 
study by Shanks et al. (2005) have shown the contentious nature of heparin in that it may 
actually promote staphylococcal biofilm formation at clinically relevant concentrations (5,148). 
In instances where heparin is mandatory, saline lock solution must be introduced prior to 
locking the catheter lumen with heparinised solutions (146,147). 
 
As a recent approach in tackling CRBSI, antimicrobial catheter lock solutions applied within 
the catheter lumen are used. There are two types: antibiotic and antimicrobial (non-
antibiotic) locks. This is an important therapeutic solution especially in cases where the 
salvage of a previously infected catheter is possible and desirable. The principal purpose of 
an antibiotic lock solution (ALS) is to eradicate early biofilm formation (10,11,149,150) inside the 
catheter lumen by using a small volume of highly concentrated antibiotics such as 
vancomycin and gentamycin for a period of 12 – 72 hours (11). However antibiotic lock 
solutions are not ideal as they can lead to the emergence antibiotic-resistant organisms. The 
use of glycopeptide antibiotics such vancomycin should particularly be avoided to prevent 
the development of vancomycin-resistant Gram-positive microbes. These antibiotics are 
currently the only available treatment to infections caused by penicillin-resistant enterococci 
and methicillin-resistant staphylococci (49). Additionally, ALS reduces access to the catheter 
for 7-14 days as it is necessary for the long-term catheter to be locked for this length of time 
which could result in patient distress especially for those who have limited venous access 
(10,11). Lastly, the removal of catheter is still recommended for cases involving S. aureus and 
P. aeruginosa since there is still a high risk of ALS failure in eradicating these pathogens (10,11). 
Thus, this is not an efficient way of eradicating biofilms and there is a need for a solution that 







Non-antibiotic substances such as ethylenediaminetetraacetic acid (EDTA), ethanol and 
citrate have also been discovered to reduce the risk of CRBSI. Chelators like citrate and EDTA 
can be used as alternatives to heparin as they have both anticoagulant and antimicrobial 
capabilities (5). Cell membranes appear to be degraded when calcium and magnesium ions 
are chelated, causing an increase in their permeability, ultimately leading to cell death (17). 
Bookstaver et al. (2009) showed that a 4-hour time point, the synergy between gentamicin 
and EDTA showcased a 3.98 log unit reduction of methicillin-susceptible S.aureus, a 
significantly greater decrease than other lock solutions and even more so in solutions 
without EDTA (150) . In addition, gentamicin-EDTA solutions have been proven to reduce 
biofilm-producing strains of E. coli and P. aeruginosa (10). Similarly, a study by Lebeaux et al. 
(2015) disclosed that EDTA improves the effect of gentamicin in eliminating bacteria by up 
to 3 log units (11). They also found that EDTA alone was better at eradicating S. aureus in 
comparison to vancomycin. The addition of EDTA to vancomycin and amikacin, used for 
Gram-positive and Gram-negative bacteria respectively, resulted in an increased rate of 
eliminating most strains of biofilm-forming bacteria by up to 50% (11). However, this method 
still requires the use of antibiotics which, as mentioned above, is not a suitable solution. 
 
Correspondingly, citrate has been shown to significantly lower bacterial colonisation 
compared with heparin locks (96). Weijmer et al. (2005) studied the effect of using 30% 
trisodium citrate (TSC) against heparin lock solutions in haemodialysis patients. In 
comparison to a total of 33 episodes of CRBSI in patients administered with heparin lock 
solution, only 9 patients assigned to TSC suffered CRSBI (151). Bloodstream infection rates 
decreased with TSC in both tunnelled, cuffed and untunnelled, uncuffed catheters compared 
to heparin. Additionally, this suggested that fewer patients would die due to sepsis as a result 
of using TSC, with no increased risk of catheter malfunction for discontinuing the use of 
heparin. Similarly, the recommended 46.7% TSC also significantly reduced CRBSI cases and 
catheter days at risk, reportedly due to the significant decrease in staphylococcal infection 
(17). However, citrate is said to support the growth of other biofilm-forming microorganisms, 
specifically E. coli and K. pneumoniae, leading to CRSBSI risk (152). Similar to heparin use, this 
too highlights the contentious properties of citrate lock solutions which could possibly be 
explained by the lack of standardisation in the assessment of effectiveness as well as the 







Another substance used as lock solution is taurolidine. Studies (19,152–154) have shown the 
effectiveness of 2% taurolidine as well as 1.34% taurolidine-citrate (TC) and 1.34% 
taurolidine-citrate-heparin (TCH) in eradicating bacteria and fungi (154). Olthof et al. (2015) 
showed that lock solutions containing taurolidine efficiently reduced the growth of S. aureus 
and E. coli (152).  It was found that even after 60 hours of culture, no microbial growth was 
observed. Additionally, the study concluded that the more concentrated (2%) taurolidine 
lock solution (TLS) allowed the inhibition of growth of both bacteria for ten hours longer in 
comparison to the commercially available diluted solutions. Moreover, it seems that citrate 
does not contribute to the antimicrobial activity (152,154). This was discovered when the 
commercially available 2% taurolidine was diluted to 1.34% (concentration of taurolidine in 
TC and TCH lock solutions) and no significant difference in bacterial growth inhibition was 
seen between each parameter (152).  The effectiveness of taurolidine in inhibiting growth can 
be explained by its involvement in the chemical reaction with endotoxins, exotoxins and 
microbial cell wall (152). This leads to a decrease in the microorganism’s pathogenicity and 
adhesion to various surfaces. Taurolidine is derived from formaldehyde and aminosulphonic 
acid taurinamide which are effective at eradicating a range of bacteria, fungi and biofilms 
(19,152,154). The use of taurolidine therefore has many advantages including its non-toxicity 
(metabolised into water, carbon dioxide and taurine) and, equally as important, the absence 
of antibiotics means that it doesn’t contribute to antimicrobial resistance (19,152).  A 
disadvantage of TLS is its cost – €300 more than heparin treatment (around €1,500 per year) 
and, as such, an analysis of its cost-effectiveness is required (145). Additionally, another study 
by Olthof et al. (2014) reported that approximately 7% of their patients with TLS experienced 
side effects (i.e. mouth tingling sensation despite intravenous delivery) that made them 
retract the use of or swap to a different solution of taurolidine in the said patients (155). 
 
Besides the aforementioned locks, ethanol solutions have also been suggested. Ethanol is 
known for its effectiveness in eradicating a wide variety of microorganisms including biofilm 
formation (9). Peters et al. (2013) discovered that the metabolic activity of monomicrobial 
and polymicrobial biofilms made up of C. albicans and S. aureus, cultured on polystyrene and 
silicone, were inhibited using only 10% ethanol (EtOH) and were eradicated with ethanol 
concentrations greater than 20% when exposed for at least 2 hours (98). However, they found 
that regrowth was still possible at smaller concentrations of EtOH. It was also observed that 
30% and 50% of ethanol exposure was required to prevent biofilm regrowth of C. albicans 






cell regrowth of C. albicans in silicone disks after administering EtOH concentrations below 
35% for 2 and 4 hours (156). This suggests that ethanol solution ≥ 35% along with a treatment 
time of at least 4 hours is necessary for adequate sterilization and biofilm removal (156).  A 
study by Balestrino et al. (2009) cultured biofilms composed of C. albicans, S. epidermidis, K. 
pneumoniae and P. aeruginosa on silicone catheter fragments for 4 hours and 24 hours (13). 
They showed that a 20 minute exposure to 60% ethanol solution fully eradicated the biofilms 
irrespective of incubation time,  with the exception of S. epidermidis, which required an extra 
10 minutes before complete eradication (13).  
 
Ethanol has been widely used as an effective disinfectant against bacteria and fungi with 
little to no adverse effect and, as per the previously mentioned studies, it is an attractive 
efficacious solution to biofilm formation in catheters. However, the effects of high EtOH 
concentrations on the catheter and catheter material should also be considered. Laird et al. 
(2005) administered 3 mL of 100% ethanol lock solution for 24 hours in three cases of CVCs 
inhabited by coagulase negative staphylococci (157). Precipitated material was noticeably 
visible upon line aspiration and all three CVCs rapidly occluded, with one being completely 
sealed that it could not be spared and had to be removed (157). Removal due to occlusion after 
a short period of time is not ideal for long-term indwelling devices such as CVCs. 
Furthermore, a systematic review by Mermel and Alang (2014) presented twenty clinical and 
eight in vitro studies of ethanol lock solutions with adverse effects (158). The effects varied 
and included catheter fracture, dysfunction, occlusion and catheter removal (158). A more 
recent study by Meckmongkol et al. (2018) also revealed that due to EtOH lock therapy, there 
was an increased catheter breakage rate from 0 to 13.7 and thrombosis rate from 0 to 3, 
both per 1,000 catheter days (159). This further question the efficiency of ethanol lock solution 
in catheter salvage. Contradicting studies were also mentioned which showed an increase in 
biofilm formation of S. epidermidis (160)  and S. aureus (161) in the presence of ethanol.  
Moreover, it is important to remember that ethanol does not have anticoagulant properties 
and thus can lead to other unwanted effects i.e. thrombosis.    
 
An alternative lock solution component is sodium bicarbonate (NaHCO3). Sodium 
bicarbonate has the ability to inhibit fibrin formation, and thus reduce blood clot 
development, through the chelation of calcium ions (162). Apart from this, it also has the ability 
to hinder bacterial adherence thus inhibiting biofilm formation (162,163). Farha et al. (2018) 






bicarbonate. The work states that bicarbonate selectively dissipates the pH gradient found 
in the transmembrane which, in addition to the membrane potential, completes the proton 
motive force (PMF) of bacteria (163). This is significant as the efficiency of antibiotics as well 
as several components of bacteria’s distinct immunity are dependent on the uptake and/or 
kinetics of PMF (163). Moreover, the team found that by employing the bicarbonate system, 
superfluous protons are consumed thus causing the proton gradient of the bacterial 
transmembrane to short-circuit leading to microorganism complications/growth disruption 
which in turn could reduce the risk of CBRSI (163).  
 
Biofilm formation of P. aeruginosa as well as growth of several planktonic bacteria were seen 
to be impeded by the presence of concentrated bicarbonate (164). A recent study by El-
Hennawy et al. (2020) found that 15 out of 226 catheterised patients who received normal 
saline lock solution had catheter removal due to CRBSI (162). On the other hand, only 1 out of 
225 patients who had been given a NaHCO3 lock solution had catheter loss due CRBSI, 
translating to a significant comparison of 6.6% to 0.4%, respectively (162). Its effects on fungal 
activity were also studied by Letscher-Bru et al. (2013), where they discovered that 10 g/L 
concentration of NaHCO3 impeded 80% growth of all fungal specimens in vitro and fully 
inhibited the growth of 19 out of 24 fungoid infected clinical samples ex vivo (165). The 
presence of bicarbonate in the bloodstream as well as in several tissues allows the 
exploration of NaHCO3 lock solution as a safe method of reducing CRBSI. Still, additional 
studies are required to further prove the efficacy of sodium bicarbonate on the in situ 
susceptibility of biofilm-forming microorganisms. Moreover, research on the effect of 
bicarbonate on intravenous fluids as well as the catheter line integrity should be considered. 
  
One potentially major disadvantage of using a lock solution is its transfer from the catheter 
line into the circulation at injection and in inter-dialytic sessions (96). The parabolic flow 
distribution during injection and the gravity induced discharge, due to fluid (blood and lock 
solution) density differences from the distal end of the catheter, can cause the leakage of 
lock solution contents into the bloodstream (96).  This could then cause various events from 
allergic reactions to arrhythmias and toxicity. In addition, antibiotic lock spillage can emerge 
as the source of resistance (96). It is also unlikely that a general, standardised lock solution will 
be generated due to the variance in epidemiological data, the diverging requirements to 







Although these are all adequate preventative measures, and should still be continued to use, 
they do not fully eliminate the risk of microbial infection.  Therefore, in order to eradicate 
microbial colonisation and thus reduce the risk of CRBSI to zero, a coordinated and 
simultaneous adherence to aseptic techniques and introduction of novel technology is 
necessary.  
 
2.5 Emerging Technologies 
 
2.5.1 Reactive Oxygen Species 
 
Another pathway in eradicating biofilm formation, especially those formed by drug-resistant 
microorganisms, is the production and exploitation of reactive oxygen species (ROS). The 
term reactive oxygen species encompasses agents such as: hydrogen peroxide (H2O2), 
peroxide (O2-2), hydroxyl radicals (OH·), hydroxyl ions (OH-), superoxide anion (O2-) and 
singlet oxygen (1O2) (166,167). These are normally generated as by-products of cellular biological 
processes specifically during electron transport/oxidative metabolism in the mitochondria or 
as a response to bacterial contamination, cytokines and xenobiotics (168).  
 
Through its activity in cellular processes, ROS are able to induce oxidative stress when its 
concentration goes beyond the capacity of the cell to mount an adequate antioxidant 
counteraction, leading to an imbalance in the equilibrium (168). This leads to cellular adverse 
effects like damaging cellular structures such as deoxyribonucleic acid and cell membrane, 
which eventually leads to cell death (169). Reactive oxygen species are known for their 
effectiveness against infection-causing Gram-positive and Gram-negative pathogens and 
more importantly, multi-drug resistant organisms (166). Additionally, biofilm-forming 
microorganisms commonly isolated from CVCs include C. albicans and S. aureus. These are 
notoriously opportunistic pathogens that can, not only cause diseases on their own, but can 
also co-infect leading to morbidities such as biofilm associated infection and sepsis (169). What 
makes them more formidable is their ability to resist existing antifungal and antibacterial 
agents, respectively. A solution to this problem, as well as alleviating the drawbacks from 
previously mentioned methods, may be the employment of reactive oxygen species.  
 
The effect of reactive oxygen species on the elimination of pathogens and biofilms inhabiting 






being researched (166,170,171). It is stated that the employment of the mechanistic action of ROS 
in controlling and eradicating microorganisms is the first fully novel antimicrobial system 
used for early clinical intervention for a number of decades (172). An example of this approach 
is the application of honey which has been known for its curative and antiseptic 
functionalities for over a millennium. Medical grade honey is an example of this (i.e. manuka 
honey) which is composed of sugar, methylglyoxal and ROS hydrogen peroxide (171,173). 
Several studies have shown its antibacterial (174–177), antifungal (178–180) and more importantly, 
anti-biofilm (181–183) properties. An engineered honey, known as Surgihoney™, was developed 
which, through controlled-ROS release, eliminates bacterial contamination and prevents 
biofilm formation on wounds (172). Surgihoney™ is based on organic, natural honey (which 
produces inconsistent, low levels of hydrogen peroxide) that has underwent a bioengineered 
process whereby its antimicrobial potency is enhanced and managed through 
controlling/intensifying its hydrogen peroxide activity and allowing the consistent release of 
ROS (184,185). Subsequent investigations (184–187) have evidently disclosed that Surgihoney™ has 
a greater potency in eliminating bacteria, fungi and biofilms compared to other types of 
honey. This enhanced efficiency is mainly explained by the increased production of ROS thus 
signifying its potential importance in reducing CRBSI cases. Although it is clear that 
Surgihoney™ is an effective method in eradicating microorganisms and a suitable alternative 
which does not add to antimicrobial resistance, it is unfortunately not applicable to CVC 
systems. Challenges would arise in integrating the gel within the catheter line and problems 
with leaching as well as damage to the line may also become problematic. However, the 
employment of ROS mechanisms in preventing biofilm formation continues to be a valuable 
method. 
 
Nair et al. (2016) studied several phytochemicals and discovered plumbagin as a naturally 
occurring quinone that has inhibitory antimicrobial properties that can eradicate catheter-
colonising pathogens (169). They found that plumbagin-treated C. albicans and S. aureus 
respectively produced 1.5 and 2.5 times more reactive oxygen species (ROS) in comparison 
to the non-treated pathogens while hydrogen peroxide, a known inducer of ROS, caused 3- 
and 3.5-fold increase, respectively (169). Figure 2.5.1 displays the release of ROS from 
plumbagin. The same study showed that plumbagin effectively disrupted both the 24-hour 
old mono and polymicrobial biofilms produced by the said microorganisms cultured in glass 
tubes. The minimum inhibitory concentration (MIC) of plumbagin (5 µg/mL) decreased 






reduced this by 67% and 92.5%. However, plumbagin treatment was less efficient at 
eradicating the polymicrobial biofilm and even less so when the pathogens were adhered 
onto urinary catheter silicone tubes and later treated with the quinone. Additionally, at 50 
µg/disc, plumbagin did not show any inhibitory action against other common pathogens 
found in catheters such as P. aeruginosa and K. pneumoniae. 
 
 
Figure 2.5.1 Plumbagin mechanism of action to release ROS (188).  
 
Davis et al. (2013) successfully electropolymerised plumbagin on to carbon fibre and 
exploited its pH-dependent redox properties as a basis of a pH sensitive probe (189). It is 
evident therefore that plumbagin can have a dual purpose in CVC systems wherein it could 
potentially aid in the eradication of contaminants whilst also being capable of monitoring 
the condition of the line. However, although effective at killing some microorganisms, 
plumbagin’s ability to damage DNA, cause instability of genome and trigger telomere 
dysfunction (190,191) can alternatively cause adverse effects if healthy cells are unintentionally 
targeted.  The ability to covalently tether plumbagin to the catheter would offer a solution 
however, the possibility of leaching remains to be a challenge. As such, the question lies on 
whether the benefits of using plumbagin for eradicating biofilm formation outweigh the risk 







Nevertheless, the key takeaway from this section is the underlying principle of ROS release 
and its potency in eradicating formidable pathogens. This knowledge can be exploited to 
design and develop methods in eradicating pathogen colonisation and biofilm development 
in catheter systems and thus eliminate the risk of catheter-related bloodstream infection. 
 
2.5.2 Enhanced Catheter Systems 
 
Previous methodologies primarily focus on decreasing the rate of CRBSI by actively 
eliminating pathogens that are already present in the catheter system. In spite of some 
successes, there is still a need for a vigorous diagnostic and therapeutic method that 
completely impedes (or eradicates) central line pathogen contamination.   
 
As mentioned in Section 2.4.1, the catheter hub is most common nidus related to CRBSI. It 
is therefore predictable that new hub designs are developed to help reduce the risk of 
infection. Perhaps one of the first instances of this was in 1996 where Segura et al. (1996) 
designed and employed a catheter hub which enclosed an antiseptic chamber saturated with 
3% iodinated alcohol (192). Of the 151 patients included in the study, 73 patients had catheters 
with the control hub design while 78 received the new design (192). In comparison to the 
control, there was a four-fold decrease in catheter sepsis rate and a reduced catheter hub 
contamination in patients who received the alcohol-filled hub. A contradicting study was 
however completed by Luna et al. (2000). They found no significant difference between the 
control and new product group and have stated that the employment of the antiseptic 
chamber had similar effects as standard good clinical practices (193). Nonetheless, this does 
not hinder the need for the development of a new hub design that would significantly and 
efficiently tackle hub contamination and consequently, catheter-related bloodstream 
infection. 
 
A more recent technological advancement is the development of a smart central venous port 
by Paredes et al. (2014). Their miniaturised system is composed of an antenna, electronics 
and a biosensor for the rapid and early detection of biofilm onset (194). The two former 
components are fundamentally required for the operation and long-range data transmission 
of the product, respectively (194). The system is powered via a 50 mAh coin-cell battery which, 
it was reported can be active for 11 months (194). The label-free interdigitated biosensor is 






deposition of radio frequency sputtered gold film. Through conducting impedimetric 
methods, the microelectrode is able to analyse the condition of the port’s chamber and 
therein provide an assessment of the condition of the line. The team has successfully 
evaluated the effect of varying frequency on the impedance and equivalent serial 
capacitance measurements in the presence of S. epidermidis (194).  The results demonstrated 
that in the presence of bacteria, then consequently biofilm formation, the capacitance 
measurements increase while the impedance signals decrease, with significant changes 
detected as early as 10 hours after bacteria introduction.  Additionally, the lowest frequency 
of 10 Hz has displayed better measurement changes and hence sensitivity to bacterial 
contamination.  
 
While the system’s advantages rest on detecting bacterial colonisation, validation of the 
system in complex solutions is absent and it lacks the much-needed therapeutic effect. The 
in vitro detection also depends on pathogen concentration and location which typically vary 
in each case of CRBSI. Flaws may also be observed with the trigger process of the device as 
it relies on a sequence pattern stimulated by an external signal. Moreover, the system 
requires improvements on its ability to decipher between steady and non-steady stages 
during electrical analysis. Although electronic compensations for minor and/or long-term 
changes were made, it is stated that false positive results can nonetheless occur and thus 
still requires medical staff intervention (194). Further enhancement of this system along with 
the integration of a biofilm-eradicating component could nevertheless assist in combatting 
catheter-related bloodstream infection. 
 
It should be noted that an electro-modulated smart catheter system was reported and 
ostensibly was at early stage development by Dr. Dipankar Koley and his team in 2012. He 
stated that the system chemically detects pH changes which in turn activates the release of 
therapeutic nitric oxide (NO). The smart activation and deactivation of the anti-biofilm 
compound allows its preservation and therefore the design can theoretically be used for over 
a week (195) . As of writing, no further information and commercial availability have been 
presented. Although this is the case, the release of NO as an effective eradication method 
has continued to be studied by others (196,197). In catheter applications, the reactive nitrogen 
species (RNS) plays a key role in not only reducing platelet adhesion, but it also possesses 
antifouling properties suitable for in situ purposes. A study by Pant et al. (2018) found that 






be further functionalised to become a NO donor, the RNS can be stored and then released 
to provide anti-fouling characteristics which remains to be effective even after the NO 
biocides have been distributed (196).  
 
In a separate study by Mihu et al. (2017), the team exploited the thermal reaction between 
nitrite and glucose during sol-gel formation process to entrap and then later generate NO 
directly from the nanoparticles (197). The team notes that the adhesion of methicillin-resistant 
S. aureus is hindered significantly upon incubation with 2.5 mg/mL and >5 mg/mL 
concentrations of nitric oxide nanoparticles - reducing cell growth by 40% and 50%, 
respectively. More importantly in this case, the latter condition reduced the pathogen’s 
biofilm viability by 51.8%. Additionally, bacterial growth was reduced by half after 8 hours of 
exposure without incubation with only 2.5 mg/mL concentration of NO and which remained 
even after 24 hours. This means that the interaction of the nanoparticle with the pathogen 
has a similar effect to that of antibiotic lock solutions while offering reduced dwell times (197). 
This therefore indicates that the impregnation of catheters with NO-releasing nanoparticles 
is a viable route to replace, or an alternative to, prophylactic locking and provides a pathway 
where antibiotics are no longer required. However, further research into the in vivo effect of 
NO nanoparticle release is required. 
 
2.6 Electrochemical Methods 
 
The accessibility and availability of other electrochemical methodologies as a potential 
pathway to monitoring catheter lines and reducing catheter related bloodstream infection 
are briefly discussed in this section.  
 
2.6.1 pH Sensing 
 
Due to the products and by-products produced by biofilm metabolism, commonly lactic acid, 
acetic acid and ammonia, the presence of biofilm can induce changes to its local pH 
environment and, as such, pH can be an indirect method of detecting the presence of 
bacteria. Detecting pH electrochemically has been widely used for its ease of use and fast 
analysis. The most ubiquitous form of electrochemical pH sensing is the variety of 
commercially available pH sensors. In general, commercial glass pH sensors contain an 






reference electrode that is non-polarisable and is unaffected by H+ activity. Hence, the sensor 
can measure the change in H+ ion concentrations and thereby pH changes. However, 
traditional glass pH sensors are rigid and have been gradually incompatible in miniaturised 
systems – especially when considering the physical dimensions of most CVC lines.  
Conventional glass pH probes also often require calibration to reduce potential drifts caused 
by the dehydration of the membrane, leading to a decreased sensitivity towards hydrogen 
activities (198). This can become problematic in many applications where the probe is 
expected to accurately measure pH over a long period of time without intervention i.e. 
oceanographic, aquifer and source water network monitoring. Additionally, higher alkaline 
levels would normally affect the accuracy of glass probes since alkali ions (similarly sized to 
hydrogen ions) can permeate through the glass membrane causing a false increased 
measurement of hydrogen activities (198). Thus, several, more flexible and readily scaled down 
materials have been characterised and employed as new pH sensing electrodes. 
 
The most common reason for commercial pH probes requiring frequent recalibration is due 
to reference electrode drifts (199). Throughout the years, parts of the sensor have been 
enhanced to try and overcome this issue. A primary example is the use of double junction 
probes which requires two junction to get through to the test solution which, in turn, delays 
electrolyte poisoning and help maintain the stability of the reference electrode (199). If the 
test solution and conditions/environment remain the same, algorithms can be used to 
predict reference electrode drift  (199).  Although predicting and delaying drift is useful, this 
does not stop the need for calibration. As such, a more recent and novel technology 
developed by ANB Sensors has negated the need for manual reference recalibration by 
creating a sensor that can self-calibrate. Their technology employs a second electrode into 
the reference chamber alongside the reference electrode (199).  The former reference tracking 
electrode is exploited to periodically track and measure any drift in the latter and 
automatically offsets the pH measurement (199). In addition, their device can be integrated 
into existing conventional glass pH probes and eliminates the requirement for frequent, 
manual calibration (199).  
 
The main issue in developing miniaturised systems – whether based on potentiometric or 
voltammetric detection also relates to the reference electrode. As with the glass electrode, 
the inclusion of a silver-silver chloride half cell with a predetermined chloride reservoir is not 






silver chloride pseudo reference in which the potential is determined by the chloride 
concentration within the sample. In the case of physiological solutions, it can be anticipated 
that the chloride concentration will be tightly regulated by the homeostatic checks and 
balances of the body’s metabolism and should be relatively constant (typically 0.1 M).  
 
A study by Robinson and Lawrence (2006) were among the first to explore an alternative to 
the pseudo reference approach through the use of a vinylferrocene and vinylanthracene-
containing copolymer as a pH sensitive modifier (200). The former moiety is pH insensitive and 
therefore acts as an internal reference while anthracene is purposed as the pH sensitive 
component due to its pH dependent redox activity. The copolymer was therefore exploited 
as the basis of a single component pH sensor. The pH was measured through employing 
square wave voltammetry and using the oxidation potential of anthracene with respect to 
that of the ferrocene peak position. A near Nernstian behaviour of 54 mV/pH was observed 
(pH 4, 7 and 9). It should be noted that the probe is also capable of detecting sulphide under 
cyclic voltammetric conditions wherein the sulphide is subjected to an electrocatalytic 
reaction with the oxidation of ferrocene (200). In a separate study, the team also investigated 
the effect of derivatised carbon nanotubes on the copolymer’s ability to determine pH (201). 
It was observed that the presence of the nanotubes led to a better Nernstian response (59 
mV/pH vs 63.1 mV/pH) and the relationship between the peak potential and pH remained 
linear for a wider pH range  - change in Nernstian response occurred at pH 11.7 compared to 
pH 9.5 in the absence of carbon nanotube (201).  
 
Several studies including those completed by Lawrence at al. (2007) (202), Lafitte et al. (2008) 
(203), Compton et al. (2011) (198) and Gao et al. (2018) (204) have also used ferrocene as a non-
pH dependent internal reference. These studies used varying pH sensitive compounds (i.e. 
anthraquinone, phenanthraquinone, nitrosophenyl and alizarin) but the core remit remains 
the same in that ferrocene is used as the pH insensitive internal reference. The primary 
advantage of this is that, in principle, the produced electrode would be calibrationless since 
the peak potential of ferrocene will remain consistent irrespective of the solution 
composition. Since ferrocene is unaffected by these issues, its employment as an internal 
reference can therefore provide a suitable solution. Lawrence et al (2016) (205,206) have also 
developed a novel approach to the reference system for systems in low buffered media 
where the use of appropriately functionalised quinone species can set the local environment 






properties. The voltammetric response at the electrode is dictated by the chemistry of the 
redox species rather than the sampled solution (205,206). It should be noted that in the present 
application however, the buffering capacity of the biological solutions explored is high and 
the pH inherent to those solution will dictate the local pH at the electrode. 
 
Another pH sensitive sensor studied is the use of Fast Blue RR diazonium salt-modified 
carbon fibre electrode. Makos et al. (2010) showed that the carbon-based cylindrical 
microelectrode was functionalised through the voltammetric reduction of the diazonium salt 
(207). By doing so, the redox mechanisms of the electrochemically active species’ p-quinone, 
initiated through fast cyclic voltammetry and which are dependent on hydrogen ion 
concentration, are then exploited as basis of a pH probe (207). The modified electrode was 
successfully tested in both in vitro and in vivo microenvironments, revealing its sensitivity to 
physiological pH changes and limit of detection to 0.005 pH units (207).  
 
Mclister et al. (2015) have functionalised both oxidised polyamide (208) and anodised carbon 
fibre mesh (209) with the redox-active polytryptophan as a premise for pH detection 
specifically in wound dressings. The former study employed square wave voltammetry and 
the developed redox wire expressed a Nernstian behaviour of 59 mV/pH for the physiological 
range of pH 3 - pH 8 with a minute error of only 0.04 pH units (208). Similarly, the latter 
research further proves the efficacy of the homopolymer in detecting pH as the modified 
carbon fibre sensor exhibited a sub-Nernstian behaviour of 51 mV/pH in the same 
aforementioned functional range (209). The new pH probe was then tested in a complex 
biofluid solution of horse blood to simulate wound environment. Upon consecutive scanning, 
the oxidation peak of tryptophan had a marginal shift of ±5 mV corresponding to only ±0.1 
pH unit (209). This result is encouraging in that the sensor can continue to measure pH in a 
challenging milieu which is specifically crucial in catheter systems. 
 
As previously mentioned, Davis et al. (2013) have also used plumbagin as a pH sensitive 
moiety capable of being electropolymerised on to carbon fibre for use in catheter systems 
(189). The probe was found to have a sub-Nernstian behaviour of 51 mV shift per pH in the 
physiologically relevant range of pH 3 – pH 8 (189). The ability of the probe to produce an 
unambiguous signal even in the complex medium of blood, where biological interferences 
are present, was also observed. The employment of polyplumbagin proved to be 






competing signals (189). Again however, the possibility of plumbagin leaching and its direct 
access to the circulatory system may prove to be counterintuitive in CVC applications.  
 
Urate has also been investigated as a pH sensitive analyte by Phair et al. (2014) (210). Although 
uric acid is often known as an interferent in electrochemical sensing processes, the team 
used the biomarker’s pH dependent redox characteristics as well as its inherent low 
oxidation potential as an effective, indirect method of determining local pH (210). The study 
employed an anodised carbon fibre probe, which has a 10 µm diameter suitable for 
integration in most central line catheters, as the conductive substrate to detect urate (200 
µM) in various pH buffer solutions. The observed response showed a Nernstian behaviour of 
58 mV per pH shift in the range of pH 5 – pH 8, which is where any fluctuations in local pH 
due to biofilm presence is said to occur (210). The system was further tested in whole blood 
and a mean pH of 7.40 was obtained (N = 8; relative standard deviation percentage = 0.38) 
which proves to conform with that expected of normal blood pH (210). The team also noticed 
that urate accumulated on the anodised carbon surface through passive adsorption and 
further studies on this could be beneficial. This study therefore showcases the potential of 
urate to be exploited as a naturally occurring pH dependent redox biomarker.  
 
Similar studies (205,211–218) using various types of electrodes modified with different 
electroactive species (i.e.  iridium oxide (215,216), zinc oxide (217), salicylaldehyde (218) and salicylic 
acid (218)) for the purpose of creating a solid state potentiometric pH sensors have also been 
extensively reviewed. The research mentioned here demonstrates easily designed and 
manufactured stable microelectrode sensors capable of measuring real-time pH changes. 
These sensors are cheap, sensitive and scalable alternatives to traditional pH sensors. 
Miniaturised electrochemical pH sensing probe functionalised with a biocompatible 
molecule can therefore be integrated into a smart electrochemical system for the detection 
of contamination.  
 
2.6.2 Inhibition of Pathogen Growth 
 
Electroanalytical sensing of intracellular generation of reactive oxygen species has been well 
studied (219–223) and some have discussed the deliberate electrochemical release of ROS or 
oxygen reduction outside biological processes for anti-pathogen purposes (224,225). The 







Apart from this, electrochemistry is also known to render pathological growth by inducing 
surface polarisation, also known as the bioelectric effect (Figure 2.6.1). The role of applying 
controlled potential and/or current in inhibiting biofilm formation has been thoroughly 
reviewed (224,226–229). Although there are differences in their membrane structure, both Gram-
positive and Gram-negative bacteria are negatively charged due to the presence of anionic 
phospholipids in their cell wall and outer membrane, respectively (224,230,231). Bacterial 
attachment could therefore be delayed through electrostatic or electrophoretic repulsion by 
employing a negative charge on the surface. On the other hand, a net positive polarized 
surface can generate reactive chlorine species (i.e. hypochlorous acid and sodium 
hypochlorite) which could also aid in eradicating contaminants (224,232). The reaction sequence 
for the generation of hypochlorous acid (HOCl) is summarised in Equation 2.6.1. 
 
 2	Cl! ⇌	Cl" + 2e! 
Cl" +	H"O	 ⇌ HOCl + HCl 
…Eq. 2.6.1 
 
An example of this was completed by Sandvik et al. (2013) where the team studied the effect 
of direct electrical current in the viability of S. epidermidis and P. aeruginosa – both known 
biofilm-forming microorganisms found in catheters (232). The bacteria were grown in a 
bioreactor containing normal saline concentration of sodium chloride and were exposed to 
current for 24 and 20 hours, respectively. A log reduction of up to 6.7 log10 CFU/cm2 was 
recorded and no significant difference was found between the presence and absence of 
ciprofloxacin antibiotic (232). Additionally, the team found a significant positive correlation 
between current density and generation of free chlorine which is likely the primary 
contributor to the effectiveness of direct current in diminishing bacterial growth (232). 
Although the efficacy of this involves saline solution and thus would be useful for catheter 
systems, Sandvik et al. (2013) state that free chlorine would have cytotoxic adverse effect to 
surrounding tissues (232) and can also possibly affect the catheter material. Therefore, designs 
must be made to ensure that its release, similar to reactive oxygen species, is localised only 







Figure 2.6.1 Bioelectric effect - a net negative surface charge repels bacterial attachment thus prevents biofilm 
formation. 
The co-application of surface repulsion and electrochemical production of localised 
antimicrobial compounds is an attractive method that could be incorporated into existing 
technologies. With the correct design and a non-antibiotic based biocompatible compound, 
electrochemical techniques have great potential for exploitation to control and inhibit 




The role of intravenous therapy and thus catheterisation are evidently imperative in modern 
healthcare settings. The importance of lifesaving indwelling devices is unquestionable, 
however, they can be a major source of nosocomial infections. The presence of 
contamination and biofilm formation hinders the functionalities of catheters. Consequently, 
healthcare associated blood stream infection poses a great threat to patient wellbeing as 
well as an added burden to healthcare providers.  
 
Without an effective diagnostic and preventative modality, and the continuously increasing 
lifespan of indwelling devices like central venous catheters, catheter-related bloodstream 
infection will unceasingly pose as a challenge in the healthcare industry. Although there is 
extensive research around various techniques and treatments for CRBSI, as summarised in 
Table 2.7.1, there is still an urgent and pressing demand for a potent novel technology that 
can eradicate planktonic and biofilm-forming microbes in order to completely reduce the risk 








Table 2.7.1 A summary of current practices and emerging technologies in the prevention of CRBSI. 
Method Advantage Disadvantage 
Catheter removal Completely removes risk of CRBSI 
Not always viable; requires plenty of 
resources 
Blood culture 
Determines cause of infection allowing 
correct CRBSI management to occur 
Not easily and readily accessible; 
doesn’t prevent CRBSI 
Antibiotic treatment Readily available and eliminates bacteria 
Expensive; may lead to microbial 
resistance; not capable of fully 
eradicating biofilm-forming pathogens 
Hand hygiene / 
aseptic technique 
Easy to do and reduces risk of infection 
from healthcare personnel/patient 
Inefficient 
Catheter type and 
insertion sites 




Effectively lowers rate of infection 
Only effective for up to 14 days; 
expensive; can lead to antibiotic 
resistance 
Lock solutions 
Proven to eradicate biofilm-forming 
bacteria and fungi 
Requires long-term catheters to be 
locked for up to 14 days; spillage may 
lead to other morbidities; can become 
source of antibiotic resistance; some 
solutions are only effective for certain 
microorganisms 
Plumbagin 
Does not require antibiotics and 
completely eradicates planktonic 
microorganisms and biofilms 
Can cause cancer 
Iodinated alcohol 
filled-catheter hub 
Inhibits pathogen contamination at 
commonest source prior to entering the 
main catheter line 
Contradicting efficacy results  
Smart central 
venous port 
Rapid and easy method of detecting the 
onset of biofilm formation 
Lacks therapeutic requisite of a smart 
catheter system 
 
The primary aims are therefore to produce a rapid and efficient system to not only reduce 
financial costs, but more importantly, to improve patient outcome without numerous 
professional healthcare interventions. It is widely acknowledged that the presence of a 
biofilm would inadvertently modify the local environment’s pH as a result of pathogen 
metabolism. It is therefore envisaged that pH could be effectively exploited as a potential 
indicator of contamination within the catheter system. Although there are many pH sensitive 
modifiers/sensors, the issue lies in securing a biocompatible redox probe whose analytical 
signals are devoid of interferences that would normally hinder existing pH sensors.  Ideally, 
the probe would not only monitor the line, but can also eradicate biofilm formation through 
the release of reactive oxygen species via the electroreduction of oxygen.  The aim of this 






whose redox characteristics are pH dependent and whose monomers/oligomers are 
biocompatible, which means leaching wouldn’t become problematic. Additionally, it has the 
dual capability of electro-generating reactive oxygen species to actively combat pathogen 
contamination. Equally as important, the suggested system could be easily integrated into 


















The following section will provide information regarding the materials, methods and 
instruments used throughout the project. It will detail the underpinning reason for using 
certain techniques, their meaning and influence, as well as the analysis of data obtained. 
Broader discussions of specific experimental details are detailed in the appropriate individual 







3.1 Materials and Instrumentation 
 
In general, the majority of the chemicals were purchased from Sigma-Aldrich (UK), were the 
highest grade available and were used without further purification, unless stated otherwise. 
Stock solutions of custom synthesised phenol flavin derivative and riboflavin (typically 250 
µM) were dissolved with methanol and acetone. Britton-Robison (BR) buffers (0.04 M acetic, 
boric and phosphoric acids), with the addition of concentrated sodium hydroxide to adjust 
pH to desired value, were used to prepare all other solutions unless specified otherwise. A 
concentration of 0.1 M potassium chloride completed all BR buffer solutions which supplied 
ample electrolytes and defined potentials of pseudo-references. All solutions were prepared 
with deionised water from an Elgastat water system (Elga, UK). Total parenteral nutrition 
was provided by ITH pharma (London, UK). 
 
Electrochemical analyses were completed using a µAutolab Type III potentiostat (Eco-
Chemie, Utrecht, The Netherlands) at room temperature (22°C ± 2°C). A standard three-
electrode system was generally employed with platinum wire as the counter electrode and 
a conventional silver/silver chloride half cell (3 M KCl, BASi, UK) serving as reference 
electrode. A range of materials acted as the working electrode throughout this work namely: 
carbon fibre mesh (Toray, TGP-H-30/TGP-H-60), glassy carbon, carbon-loaded polyethylene 
and carbon-based screen printed electrode. In instances where a two-electrode 
configuration was utilised, silver/silver chloride deposited onto carbon-based electrode 
acted as both the reference and counter electrode. Additional experimental details are 
specified in each chapter. 
 
3.2 Electrochemical Instrumentation 
 
Electrochemistry centres around the movement of electrons between the working electrode 
and electrolyte solution, driven by chemical processes.  The qualitative and quantitative data 
provided by the resulting electric response also provides an insight to the kinetics and 
thermodynamics of the chemical reaction that occurred.  In this instance, electrochemistry 
is exploited to indirectly detect the presence and, ultimately the eradication of 
contaminating microorganisms as a means of reducing catheter-related bloodstream 
infection. This is achieved through the use of redox probes capable of undergoing oxidation 







The rising popularity of electrochemistry in the field of medicine, along with other industrial 
areas, is explicable for a myriad of reasons. For instance, it offers a quicker and cheaper mode 
of analysis in comparison to traditional laboratory methods such as spectroscopy. It also 
facilitates a straightforward modification method of electrode surfaces which may be 
necessary to increase their sensitivity, selectivity, efficiency and/or practicality. Additionally, 
the flexibility and compatibility of electrochemistry, in terms of being able to use different 
types of electrodes, regardless of size, cost, application etc., amplifies its advantages over 
current methods used as well as its applicability to a variety of fields.  
 
3.3 Electrochemical Cells 
 
A three-electrode system is generally used in electrochemical analyses. This is composed of 
a working electrode (WE), a counter electrode (CE) and a reference electrode (RE). The 
potential applied to a working electrode is controlled by a potentiostat and is a function of 
the reference electrode’s fixed potential.  Each type of electrode is further discussed in the 
following sections. A potentiostat is used to control the electrode system, specifically the 
voltage difference between the working and reference electrode and is a critical instrument 
in most electroanalytical experiments. The reader is directed to more comprehensive texts 
for information on the instrumentational and operational characteristics inherent to 
potentiostat design (233–236). 
 
3.3.1 Working Electrode 
 
In electrochemical analyses, the working electrode is the main point of interest as this is the 
site of all significant electrochemical reactions. Although the WE can be a plethora of 
compositions/configurations depending on requirements (e.g. potential window, catalytic 
functions, stability, cost, size), a common characteristic of a working electrode is its relative 
inertness allowing for the transfer of electrons from the induced redox reactions.  Some 
examples are gold, carbon, graphene and palladium. Exceptions to this rule are copper and 
nickel electrodes whose surface oxidation within the electrolyte results in catalytic species 
(i.e. CuO, NiO) that can further catalyse the oxidation of other analytes (i.e. carbohydrates) 







Different materials can lead to different electrochemical responses but, in the context of 
electroanalytical applications, a material with fast electron transfer kinetics is generally 
preferred as a working electrode (235,237,239–241).  It is also a necessity that the WE’s surface is 
clean and its surface area is clearly defined as these affect the resulting response. Depending 
on the electrode used, the surface may be cleaned through polishing and may also be 
modified electrochemically to enhance the signal response i.e. via anodisation, or to 
decrease the potential required to initiate a reaction (235,242–245). Steps ensuring result 
reproducibility and repeatability is also a must.  
 
3.3.2 Reference Electrode 
 
Regardless of whether the electrolytic set-up is a two- or three-electrode system, a reference 
electrode is compulsory. The reference electrode’s function is to provide a stable, constant 
potential which is used to monitor the working electrode’s potential. There are three 
common types of reference electrodes used in aqueous solution: standard hydrogen, 
saturated calomel and silver/silver chloride (Ag/AgCl) electrode. This study uses a Ag/AgCl 
reference electrode and hence will be discussed further. Silver/silver chloride half cell 
reference electrodes are composed of a silver wire coated with silver chloride, encased in a 
glass cover typically filled with 3 M potassium chloride (KCl) solution. The KCl solution 
provides a stable environment, maintaining the constant potential of the reference 
electrode. Generally, reference electrodes have a potential independent of the electrolytic 
solution in the cell and is separated from the solution through a porous junction that is 
typically made from ceramic (i.e. Vycor®). The frit acts as a barrier restricting the transport 
of chloride ions from the internal solution to the sample matrix and, similarly, any 
contaminants from the latter into the sheath. Crucially it allows electrical conduction 
between electrode and solution. A typical Ag/AgCl reference electrode assembly is displayed 








Figure 3.3.1 Configuration of a conventional silver/silver chloride reference electrode. Adapted from (245). 
 
Reversible redox reactions occur within the cell at a fast rate allowing the rapid adjustment 
to changes in ionic activity in the working solution. The maximum difference between redox 
potentials is called the electromotive force (emf). Alongside the standard potential, the 
convention of emf is used to allow the computation of cell potentials from two half cell 
reactions to be easier and more straightforward. The relationship between the 
electrochemical cell potential, the relative redox activities and the standard potential in a 
cell reaction is mathematically expressed by the Nernst equation (Eq. 3.1). In a one-electron 
transfer, as in that occurring in a RE, n is set to 1 and the oxidation/reduction activities are 
replaced with their more experimentally accessible concentrations. It is important to note 































𝐸 = 𝐸# − 	0.05916 ∗	 log[𝐶𝑙('()! ] 
…Eq. 3.1 
where: 
E = electrode potential 
E0 = standard electrode potential 
R = gas constant (8.314 JK-1 mol-1) 
T = temperature (298.15 K) 
n = number of electrons transferred to electrode during reaction 
F = Faraday constant (96485 C mol-1) 
[A] and [B] = activities of the oxidised and reduced species, respectively. 
 
From the equation above, the electrode potential due to the redox reaction occurring in a 
silver/silver chloride reference is solely dependent on the chloride ion concentration 
(assuming temperature is held constant). Hence, to maintain this directly proportional 
relationship, the employment of a stable, concentrated (typically 3 M) KCl solution is an 
integral part of the reference electrode system. 
 
3.3.3 Counter Electrode 
 
The ability of the reference electrode to quickly adjust to changes in ionic activity leaves it 
vulnerable to damages caused by large current densities and susceptible to losing their ideal, 
non-polarizable characteristics (235). To prevent this, a three-electrode system is commonly 
used whereby a third electrode, the counter or auxiliary electrode, is added to the 
configuration. By doing so, current caused by the potential application to the WE to initiate 
analyte reduction or oxidation, will flow through the counter instead of the reference 
electrode thus completing the electrical circuit. As such, the flow of electrons between the 
two electrodes defines the corresponding current. An opposite reaction to that occurring in 
the working electrode transpires in the CE (i.e. if oxidation occurs at the WE, reduction occurs 
at the CE and vice-versa), therefore it is imperative that the CE is inert against the reactions 






deter the inhibition of the reaction kinetics occurring in the former to those happening in the 
latter. Platinum-based electrodes are typically used as the CE within laboratory-based 
systems due to their inertness and high conductivity but carbon is frequently used in 
disposable screen printed systems where cost is an over-riding factor. For experiments 
producing large currents and to inhibit the generation of by-products from certain 
experiments, the counter electrode may be isolated in a separate cell and adjoins the circuit 
via a glass frit (235,245). 
 
3.3.4 Buffer Solutions 
 
A high concentration of supporting electrolyte(s) in an electrochemical cell is required to 
increase solution conductivity, limit analyte movement via migration, and attain charge 
balance which decreases solution resistance to charge transfer. Therefore, this allows 
electrochemical reactions and measurements to be recorded. Buffer solutions, such as 
Britton-Robinson (BR) buffers used in this work, provide sufficient electrolytes and are also 
inert allowing the detection of the electroactive species of interest. The use of buffer solution 
also minimises the change in local pH of the electrode surface caused by chemical processes 
where hydrogen ions (H+)/hydroxides (OH-) are generated or exhausted. Rearrangement of 
the Nernst equation to establish the change in potential due to the log change of H+ 
concentration (1 pH unit) is displayed in Eq. 3.2 below (all characters represent their common 
meaning as displayed previously). This shows that under standard conditions, a 59 mV 
potential shift should be seen per pH unit. If a process acts in such a way, it is said to have a 
Nernstian behaviour.  
 
𝐸 = 𝐸# +	
2.303𝑅𝑇
𝑛𝐹




𝐸 = 𝐸# + 0.05916V ∗ 𝑝𝐻 
…Eq. 3.2 
 
3.4 Mass Transport Mechanism 
 
A typical electrochemical reaction involves the interaction between electrode and 
electrolytic solution. Although the potential difference within the cell affects the electrolysis 






surface also plays a major role in influencing the rate of reaction. Such movements are 
categorised into three types of mass transport: diffusion, convection and migration. Details 




Most electrochemical experiments rely on molecular movement through diffusion. In fact, 
this is the only mode of transport that is included in theoretical treatments and modelling 
(245). Diffusion occurs when there is a concentration difference between two points in a cell, 
causing the movement of electroactive species from an area of high concentration to a low 
concentration area. For instance, diffusion arises at electrode surface where the 
concentration of the analyte is less than in the bulk solution, and vice versa in terms of 
chemical reaction product, leading to a concentration gradient (Figure 3.4.1). Therefore, 
diffusion pushes the original material from the bulk solution towards the electrode surface 
and simultaneously moving the resulting product away from the electrode. Diffusion is 
defined by Fick’s first law of diffusion as highlighted in Eq. 3.3. 
 
 


















𝐷*   = diffusion coefficient (cm2/s) of particle 𝑖 
+,!
+-
 = concentration gradient at distant 𝑥 
 
Additionally, Fick’s second law (Eq. 3.4) describes the change of concentration due to 
diffusion with respect to time. This now describes the relationship between concentration, 











In electrochemistry, convection is the hydrodynamic transport of particles in a solution via 
natural source i.e. heat, or mechanical forces such as stirring or vibration or through density 
gradients. It can also be induced through ultrasound where acoustic streaming and cavitation 
induce forced convection at the electrode – a topic covered in Chapter 4. If mechanically 
induced, convection precedes all other mode of mass transport. Figure 3.4.2 displays the use 
of a stirring rod in a solution and the effect of convection.  
 
 









Migration is the movement of ionic solutes as a result of a localised electric field, i.e. 
positively charged particles are attracted to negatively charged electrode and vice-versa. The 
application of potential to a solid electrode in an ionic solution changes the charge migration, 
as exemplified in Figure 3.4.3. The effect of migration in electrochemical analysis is reduced 
by the employment of solution containing highly concentrated inert analyte. The relatively 
higher concentration of electrolyte to analyte increases the statistical probability that the 
electrolyte will migrate and transport the charge to the electrode surface, thus leaving the 
electrochemically active species preserved and unaffected by migration.  
 
 
Figure 3.4.3 A simplified diagram of charge migration change as result of potential application. 
  
3.5 Electrochemical Techniques 
 
A variety of electrochemical techniques are available including voltammetry, amperometry 
and potentiometry. These methods are used throughout the project and will be further 
discussed in the following sections. Voltammetry is a common technique whereby a varying 
potential is applied to the working electrode and the current response due to the chemical 
reaction occurring at the electrode is measured. A voltammogram is used to display the 
relationship of current against voltage. Similar to voltammetry, amperometry is an 
electrochemical method wherein the corresponding current is quantified as a consequence 
of a fixed potential being applied to the working electrode instead. Finally, potentiometry is 
a technique where the potential difference between working and reference electrode in a 






throughout out this study is the computer-controlled µAutolab Type III potentiostat (Eco-
Chemie, Utrecht, Netherlands). 
 
3.5.1 Cyclic Voltammetry 
 
One of the most prominent electrochemical techniques used to characterise the oxidation 
and reduction processes of an electroactive species is cyclic voltammetry (CV). It is a simple, 
quick and efficient method which provides sensitive and qualitative analysis of 
electrochemical behaviour or composition of the molecule of interest.  This method imposes 
a potential on the working electrode which is swept linearly in a triangular form as in Figure 
3.5.1A. The starting potential, E1, is usually set where no chemical process at the electrode 
occurs and is then linearly swept at a constant rate to the second potential, E2. The latter 
potential is typically selected to be greater than the potential required to induce the 
oxidation or reduction of the analyte under investigation to ensure the required reaction is 
recorded. In linear sweep voltammetry, the scan terminates at this point however in CV 
scans, the potential is linearly swept in the reverse direction and ends at the starting 
potential E1. The anodic trace is drawn when the potential is swept positively from E1 to E2 
and reversely, the cathodic trace is defined by the negative linear sweep from E2 to E1. The 
trace resulting from this process is called a voltammogram or cyclic voltammogram. The 
resulting current is plotted as a function of the applied potential as in Figure 3.5.1B.  
 
 
Figure 3.5.1 Typical A) triangular waveform and B) cyclic voltammogram trace produced in cyclic voltammetry. 







As the potential is swept in the anodic direction, the rate at which the electroactive species 
of interest oxidises increases and the resulting current exponentially increases with the 
commencement of electron transfer. At the electrode surface, the concentration of the 
oxidised form of the analyte (Oxa) increases throughout the forward scan and builds a 
growing diffusion layer which slows down the mass transport of the reduced form of the 
analyte (Reda) to the electrode. Points X and Y represent the instants where there is equal 
balance between increased Oxa concentration and the exhaustion of Reda near the electrode 
surface, and vice-versa respectively, thus satisfying the Nernst equation E = E1/2.  At a certain 
potential (Epa) the increase in current reaches a maximum and this is called the peak anodic 
current. Beyond this peak, the resulting current relies on the diffusion of additional Reda from 
the bulk solution as a result of the concentration gradient. Simplistically, the magnitude of 
the current depends on the rate at which ‘fresh’ material can diffuse through to the electrode 
surface instead of electrode kinetics. As the scan continues to more positive potentials, the 
current decreases as the distance to transport Reda to the electrode surface increases due 
to the aforementioned diffusion layers hence decreasing the rate of diffusion (Epa® E2).  
 
When the vertex (switching) potential (E2) is reached, the direction of the scan is reversed 
towards less positive potentials. During the reverse scan, the kinetics of reduction becomes 
more favourable and essentially converts the product generated at the surface of the 
electrode back to the original form, in this case from oxidised to reduced form. The reverse 
sweep completes the voltammogram and can be explained in the opposite direction but 
analogous to that described for the forward scan. 
 
A wealth of diagnostic information can be obtained from the shape of the CV trace – starting 
with defining the reversibility of the system. Figure 3.5.2 displays a variety of the more typical 
voltammetric traces that can be observed. The electron transfer kinetics between the 
electrode and analyte defines the electrochemical reversibility of the system. If there is little 
to no barrier of electron transfer, electrochemical reversibility occurs, and the Nernstian 
equilibrium is established immediately upon any potential change. On the other hand, if a 
system is quasi-reversible, it means that a greater positive or negative potential, often 
termed an overpotential, is required to induce oxidation or reduction, respectively, leading 
to an elongated CV trace. Similarly, an electrochemically irreversible system means that a 
larger overpotential is required to induce redox reaction. The CV trace of such systems 






is at all visible). This shows that the electron kinetics are insufficient to maintain the 
equilibrium of redox species. It is also important to note that in the absence of electroactive 
species, no peaks are visible and only the capacitance background is observed.  
 
 
Figure 3.5.2 Cyclic voltammograms displaying different types of electron transfer systems. 
 
For a system to be classified as electrochemically reversible, the following characteristics 
must be followed: 
 
• The potential difference between the anodic and cathodic peak (peak-to-peak 
separation, ΔEp) must equal to 
./	
1
 mV, where n is the number of electrons transferred 
during chemical reaction, independent of scan rate; 
• The ratio between anodic and cathodic peak currents must equal to 1; 
• And finally, the peak currents must be directly proportional to the square root of 
scan rate.  
 
An important parameter to consider is the scan rate, ʋ, as it controls the speed at which the 
applied potential is scanned. Typically, higher resultant currents are detected with faster 
scan rates as this decreases the diffusion layer size. Additionally, the flux of electrons, and 
thus the current to the electrode surface increases with scan rate leading to a greater current 






describes whether an electrochemically reversible system involves a freely diffusing analyte 
or if the electroactive species is adsorbed on to the surface of the electrode. This correlation 
is mathematically expressed by Randles-Ševčik equation (Eq. 3.5). 
 







where, under standard conditions: 
n = number of electrons transferred 
F = Faraday constant (96485 C mol-1) 
A = electrode surface area (cm2) 
C0 = concentration (mol cm-3) 
ʋ = scan rate (V s-1) 
Do = diffusion coefficient of the oxidised analyte (cm2 s-1) 
R = gas constant (8.314 J K-1  mol-1) 
T = temperature (298.15 K) 
 
If the electroactive species is adsorbed on to the surface of the electrode i.e. not diffusion-
limited, the derived current will have a linear relationship with scan rate. In this case, the 
analyte’s surface concentration (Γ,), in mol cm-2, can be calculated from Eq. 3.6 where all the 








3.5.2 Square Wave Voltammetry 
 
Similar to cyclic voltammetry, square wave voltammetry (SQWV) records the current as a 
function of the linearly swept potential applied to the working electrode. The main 
difference is that the potential imposed in SQWV is swept in time over a set span of values 
by using a voltage ramp with a staircase shape instead of the triangular fashion that occurs 
in CV. In a square wave cycle, the current is measured twice, once at the end of the forward 
step direction and then again at the end of the reverse step direction, which consequently 






of the analyte under investigation (247). Simplistically, the resulting current (ΔI) is calculated 
as the difference between the currents at the end of the forward pulse and at the end of the 
reverse pulse of each staircase step (Figure 3.5.3A) which is then plotted against the sweep 
potential to display a peak-shaped voltammogram (247), as illustrated in Figure 3.5.3B. The 
time to complete one staircase or square wave period is expressed as τ and the frequency in 
Hertz (Hz) is calculated as the reciprocal of τ. The two characteristics that determines a 
square wave are amplitude (Esw), where 2 Esw is the peak-to-peak amplitude, and width of 
the pulse (tp). The scan rate, in mV/s, for this electrochemical technique can be calculated by 
dividing the step height in mV (ΔE) by the square wave period in seconds. 
 
 
Figure 3.5.3 Voltammetric profiles highlighting the A) staircase shape and B) resultant square wave 
voltammogram. Adapted from (246). 
 
It is noteworthy that the peak height/current of the resulting voltammogram is proportional 
to the concentration of the electroactive species in the solution, as mathematically 
















∆𝑖5 = differential peak current (A) 
t5  = pulse width (s) 
∆ψ5 = dimensionless peak current 
and all other symbols have their common meaning.  
 
The main advantage of square wave voltammetry in comparison to CV is its ability to 
discriminate or minimise the influence of capacitive current on the total current reading (247). 
Since current is recorded twice in each square wave pulse, there is a miniscule (a few 
milliseconds) but significant delay in current measurement. This delay allows the immediate 
reorganisation of ions at the electrode surface, attributable to potential changes at electrode 
surface, to be completed before measuring the current which leads to low capacitance 
current. In SQWV, the current due to electron transfer between analyte and electrode, 
known as the Faradaic current, is largely measured while in CV the sum of both Faradaic and 
capacitance current is recorded. Generally at trace (µM or less) levels of analyte, the former 
current tends to be overpowered by the capacitance background and hence greater 
concentrations of the analyte is required in CV than in SQWV. Subsequently, the ability to 
dissipate capacitance allows fast analysis of a myriad of electrochemically active species 
leading to a technique with higher sensitivity and hence a much improved detection limit 
than cyclic voltammetry. Furthermore, this technique eliminates the need to remove oxygen 
in the solution, unless it interferes with the chemical reaction, as the oxygen has no time to 
diffuse to the surface of the electrode.  
 
It is important to note that capacitive charging currents are due to the accumulation of ions 
at the electrode surface caused by the electrochemical reaction (248). These ions and the 
electrode’s charged surface forms a double layer, or capacitor, which stores a charge 
depending on the potential applied (248). In electrochemical techniques like CV or SQWV 
where the potential of the electrode is swept, and therefore changes continuously 
throughout the scan, the charge accumulated by the capacitor also changes and current with 
no chemical meaning flows through (248). This capacitive charging current charges or 






the significant delay in current measurement allows the dissipation of capacitance current 




Amperometry involves stepping the potential of the working electrode from a potential 
where no reaction takes place to a second potential which is then fixed and remains constant 
for a specified amount of time as exhibited by Figure 3.5.4A. The latter potential is chosen 
to induce the redox reaction of the electroactive analyte(s). Figure 3.5.4B demonstrates a 
typical amperometry profile showing the variation of current produced in response to time 
and the resulting change in concentration gradient is shown in Figure 3.5.4C. 
 
 
Figure 3.5.4 Common amperometric parameter profiles: A) potential and B) current as a function of time. C) 
Influence of time and distance to electrode surface on the concentration gradient of analyte. Adapted from (246). 
 
This technique reveals the change in concentration gradient around the electrode surface 
which is useful in determining physical factors of the electrochemical system of interest such 
as diffusion coefficients and electrode surface area. The large potential shift driving the 
reaction causes a variation in the analyte’s concentration at the electrode surface thus 
generating a concentration gradient which, in turn, leads to its diffusion from the bulk 
solution towards the electrode and ultimately expanding the diffusion layer with time. The 
reduction of analyte flux towards the electrode along with the growing diffusion layer 
decreases the current density thus explaining Figure 3.5.4B. The difference in analyte 
concentration with respect to time is explained by Fick’s second law of diffusion (Eq. 3.4). 
Derived from this law, the Cottrell equation (Eq. 3.8) mathematically expresses the current 






step methods such as chronoamperometry. To use this equation however, the current must 








Where ‘a’ correlates to the analyte of interest and all other characters represent their 




Another popular electroanalytical technique used is potentiometry. This method measures 
the working electrode’s potential as a function of time relative to the reference electrode. In 
contrast with previously discussed methods, potentiometric measurements occur under 
zero net current i.e. no current flow in the cell. As such, there is no change in the 
arrangement and composition of the electrochemically active compound therefore 
quantitative potential measurements can be recorded which exhibits the activity of the 
analyte near the surface of the electrode. Potentiometry is used in this project to 
characterise the pseudo reference electrodes. In such cases, the scan is conducted over a 
period of 180 seconds during which the potential is allowed to stabilise and then the average 
value of the concluding ten seconds of the scan is typically recorded. In general, such scans 
are conducted for various concentrations of analyte (typically chloride ion or hydrogen ion) 
and the average potential plotted against the log of the concentration in accordance with 
the conventional Nernst type relationship normally used with ion selective electrodes (235,247).  
 
3.6 Characterisation Methods 
 
Throughout this work, a variety of techniques were used to characterise the physical, 
chemical and surface attributes of the electrode/system of interest. The following section 









3.6.1 Scanning Electron Microscopy 
 
Invented by Manfred von Ardenne in 1937, a scanning electron microscope (SEM) is a 
ubiquitous and powerful magnification tool which produces a high-resolution image of solid 
samples through raster scanning the surface with a demagnified, high energy focused beam 
of electrons - instead of light that is traditionally used. The electrons interact with the atoms 
on the specimen’s surface allowing the generation of signals detailing the morphology and 
topography of the sample under investigation. Figure 3.6.1 displays a typical configuration 
of a SEM and the electron’s route of travel to the specimen surface. The SEMs used in this 
project are the SU5000 FE-SEM (Hitachi, Japan) and JSM-6010 (Jeol Ltd., Japan). 
 
 
Figure 3.6.1 Simplified schematic diagram of a typical scanning electron microscope. Adapted from (249). 
 
The major components of a SEM are the electron source, the column with electromagnetic 
lenses where electrons travel through, electron detector, sample chamber and the output 
display screen. Electrons are produced at the top of the column using an electron gun 
equipped with a tungsten source filament which is employed as a cathode. Tungsten is 
typically used in this application due to its low cost and highest melting point in comparison 






generating the electrons which then accelerate downwards to the anode through lenses and 
apertures. As the name suggests, the sample stage inside the chamber holds the sample of 
interest and, once the SEM is in operation, the sample is kept under vacuum within the 
column and chamber. With the additional use of scanning foils, the incident electron beam 
is focused towards the target allowing the beam to interact and scan over the surface of the 
sample.  
 
Upon being decelerated on the surface of the specimen, the kinetic energy of the electrons 
dissipates thus leading to the emission of a range of electrons (secondary, backscattered and 
Auger electrons) and X-rays. Through the inelastic collision between the electron beam 
(primary) and the electrons in the outmost shell of the specimen’s atoms, an energy transfer 
occurs leading to the excitement and ejection of loosely bound secondary electrons. Within 
the scanned region, the signal intensity of secondary electrons is dependent on surface 
morphology and topography thus giving information on such characteristics of the sample’s 
surface. On the other hand, backscattered electrons are produced from the elastic scattering 
of the interaction. The signal it produces are used to determine the atomic number, and 
hence the element, as the absorbance of backscattered electrons increases with atomic 
number. The beam of electrons can also excite an electron in the inner shell of the sample’s 
atoms causing the emission of X-rays. Upon doing so, the higher energy electron is forced to 
replace the detached electrode leading to energy emanation. This energy is then taken up 
by another electron, called an Auger electron, which is also released from the atom. The 
combination of X-ray and Auger electrons provide valuable data regarding the profusion of 
elements and superficial composition of the specimen of interest. The released signals are 
then identified by their respective electron detectors and an image is produced.  
 
Samples under investigation must be conductive as electrons are used to produce signals 
which means that charging could occur if an insulated material was employed. To avoid the 
latter, sputter coating of conductive metals (i.e. gold, gold/palladium and carbon) onto the 
specimen are typically completed. Additionally, it is common sense, but vital, that the sample 
should be able to withstand being under vacuum over a period of time. It is also notable that 
the collisions between beam and sample do not cause sample volume loss, thus the same 








3.6.2 X-Ray Photoelectron Spectroscopy 
 
Spectroscopic methods are dependent on the interaction between the sample and 
electromagnetic radiation. An example of this is X-ray photoelectron spectroscopy (XPS) 
which involves the use of a primary radiation source, an electron energy analyser, the sample 
under investigation and an ultra-high vacuum sealed chamber encasing the system (250).  
Often, in addition to emitted photoelectrons, XPS analysis also instigates Auger electron 
emission and as such, both can be detected and measured in the same analytic instrument 
therefore basic principles of both will be summarised here. The XPS system used in this 
project is the Axis Ultra DLD Spectrometer (Kratos Analytical Ltd., UK).  
 
As the name suggest, X-ray photoelectron spectroscopy involves the irradiation of the 
specimen being studied with X-ray photon energy. This energy must be sufficiently high to 
induce electron excitation, break surrounding attraction forces of the element and thus 
electron photoemission from the core bound state. Upon impact between X-ray and sample, 
some of the ejected electrons are inelastically scattered throughout the sample towards the 
surface whilst other electrons are promptly emitted into the vacuumed environment without 
energy loss (Figure 3.6.2). The kinetic energy of the freely ejected electrons is then collected 
and analysed by an electron energy-selective analyser, constituting the characteristic peaks 
found in XPS spectra. Conversely, excited electrons which suffered energy loss from inelastic 
scattering contributes to the spectra’s background.  
 
 







The kinetic energy of electrons measured by the spectrophotometer is dependent on the 
incident X-ray photon energy and therefore does not determine the intrinsic characteristics 
of the sample under investigation. The binding energy of the electron however provides 
specific information about the electron including its atomic energy level and thus identifying 
its parent element (250).  The relationship between the parameters involved in XPS are 
expressed in Eq. 3.9. Apart from the binding energy, all other factors are either known or 
measurable. 
 
E7 = E5 − E8 − 	∅ 
…Eq. 3.9 
where: 
E7 = binding energy of electron 
E5 = incident X-ray photon energy 
E8 = kinetic energy of electron 
∅ = spectrometer work function 
 
Upon the liberation of core-level electrons, the newly ionised element must restore back to 
its ground state. To do so, two possibilities can occur: X-ray photon emission, known as X-ray 
fluorescence, or Auger electron release. The latter happens when a higher energy level 
electron replaces the emitted core-level electron. Confirming with the conservation energy, 
the ejection of another electron from the atom ensues leading to Auger electron release. An 
estimated value of the kinetic energy of Auger electrons can be calculated as the difference 
between the energy levels of the outer electrons and the energy of the core hole left by the 
primarily emitted electron. This kinetic energy is independent of the incident beam energy 
or composition thus generating important quantitative chemical data about the atoms 
present in the studied specimen.  
 
A typical XPS spectrum is displayed as a graph of intensity against binding energy of the 
photoemitted electrons. Individual energy peaks seen on an XPS spectrum are directly and 
uniquely related to a specific elemental core level transition, occurring at a specific binding 
energy, therefore is useful for specifically determining elements present in the material 
examined. Additionally, the peak intensity and peak area produce quantitative data 
regarding individual elements and number of atoms in each element, respectively. Through 






state of the elements existing in the specimen can also be verified. Additionally, the slight 
shift due to photo-ejection of electrons from core levels provides information on the outer 
valence configuration of the sample. Moreover, the type of bond (i.e. single or double bond) 
connected to individual elements can be determined through analysis of each XPS peak. As 
such, XPS is a valuable analytical surface characterisation technique which determines not 
only the elements present in the sample but also the elemental bonds. 
 
3.6.3 Raman Spectroscopy 
 
Another spectroscopic method used in this project is Raman spectroscopy - a technique 
based on the frequency difference of the scattered radiation from the incident (primary) 
radiation, caused by the inelastic collision between the latter and the sample’s vibrating 
molecules, also known as the Raman effect (Figure 3.6.3A). This change, and thus the Raman 
shift, is unique to the molecule that produced it and hence useful for analytical purposes. It 
is a non-destructive method to characterise crystalline, nanocrystalline and amorphous 
carbons (252). The Raman spectra in this project were obtained using a LabRAM 300 
spectrometer (Horiba, Japan).  
 
Raman spectroscopy involves the use of a monochromatic laser beam, in this case Helium-
Neon laser, to produce the incident light. After its interaction with the molecules on the 
material, most radiation scatters with the same wavelength, and hence frequency, as that of 
the primary radiation which constitutes Rayleigh scattering. Only a small fraction of scattered 
radiation has Raman effect properties. With regards to electrons, the absorbance of energy 
from the incident photon causes them to rise to a virtual energy state and then falls back to 
a vibrational state as they lose energy. If the electrons return to their original vibrational 
state, these correspond to Rayleigh scattering, otherwise it is Raman scattering.  Stoke lines 
in Raman spectra are produced when the incident radiation has a higher frequency than the 
scattered radiation whereas anti-Stokes lines are generated if the opposite happens, as 








Figure 3.6.3 A) Types of radiation and B) corresponding electron energy levels attributed to Raman 
spectroscopy. Adapted from (253,254). 
 
Conventional Raman spectroscopy primarily focuses on Stoke bands as these have higher 
intensity than anti-Stokes since it involves shifting from lower to higher energy states. The 
latter is used more with fluorescent samples as anti-Stoke lines are not affected by 
fluorescence while Stoke lines are. Of note, for a molecule to be Raman active, its charge 
distribution must able to distort from its norm upon the application of an external force, in 
simple terms its polarizability must change during molecular vibration.  
 
Generally, Raman spectrometers use mirrors and lenses made with glass as optical 
components. Additionally, filters are used to isolate and focus the single laser beam whilst 
different types of notch filters and grating monochromators separate weak Raman radiation 
from Rayleigh radiation. The scattered photons are then converted into charge and detected 
by an array of charge transfer devices such as charge-coupled devices. The produced Raman 
spectrum is displayed as intensity against the shift in wavelength. Depending on the 
configuration of the spectrophotometer used, the spectra can cover wavenumber ranges of 
400-5 cm-1 and 4000-3800 cm-1 thus allowing the detection of Raman induced molecular 
vibrations which transpire between 4000-400 cm-1 (255).  
 
Disordered graphite typically generates a Raman spectrum consisting of two sharp modes: D 
peak (around 1350 cm-1) and G peak (1580-1600 cm-1). The former peak arises as a result of 
out-of-plane vibrations due to defects within the lattice structure and can therefore be used 
as an indicator of disorder. The G band on the other hand correlates to the graphitic in plane 
vibrations of sp2 bonded carbon atoms and is due to the C-C bond stretching. Raman 
spectroscopy is a sensitive technique used to characterise the disorder as well as to 
determine sp2 carbon systems. In the presence of impurities randomly dispersed in the 






peak and D’ peak (1610 cm-1). This is explained by the interaction between the extended 
phonon mode of graphene and the localised vibrational modes of impurities. The intensity 
ratio between the D and G bands (I(D/G)) corresponds to the number of defects present in 
the sample, i.e. higher I(D/G) means greater number of defects.  
 
3.6.4 UV-Vis Spectroscopy 
 
Ultraviolet-Visible spectroscopy (UV—Vis) refers to the study of absorption or reflection of 
light in the ultraviolet and visible range. Similar to previous methods, UV-VIS spectroscopy 
involves a light or electromagnetic radiation source (i.e. hollow cathode lamp such as 
tungsten lamp), a sample holder (i.e. quartz cuvette) and a detector. There are two types of 
absorbance spectrometers used in UV-Vis namely single beam and double beam. As the 
name suggests, the former uses a single beam of light which passes through the sample and 
a reference or blank scan must be measured prior to taking measurements to standardise 
and offset results attained from the absorbance of the sample cell and solvent/water. A 
reference solution is typically water or solvent used to dissolve the compound of interest. 
Alternatively, a double beam spectrometer splits the light beam into two so that one beam 
passes through a standard reference solution and the other through the sample thus 
eliminating the need for a blank scan. A monochromator is typically used between the light 
source and sample to isolate the spectral wavelength of interest as shown in Figure 3.6.4A. 
The detector then measures the energy absorbance of light. 
 
 
Figure 3.6.4 A) Schematic diagram of a typical UV-Vis spectrometer. B) Possible electron jumps caused by visible 







As the light passes through the sample, the electrons absorb light energy and are excited 
from a binding or non-binding state to an empty anti-bonding orbital (Figure 3.6.4B). Since a 
typical UV-Vis spectrometer works at a range between 200 – 800 nm range, only a limited 
number of electron jumps are possible (red lines) while some occur when electrons absorb 
light outside the wavelength range (black dotted lines).  The groups in a molecule which 
absorb light and therefore responsible for its colour are known as chromophores. 
Understandably, each jump needs a fixed amount of energy where bigger energy absorbance 
leads to a greater electron jump. Each wavelength, and thus frequency, of light corresponds 
to a specific energy value as detailed by Bohr-Einstein equation (Eq. 3.10).	Electrons that 
excite easier require lower energy meaning they absorb the energy from light with a longer 
wavelength or a lower frequency while the opposite occurs with larger orbital jumps where 






𝐸 = 𝐸" − 𝐸4 = ℎ𝑣 
…Eq. 3.10B 
where: 
𝑣 = frequency of light 
𝑐 = speed of light (2.998 x 108 ms-1) 
𝜆 = wavelength of light 
𝐸 = energy of light 
ℎ = Planck’s constant (6.626 x 10-34 Js)  
 
In a typical UV-Vis configuration, a scan ranges from 200 to 800 nm thus covering near 
ultraviolet and approaching near infrared wavelengths. This narrow range means only 
specific energy absorbance and thus electron jumps can occur. From Figure 3.6.4B the red 
lines indicate the possible jumps in the UV-Vis range and reveals that a molecule must 
contain either pi bonds or atoms with non-bonding orbitals (i.e. lone pair in oxygen). A 
standard UV-Vis spectrum displays absorbance (a.u.) value against wavelength (nm).  
 
Ultraviolet-Visible spectroscopy is ubiquitously employed in analytical environments, 
normally to gather concentration data of a particular compound. The relationship between 
absorbance and concentration of a molecule in a fixed path length (normally 1 cm) is 






concentration of analyte of interest are employed to generate standard calibration curve 
where change in absorbance is measured as a function of concentration. This is then used as 





= 	𝜀 ∗ 𝑐 ∗ 𝐿 
…Eq. 3.11 
where: 
A = absorbance (a.u.) 
I0 = intensity of incident light at a given wavelength 
I = intensity of transmitted light 
𝜀 = molar absorptivity of molecule/compound in solution (L mol-1 cm-1) 
𝑐 = solution concentration (mol L-1) 
L = pathlength (usually 1 cm) 
 
It noteworthy that individual types of bonds in a molecule are correlated to a specific 
absorption peak wavelength and can thus be used to determine the functional groups 
present in the molecule under study. However, UV-Vis absorption spectra can be affected by 
a myriad of variables including solution pH, temperature, effective slit bandwidth and the 
presence of interfering substances. As such, these factors must be controlled and accounted 
for first in order to produce qualitative data identifying the specific compound/molecule 
present in the sample. 
 
3.7 Surface Modification 
 
Electrochemical techniques were used throughout the project to improve electrode 
response and/or modify electrode surfaces. These methods are briefly described in the 
following sections and will be further expanded upon in corresponding chapters. 
 
3.7.1 Electrochemical Anodisation 
 
Enhancing electrode surfaces, and thus electrode responses, are often necessary in 
electroanalytical methods. An example method is electrochemical anodisation. This can be 






whereby the working electrode is submerged in 0.1 M sodium hydroxide (NaOH) solution 
and an oxidation potential of +2 V applied for a particular amount of time (typically between 
60 and 300 seconds). This results in an increase in oxygen functionalities at the surface which 
can also lead to changes in the crystal structure of the sample’s layers and its microscopic 
surface texture.  As such, this process creates more edge plane sites which can allow faster 
electron transfer kinetics thus improving electrode sensitivity and voltammetric response 
(210,243,258,259).  Where necessary, anodisation details are described for each type of electrode 
employed in each chapter. Chapter 4 will also further clarify the effects of anodisation as 




Electropolymerisation is a simple and efficient method to modify the surface of the electrode 
and therein change the properties and function of the sensor. This can be done to provide a 
permselective barrier against matrix interferences or to immobilise redox groups directly on 
the surface. In this project a flavin derivative functionalised with a phenol substituent was 
used as an electropolymerisable monomer through which to modify carbon-based 
electrodes. The electrochemical polymerisation is completed through inserting the working 
electrode in solution containing the required monomer and the application of potential or 
employment of cyclic voltammetry for a certain amount of cycles, which enables the 
oxidation of the phenolic group. This results in the formation of a film comprising of a non-
conductive polyphenylene backbone but with pendant flavin redox centres. This work is 













Effect of the Co-Application of Ultrasound and Electrochemical 







Modification of carbonaceous surfaces through electrochemical oxidation processes are well 
known to enhance the electrochemical properties of carbon electrodes. In this case, a 
detailed study on both the influence of anodisation alone and with the co-application of 
ultrasound during electro-oxidation was performed. Chronoamperometry (+2 V) was 
employed to initiate electrochemical modification and the effect of prolonged anodisation 
periods in both experiments was examined. Surface sensitive techniques (SEM, Raman, and 
XPS) as well as electrochemical methods were employed to determine the resulting 
disparities generated by the presence and absence of ultrasound during anodisation. 
Ultrasonic cavitation and acoustic streaming led to greater physical deterioration and 
achieved contrasting net changes in various carbon-oxygen surface functional groups 










The work presented in this chapter forms the basis of a publication in: 
Casimero C, Hegarty C, McGlynn R, Davis J. Ultrasonic exfoliation of carbon fibre: 








Carbon is one of the most ubiquitous electrode base materials used in electrochemical 
applications due to its versatility, extensive interfacial chemical properties, variance of 
physical form, and the electrodes which can be produced using carbon are relatively 
inexpensive and methodically simple to fabricate (260). Carbon electrode fabrication 
techniques, beyond using solid graphite, include: screen printing (261–264), drop casting (265–267), 
pyrolysis of polymers formed via electrospinning (268,269) and polyacrylonitrile (PAN) fibre 
extrusions processes (244,270,271). The interest in the latter, as well as other synthetic and bio-
based equivalents,  has been increasing over the last few years and is the commonest 
precursor (>90 %) in creating carbon cloth electrodes (244,272). These electrodes can be made 
up of woven, aligned or randomly intertwined matrices of carbon fibre whose unique 
properties (i.e. vast surface area, electrical conductivity, chemically inertness and macro 
porosity) offer many advantages in electroanalytical applications.  
 
Although carbon fibre systems possesses sufficient conductivity for some electrochemical 
applications, its unmodified form tends to have a relatively featureless surface and, as such, 
it is relatively common to modify the fibres via chemical, plasma or electrochemical methods 
to enhance electrode performance (243,244). Surface modification was originally envisaged 
from engineering perspectives intended to improve mechanical and structural 
characteristics aimed for high load bearing purposes (273,274). Such processes also generated 
a greater range of active functional groups and increased surface area that lead to 
augmented performance and adaptability of the carbon mesh when employed as an 
electrode. The effect of different surface modifiers and treatments along with their influence 
on electrode performance has been extensively reviewed (244,275–278) and, while there is a 
variety in technique, the end result typically involves surface oxidation which in turn 
amplifies the population and diversity of carbon-oxygen functional groups (242,275,279,280). 
Figure 4.1.1 summarises the various types of oxygen functionality typically generated 
through the oxidation of carbon fibre surfaces, reportedly analogous to those observed in 
graphene oxide fragments (281) though fixed to the body of the fibre structure instead. It is 
important to note that these are indicative solely of base functionality and a range of forms 








Figure 4.1.1 Summary of different oxygen functional groups present on the surface of carbon fibre generated 
through oxidation (adapted from (282)). 
 
It should be noted that a representative nitrogen functionality has been added in the figure 
above as it was envisaged that a minute population (i.e. pyrrolic and pyridinic) would be 
present within the graphitic planes. In the absence of an external source of nitrogen, such 
occurrence can be explained by the incorporation of PAN nitrogen into the lattice during the 
carbonisation process of the carbon fibre production (284). The majority of functional groups 
found in unmodified fibres however are sp2 carbon and it is the oxidative destruction of the 
latter that results in the carbon-oxygen functionality. Electrochemical oxidation, also known 
as anodisation, is an effective method to allow surface etching along with generating oxygen 
groups through the application of a positive potential (242,275,279,280) and it’s now common for 
carbon fibre-based electrodes to undergo this treatment to enhance electron transfer 
kinetics prior to employment (242–244).  
 
This chapter focuses on the influence of the simultaneous application of electrochemical 
anodisation and ultrasonic activation in enhancing electrochemical properties of carbon 
mesh electrodes.  It is known that the macro/micro acoustic streaming processes and 
cavitation caused by ultrasound can have a radically positive effect on its electrochemical 
activities (285,286) and has been proven to work in both porous and planar substrates (287,288). It 
was envisaged that such effects could also enhance the influence of anodisation by 
facilitating further permeation of electrolyte through the fibre matrix, removing bubbles and 
accelerating delamination of mechanically weak carbonaceous layers (289). Additionally, it was 
expected that this co-application would increase the manifestation of new graphitic layers, 










All chemicals were purchased from Sigma Aldrich (UK), were of the highest grade available 
and were used without further purification. Britton-Robinson buffers composed of 
phosphoric, acetic and boric acids, each at 0.04 M concentration, were used throughout the 
experiment, unless otherwise stated. Each BR buffer was adjusted to the correct pH unit by 
adding concentrated sodium hydroxide (NaOH). Toray carbon paper (TGPH-30, no wet 
proofing) was obtained from University of Surrey. 
 
4.2.2 Electrode Design 
 
Carbon fibre mesh was segmented and these sections were thermally sealed within a 
commercial polyester laminate (290), designed with a 4 x 4 mm window to establish a 
standardised geometric area which enables analogous comparisons before and after 
modification. The carbon film was connected to an electrically conductive copper adhesive 
tape, as shown in Figure 4.2.1, to allow connection to the potentiostat. 
 
 









4.2.3 Electrochemical Configuration 
 
A µAutolab Type III computer-controlled potentiostat (Eco-Chemie, Utrecht, Netherlands) 
was used to execute all electrochemical analysis. A standard three-electrode set-up was used 
throughout with carbon fibre mesh acting as the working electrode, a Ag/AgCl commercial 
half cell (3 M NaCl, BASi Technicol, UK) as the reference electrode and a platinum wire 
completed the configuration as the counter electrode. Experiments involving 
sonoanodisation were conducted through submersing the electrochemical cell in a 
conventional laboratory ultrasonic bath operating at 40 kHz. All experimentations were 




The quantification of surface composition and acquirement of XPS spectra were completed 
using an Axis Ultra DLD Spectrometer (Kratos Analytical Ltd., UK).  Spectra were analysed 
using monochromated Al Kα X-rays (hv = 1486.6 electron volts (eV)) operating at 15 kV and 
10 mA (150W).  A hybrid lens mode was employed (electrostatic and magnetic) during 
analysis with a 300 µm x 700 µm analysis area and a take-off angle of 90° with respect to the 
sample surface. Wide energy survey scans were collected across a range of -5 to 1200 eV 
binding energy, with a pass energy of 160 eV and step size of 1 eV.  High-resolution spectra 
were collected with a pass energy of 20 eV with a 0.05 eV step size, a scan width of 25 eV, a 
dwell time of 150 milliseconds and at least 3 sweeps to reduce the signal noise.  A Kratos 
charge neutraliser system with a filament current of 1.8 A and a charge balance of 3.6 V and 
a filament bias of 1.3 V was used for all samples.  Charging effects on the binding energy 
positions were adjusted by setting the lowest binding energy for the C1s spectral envelope 
to 284.8 eV, which is commonly accepted as adventitious carbon surface contamination. 
Three measurements were analysed per sample, with a Shirley background subtracted from 
each XPS spectra. The peak areas of the most intense spectral lines for each elemental 
species were used to determine the percentage atomic concentration.  Peak fitting of high-











Raman spectra were obtained using a LabRAM 300 (Horiba, Japan) spectrometer employing 
a HeNe laser (632 nm, 50 X optical lens, spot approx. 30 µm, 10 % filter, laser power 2.59 W 
(25.9 * 10 %)). The carbon fibre samples were analysed over 100 - 3500cm-1 in 5 slices (energy 
per slice 38.85 J) to cover the range with 5 spots per sample. 
 
4.3 Results and Discussion 
 
4.3.1 Preliminary Electrochemical Assessment 
 
The presence of various types of carbon in the electrode configuration inevitably 
corresponds to a vast range of interfacial structures. Simply put, graphitic carbon has two 
structural features, namely basal (hexagonal surface parallel to the graphite plane) and edge 
planes (edge surface perpendicular to the normal graphite layer), which possess significantly 
contrasting electrochemical characteristics. Although both are ubiquitous to carbon fibre, 
the former planar type is predominant in unmodified carbon fibre surfaces. Electron transfer 
kinetics is affected differently by each interfacial feature and is highly dependent on the 
nature of the redox probe used for examination. For instance, ferrocyanide and ruthenium 
hexamine are common redox species which offer different sensitivity to surface chemistry. 
Ferrocyanide is an inner sphere complex that is highly influenced by varying structural form, 
while the latter exhibits an outer sphere behaviour that is indifferent to such phenomena. In 
instances where edge plane sites are predominant along the carbon surface, a faster electron 
transfer kinetics is observed with ferrocyanide compared to those where basal layers are 
more prevalent (291–293). Using the same electrode, it is clear that the unmodified carbon fibre 
exhibits irreversible behaviour (DEp = 300 mV) towards ferrocyanide (Figure 4.3.1A), while a 
reversible cyclic voltammogram trace is observed for ruthenium hexamine (Figure 4.3.1B). 
 
Electrochemical anodisation, with or without ultrasonic treatment, significantly alters the 
graphitic plane formation with a substantial increase of carbon-oxygen functionality as well 
as carbon defect population, as depicted in Figure 4.1.1. The effect of various anodisation 
treatment periods on the cyclic voltammogram response of the carbon mesh electrode 
towards ferrocyanide and ruthenium hexamine (each at 2 mM dissolved with 0.1 M KCl) are 






response, initially examined at the unmodified electrode, towards ferrocyanide is markedly 
transformed through the process of electrochemical oxidation and the electrode behaviour 
is subsequently changed to become reversible. Additionally, the peak separation drastically 
decreases as the anodisation time increases. The typical reversible system was observed at 
electrodes which have been anodised for 300 seconds or longer as highlighted in Figure 
4.3.1C. There have been conflicting results regarding the role of surface oxides on electron 
transfer kinetics. On one hand, it is reported that anodised carbon-based electrodes have 
enhanced transfer kinetics for a range of redox probes (Fe(CN)63-/4-, Eu2+/3+, Fe2+/3+ and V2+/3+), 
with a 500 fold increase compared to its unanodised version (294,295). On the other hand 
however, there have been contradicting reports which imply that carbon oxides only have a 
minor role of only 2 to 3 factor increase towards ferrocyanide (296). 
 
Figure 4.3.1 Cyclic voltammograms highlighting the carbon fibre mesh electrode response after various 
anodisation periods without ultrasound towards A) ferrocyanide and B) ruthenium hexamine, both of which are 
at 2 mM concentration in 0.1 M KCl. C) Effect of anodisation time on the peak separation of ferrocyanide and 






As previously mentioned, ferrocyanide is recognised to be highly sensitive to surface 
chemistry (297,298) which helps explain the results attained. It was envisaged that the process 
of anodisation increased the surface concentration of oxygen functional groups and edge 
plane sites which, together, improves the electron transfer kinetics of the electrode towards 
ferrocyanide. This stands in agreement with the results by Gooding et al. (2005) where they 
determined the importance of oxygenated species on single walled carbon nanotubes 
(SWCNTs) to improve the electrode response to ferrocyanide (299). The researchers amplified 
the population of oxygen functionalities at the SWCNT through using nitric acid as the 
oxidation medium. Compton et al. (2006) also established that through the addition of multi-
walled carbon nanotubes (MWCNTs), whose exposed ends contain a large amount of oxygen 
functional groups, markedly improved the basal plane pyrolytic graphite’s response to 
ferrocyanide albeit the surface being normally renowned for its poor response towards the 
latter (298). Additionally, the group has determined that the generation of freshly cleaved edge 
plane pyrolytic graphite aids in enhancing ferrocyanide electron transfer kinetics and that 
oxygenated species actually impedes this which stands in contrast against previous 
outcomes (298). In their case however, carbon was only oxidised in air and thus it is envisaged 
that the carbon-oxygen functionality engendered through this does not have the same effect 
as that produced through more rigorous oxidative procedures, be it chemical or 
electrochemical.  
 
Upon assessing the carbon fibre electrode responses to ruthenium hexamine (Figure 4.3.1B), 
the latter’s outer sphere characteristics and thus insensitivity to surface functionality is 
observed as highlighted by the reversible behaviour detected even at the unmodified carbon 
electrode. Notedly, peak separation as well as peak height ratio was unaffected by 
electrochemical oxidation. Similar to ferrocyanide however, it should be noted that the peak 
height evidently increases with anodisation time, attributable to slight enlargement of 
electrode surface area due to the increasing carbon fibre surface delamination. In addition, 
the influence of scan rate on the anodised (300 s) electrode response towards ferrocyanide 
and ruthenium hexamine was examined to determine if carbon surface modification led to 
defects that could, in turn, lead to the entrapment of the redox species. Figure 4.3.2 displays 
the resultant linear relationship detected between peak current magnitude and square root 








Figure 4.3.2 Influence of square root of scan rate on the anodised carbon mesh electrode response in the 
absence of ultrasound towards A) ferrocyanide and B) ruthenium hexamine.   
 
Although a reversible behaviour was observed with ferrocyanide post carbon electrode 
anodisation, the combination of applying electrochemical oxidation and ultrasound achieved 
this reversibility quicker. Comparative cyclic voltammetry traces are shown in Figure 4.3.3A, 
revealing the response of unanodised, anodised (60 s) and sonoanodised (60 s) carbon fibre 
mesh electrodes. It is noteworthy that beyond 300 seconds of electrochemical oxidation, the 
presence of ultrasonic support had only minute influence in the voltammetric response 
(Figure 4.3.3B), having similar peak separations and peak heights to electrodes anodised in 
the absence of ultrasound - analogous to the behaviour previously exhibited in Figure 4.3.1C. 
The preliminary evaluation discussed here would imply that ultrasound has a kinetic 
influence on the electrode modification rather than any significant structural variation. The 
succeeding sections however discusses the likelihood that more factors could corroborate 









Figure 4.3.3 A) Cyclic voltammograms detailing the response of a carbon fibre electrode towards ferrocyanide 
(2 mM, 0.1 M KCl) after anodisation with and without the application of ultrasound. B) Cyclic voltammograms 
highlighting the effect of prolonged sonoanodisation on the carbon mesh electrode response towards 
ferrocyanide. Scan rate: 50 mV/s. 
 
4.3.2 Raman Spectroscopy Examination 
 
The difference in surface chemistry between unmodified (0 min) and anodised carbon fibre, 
with various treatment times without the aid of ultrasound, was initially assessed using 
Raman spectroscopy and representative spectra are presented in Figure 4.3.4A. The first 
order Raman spectra of the carbon fibre displays three relevant and distinguished peaks 






represents the graphitic in plane vibration with an E2g symmetry whilst the D and D’ bands 
complement the manifestation of out of plane vibrations corresponding to the generation of 
structural lattice defects and, as such, act as indicators of disorder as previously suggested 
by preceding investigations regarding oxidised carbon fibre (277,289,300). Evidently, the greater 
the anodisation time, the greater the population of oxygen functionalities as well as defects 
within the lattice including grain boundaries, aliphatic components and in-plane 
heteroatoms (akin to Figure 4.1.1). As a result, the D and D’ band peak heights intensify with 
treatment time as seen in Figure 4.3.4A.  
 
 
Figure 4.3.4 A) Representative Raman spectra of the carbon fibre surface before and after various anodisation 
periods in the absence of ultrasound. B) Influence of anodisation with and without ultrasound on the degree of 
disorder within the carbon fibre lattice. Error bars represent mean standard deviation. 
 
By comparing the ratio of intensity of D and G bands for each anodisation period, further 
knowledge into the influence of electrochemical oxidation on the carbon structure can be 
attained. Although it is quicker to achieve graphitic lattice disorder through the co-
application of ultrasound during anodisation, the former does not ultimately lead to any 






Analogous to the electrochemical responses observed previously in Figure 4.3.3A, 
sonoanodisation simply sped up the process at which the electrode response to ferrocyanide 
exhibited a reversible system. It was envisaged the application of ultrasound during 
anodisation aids the removal of oxygen bubbles generated by the imposition of the anodic 
potential (+2 V). The presence and entrapment of these bubbles within the interpenetrating 
carbon fibre mesh are expected to significantly deter the flow of electrolytes towards the 
electrode and, as such, reduces the effectiveness of the surface treatment. Essentially, the 
employment of ultrasonic waves serves to degas the electrode interface (285) and its 
subsequent cavitation effect should also aid in enhancing mass transport of fresh electrolyte 
(NaOH) to the carbon network which, in turn, promotes a faster interface remodelling. 
 
4.3.3 Effect of Anodisation and Sonoanodisation on Surface 
Hydrophobicity 
 
Contact angle measurements were used to briefly determine and compare the influence of 
anodisation and sonoanodisation on the surface hydrophobicity of carbon fibre. According 
to the contact angle measurements and the corresponding representative images shown in 
Figure 4.3.5, it is clear that the largely graphitic, unmodified carbon electrode was markedly 
more hydrophobic (>100°) in comparison to its anodised form, with or without ultrasound. 
Electrochemical oxidation on its own would have increased the number of hydrophilic C-OH 
and carboxyl functionality which would explain the improved the wettability of the surface 
(301,302). However, the ultrasound-aided anodisation showed a greater augmentation in 
hydrophilicity compared to silent anodisation, attributable to the kinetic and physical effect 








Figure 4.3.5 Contact angle measurements and corresponding representative images detailing the effect of 
anodisation, with and without the presence of ultrasound, on the surface wettability of carbon fibre. Each bar is 
an average 6 measurements and error bars represent mean standard deviation. 
 
4.3.4 Effect of Ultrasound on Carbon Fibre Morphology 
 
It is evident that in comparison to the Raman spectra obtained without ultrasound, no 
significant increase in lattice disorder was caused as a consequence of increasing anodisation 
times with the presence of ultrasonic waves. Although this is the case at the molecular scale, 
the application of sonoanodisation has a significant influence on the macro morphology of 
the carbon fibre. Figure 4.3.6 displays the effect of various anodisation times, with and 
without ultrasonic force, on the physical structure of carbon fibre. It can be seen that prior 
to anodisation (Figure 4.3.6A), carbon fibre has striations parallel to its longitudinal axis 
which are attributed to the method of production. These striations then become more 
distinct after anodisation and the outer sheath begins to deteriorate after 5 minutes of 
electrochemical oxidation (Figure 4.3.6B). It is evident that longer anodisation times exert 
greater damage to the physical properties of the fibres with the delamination of graphitic 
shards becoming more apparent (Figure 4.3.6C). It was envisaged that the increasing 
presence of oxygen bubbles, generated through the anodisation process, under semi-
delaminated sections of the carbon fibre causes such occurrences and further facilitates the 
erosion of the graphitic outer surface, which, in turn, inevitably decreases the fibre width 
(Figure 4.3.6E). However, Figure 4.3.6D highlights that the bulk physical condition of the 
carbon mesh remains mainly intact after anodisation in the absence of sonication. 
 
With the application of ultrasound, the aforementioned changes occur at an accelerated 






anodisation times in the absence (Figures 4.3.6B, 4.3.6C, 4.3.6D) and presence of ultrasound 
(Figures 4.3.6F, 4.3.6G, 4.3.6H), it is clear that sonoanodisation causes greater physical 
deterioration than its silent alternative. This is further supported by Figure 4.3.6E which 
highlights the narrower diameter observed after the co-application of anodisation and 
ultrasound. This constant narrowing unsurprisingly leads to mechanical failure of the carbon 
mesh, thus causing the notable difference in the bulk structure (Figure 4.3.6H). These 
examinations are in clear disagreement with the Raman spectra (Figure 4.3.4) where no 
significant difference between the presence and absence of ultrasound was observed at 









Figure 4.3.6 Scanning electron micrographs highlighting the surface morphology of the carbon fibre A) before 
and after B-D) silent and F-H) ultrasound-aided anodisation. E) Comparison of carbon fibre diameter as a result 








4.3.5 Influence of Anodisation on Carbon-Oxygen Functionalities 
 
High resolution X-ray photoelectron spectroscopy, focused on the C1s and O1s spectra, was 
used to assess the effect of electrochemical oxidation in the population of carbon-oxygen 
functionalities. As detailed in Figure 4.1.1, there are main functional groups (C=C/C-C, C-
OH/C-O-C, C=O and COOH) that will be generated as a result of anodisation and, as such, 
Figure 4.3.7A displays the C1s spectrum along with the deconvoluted/fitted peaks associated 
with the individual functionalities. The spectra clearly show that after 300 s of anodisation, 
there is a greater population of oxygen functionalities in comparison to those in unmodified 
fibre (Inset Figure 4.3.7A). This increase is further supported by the O1s spectra (Figure 
4.3.7B) where the initial oxygen peak derived from the presence of carbonyl/ketone 
functionalities is fragmented to C-O group, implying the increase in phenolic functionality as 
a direct result of electrochemical oxidation.  
 
 
Figure 4.3.7 XPS analysis of the A) C1s and B) O1s spectra before and after anodisation of carbon fibre mesh 
without ultrasound. 
 
Subsequently, a comparative study was completed to distinguish the difference in the effects 
of sonoanodisation and silent anodisation in the C1s and O1s spectra. Similar peaks were 
observed between both XPS spectra however, there were minute but distinct differences in 
the relative proportions of each group (Figure 4.3.8). The deconvoluted carbon functionality 
spectra, taken from carbon fibre electrodes with various anodisation periods without the aid 
of ultrasonic exfoliation (Figure 4.3.8A), illustrates that there is a significant change in the 






population and appearance of C-O functionalities as well as materialisation of relatively 
minor proportions of carboxyl (COO) and carbonyl (C=O) groups. Prolonged anodisation 
resulted in no significant difference in the latter two groups but led to a markedly different 
percentage contribution of C-O and C=C sp2 functionalities.  
 
The latter observations can be interpreted in a number of ways, but a sense of caveat is 
imperative. First and foremost, it is unfeasible to reliably differentiate between sp2 and sp3 
carbon peaks within the deconvoluted spectrum as their individual peaks are separated by 
only 0.3 eV. Although the former carbon type will be inevitably prevalent in the unanodised 
carbon fibre mesh, extended periods of electrochemical oxidation causes greater damage to 
the lattice which, in turn, could increase the population of the aliphatic sp3 carbon forms. As 
such, the reduction of C=C groups should be offset by the surge in the C-C functionalities 
however, since both XPS signals are split by only 0.3 eV, the conversion of one carbon form 
to the other would mean diminutive change in the detected C-C/C=C peak. An alternative, 
and potentially complementary, explanation could be that the constant exposure of new 
graphitic layers as a result of the oxidation-aided exfoliation of the carbon sheath leads to 
minute changes to oxygen functionality instead of its population increasing with anodisation 
time. Simply, as the previously oxidised layers are desquamated, the prolonged anodisation 
process resets with a new graphitic layer (mainly sp2 carbon) and the oxygen groups that was 
generated through electrochemical oxidation is essentially detached. Additionally, as a 
consequence of the diffusion-controlled electrolytic process, the pH of the local environment 








Figure 4.3.8 Summary of the net changes in carbon functionality on the carbon fibre electrode as a 
consequence of anodisation being conducted in the A) absence and B) presence of ultrasound. Error bars 
represent mean standard deviation. 
 
On the contrary, anodisation in the presence of ultrasound (Figure 4.3.8B) gives rise to the 
opposite outcomes. In this case, prolonged oxidation periods lead to an increase in the 
modification of the lattice, essentially damaging the sp2 carbon forms while populating C-O 
groups. The kinetic effect of anodisation discussed previously may also have an influence on 
the results observed here. Despite delamination clearly occurring at a faster rate in 
ultrasound-aided anodisation (Figures 4.3.6F, 4.3.6G, 4.3.6H) compared to silent anodisation 
(Figures 4.3.6B, 4.3.6C, 4.3.6D), it was envisaged that as the duration of the oxidative process 






peeled. Moreover, it was anticipated that the ultrasonic cavitation allows the delivery of new 
electrolyte towards the carbon fibre electrode thus enhancing the oxidative modification.  
 
Evidently, the results obtained from anodisation process in the presence of ultrasound differs 
to those observed in its absence. The major discrepancy between the two processes is the 
changes in percentage contribution of C-C/C=C and C-O functional groups but differences in 
carboxyl functionalities, although minor, are also observed. The latter groups are significant 
factors in the carbodiimide tethering of biological catalysts and, as such, the subtle changes 
in its production are also noteworthy. Carbon oxidation has been generally presumed to 
generate an abundance of carboxyl groups to be used for the coupling of biological agents 
however as per the outcomes attained here, although there is an increase, carboxyl 
functionalities are not the main output. In addition, sonoanodisation clearly produced less 
of these in comparison to anodisation alone which could be due to some other underlying 
physical effect of ultrasound or the constant exfoliation of carbon planes. 
 
4.3.6 Carbon-Quinone Electrochemistry 
 
Through the assessment of the unmodified carbon mesh’s XPS spectra, it was revealed that 
the graphitic layers of the fibres already possess a range of carbon-oxygen functional groups 
even prior to anodisation. The occurrence of electroactive quinoid groups on the surface of 
carbon materials is well-known and their detection can be completed using sensitive 
electrochemical processes like square wave voltammetry (243). The effect of various 
anodisation time periods without ultrasound assistance on the generation of such redox 
functionalities was therefore electrochemically assessed (Figure 4.3.9). A negative potential 
of -0.8 V was applied to initiate the reduction of the quinones to their hydroquinone form 
and the potential was then swept towards the more positive range to allow its re-oxidation 
(typically observed as a broad peak between -0.3 V and +0.3 V). The chronological 
voltammetric traces (Figure 4.3.9) reveal that the resultant peak formed at prolonged 
oxidation times are actually composed of various components which 
complements/replicates the heterogenous nature of the quinone functional groups that are 







Figure 4.3.9 Square wave voltammograms highlighting the carbon fibre electrode response in pH 3 BR buffer 
after various silent anodisation time periods. 
 
The C=O redox functional groups are known to be quinone constituents and, as previously 
discussed, longer anodisation times do not have much effect on their relative proportion. 
However, the square wave voltammograms highlighted in Figure 4.3.9 stands in contrast to 
this and reveals that increasing the treatment time increases quinone activity. This could 
possibly be attributed to the chemical nature of quinone whereby its oxidised form possesses 
C=O functionality but its reduced form exhibits the C-O functional groups (Figure 4.3.10A). 
Therefore, the electrochemistry of the quinone is an amalgamation of both functionalities 
and does not completely complement the C=O peak observed in the XPS spectra. 
Furthermore, not only can these functional groups be modified to 1,2 or 1,4 dihydroxy 
moieties (Figure 4.3.10A), they can also have longitudinal quinone characteristics across the 









Figure 4.3.10 Redox transition of simple quinone groups (A) and those spatially distant along the carbon lattice 




Pre-treatment of carbon fibre and other carbonaceous surfaces has been long recognised to 
play a vital role in enhancing electrode properties. While a variety of surface modification 
techniques have been applied, no study has yet involved the employment of ultrasound as a 
means of augmenting the electrochemical anodisation method. This chapter revealed that 
ultrasonic cavitation and acoustic streaming enhanced the electron transfer kinetics of the 
electrochemical anodisation technique but has been shown to generate opposing net 
changes in the populace of C-C/C=C and C-O surface functionalities in comparison to unaided 
electro-oxidation. It was envisaged that the physical destruction of the carbon surface, as a 
direct result of sonoanodisation, is a possible cause of the observed disparity. Moreover, it 
was discovered that, both in the absence and presence of ultrasound, the population of 
carboxylic functional groups remains relatively constant even with prolonged anodisation 
times. This may have significant adverse effects for succeeding modification techniques 
where there is a need to covalently bind catalytic species to the carbon fibre surface. It 
should also be noted that although there are clear advantages in employing ultrasound, it 
simply speeds up the electrochemical processes that occur with anodisation alone and as 






results obtained here supports the application of anodisation in enhancing the 
electrochemical performance of carbon-based electrodes – the chosen substrate for this 
project. This is evidently useful in developing a smart catheter system that could provide 


















The ability to measure pH changes within the lumen of the catheter has been proposed as a 
potential route through which to monitor bacterial colonisation. Traditional glass pH sensors 
would be inappropriate in this context due to their rigid nature and their incompatibility with 
miniaturised environments. As such, a robust, inexpensive and scalable polymer-coated 
carbon fibre-based pH sensor has been developed and characterised. The probe’s ability to 
measure pH changes in situ was tested through its application inside the challenging milieu 
of a microbial reactor. The latter represents an accessible approach in determining the 
influence of bacterial presence on the electrode response. The sensor was based on the 
electropolymerisation of a custom synthesized flavin-phenol moiety which demonstrated a 
pH sensitive redox response. The latter was investigated using square wave voltammetry 
wherein the oxidation peaks of the flavin film were found to provide a near Nernstian 
behaviour of 55 mV/pH with minimal drift. A key advantage of the system was that the 
oxidation peak processes were located within a potential region devoid of any common 
interferences that could hinder typical pH systems. The ability of the system to measure pH 






Part of the research described in this chapter is published as a cover/feature article in: 
Casimero C, McConville A, Fearon J, Lawrence C, Taylor C, Smith R et al. Sensor systems for 
bacterial reactors: A new flavin-phenol composite film for the in situ voltammetric 








Following on from the examination of the effect of anodisation in enhancing the carbon fibre 
mesh’s electrochemical characteristics, this chapter details the employment of an anodised 
carbon electrode as a pH sensor. Carbon fibre mesh was chosen as the initial substrate for 
the proposed sensor for its versatility, flexibility and scalability, which are prerequisites for 
miniaturised in situ monitoring. Research into replacing rigid, unadaptable traditional glass 
probes are underway by producing small, flexible and mechanically robust solid state pH 
sensors (216,303,304). These characteristics are especially important in microfluidic and 
biomedical systems where disposability is often a requirement. In the present case, the pH 
sensitive electrode assembly involves a flavin-modified pressed carbon fibre mesh whose 
functionality was then tested in a challenging milieu of a microbial reactor intended to 
manufacture kefir-fermented milk products. This provided a simple route through which to 
assess the influence of a changing bacterial system, akin to that of a contaminated catheter 
system, on the electrode response without the issues associated with traditional 
microbiological testing. This includes the length of time taken for adequate bacterial growth 
and proliferation as well as the risk of contamination that could easily affect and skew the 
data obtained. 
 
Riboflavin was first observed as a yellow-green fluorescent pigment found in milk by 
Alexander Wynter Blyth in 1872 and was the second B-vitamin characterised, hence it is also 
known as vitamin B2 (305,306). Some food, such as fresh meat, leafy vegetables and milk, are 
natural sources of the vitamin whilst others are fortified with it (305,306). Intracellularly, 
riboflavin is phosphorylated and is a precursor of flavin mononucleotide (FMN) and flavin 
adenine nucleotide (FAD) - both of which are important cofactors in numerous cellular 
processes including metabolism and other flavoprotein enzyme reaction (305–307), proving its 
key role in maintaining human health. Additionally, riboflavin has been suggested to have 
antimicrobial properties against catheter-related bloodstream-causing pathogens such as E. 
coli, C. albicans and S. aureus (308–311).  
 
Apart from its detection (312–314), the more recent focus has been the exploitation of its redox-
active flavin group as a sensor component which detects biomarkers linked with disease (315–
323). The flavin acts an electrochemical mediator and has evidently been able to aid the 






like hepatitis C (318) and chorionic gonadotropin (319). In these cases, either a chemical linker is 
used to covalently attach riboflavin to a base substrate, or it is directly electropolymerised 
on to the electrode surface. The polymerisation process occurs through the employment of 
large over-potentials but this aggressive oxidative activity is believed to significantly 
compromise the redox group and hence reduces its associated electrochemical signal. This 
chapter therefore details a newly engineered flavin-phenol moiety which, in comparison to 
riboflavin, can be electropolymerised without damaging the core redox flavin centre. 
 
Similar to riboflavin (324,325), the customised flavin molecule (Figure 5.1.1) can undergo 
reduction and oxidation (I ® II and II ® I). As opposed to the polymerisation process 
occurring directly at the flavin, it was envisaged that through the addition of the phenol 
substituent, the monomer can be polymerised through a radical cation process via the attack 
of the phenol ring (I ® III). In turn, this allows the preservation of the distinct redox 
transitions (I ® II ® I) which can then be exploited as the foundation of an electrochemical 
sensor. These transitions are dependent on H+ ion concentrations and can therefore be 
utilised as an indirect method of measuring pH. The flavin oxidation peaks are envisioned to 
be within a potential range deprived of any competing reactions. The critical advantage of 
being able to electropolymerise the flavin monomer is that it can be directly and specifically 









Figure 5.1.1 Redox transitions of the flavin unit (I® II®I) and the electro-oxidation of the phenolic substituent 
leading to the production of a polyphenylene oxide polymer (I®III). 
 
The commercialisation as well as home-based culturing of kefir-based probiotic milk 
products has been increasing since its first production from the late 19th century in the 
Caucasus mountains in Eastern Europe/Russia (326–328). Despite its name and structure, kefir 
grains aren’t simply grains but are clusters of exopolysaccharides (kefiran) encasing various 
heterogenous mixture of symbiotic bacteria and yeasts (326–328). Kefiran is a water-soluble 
glucogalactan-based film composed of highly concentrated glucose and galactose and is 
known for its gel-like properties (327,329). Microorganisms found inside the kefir consortium 
vary depending on origin country but the common, predominant isolates are lactic acid 
bacteria (i.e. Lactobacillus , Streptococcus species), yeast (i.e. Candida, Saccharomyces 
species ) and acetic acid bacteria (Acetobacter species) (327,330,331). The microbial count during 
production has an estimate range of 4.6x103 to 2.6x108 (327,330) - with lactic acid bacteria, yeast 
and acetic bacteria concentration approximately being 108 CFU/g, 107 CFU/g and 105 CFU/g, 
respectively (331). It is inevitable that the microbial population will significantly vary depending 







Consumption of kefir milk products are known for its probiotic actions and health benefits 
including aiding in digestion as well as increasing milk tolerance (328). Full fat cow milk has 
been traditionally used as the inoculation solution however milk from other animals like 
sheep and goat as well as non-animal sources like soy and rice are also being used. 
Independent from inoculation conditions (pH, temperature, fermentation duration) and 
source factors (species, location, season, etc.), which could vary the product’s nutritional 
value and flavour outcome, the underlying characteristic acidic tang, similar to a carbonated 
beverage, remains constant – owing to the microbial production of lactic and acetic acid 
during fermentation (326,327,331,332). However, the extent of the acidic taste affects the product 
palatability (333), therefore, pH monitoring within the reactor during the culturing procedure 
is vital.  In turn this can significantly influence the final product characteristics and quality 
and thus there is considerable interest in the development of disposable sensors for 
monitoring the growth processes.   
 
Although kefir-based microbial reactors do not predominantly involve CRBSI-causing 
microorganisms, its purpose in this case is to act as proof of concept and to test the ability 
of the flavin-phenol electrode to provide an unambiguous signal in a demanding milieu 
where biofouling can occur, similar to a catheter environment. Regardless of the 
manufacture process, the resultant medium is a thick, cream-like viscous concoction 
composed of proteins, sugar, lipids, minerals and naturally, an ever-expanding kefir grain 
biomass (326–328,332,333). In relation to this project, this proffers an environment that is a 
substantially challenging setting for electrochemical sensors in that, as an interfacial 
technique, must obviously be in direct contact with the microbial nidus. Due to acid 
formation during fermentation, the inoculant milk’s pH value will expectedly decrease – 
typically from pH 6.5 to pH 3.5. Additionally, the viscosity will inevitably inspissate which 
could possibly lead to surface fouling. It was envisaged that the matrix influence will be 
minimal as the flavin polymer will be directly anchored onto the electrode with a 
voltammetric approach allowing greater resolution of the peak processes. This 
electrochemical technique was envisaged to be preferable to conventional potentiometric 
methods in this case as the former offers greater selectivity to indirectly measure pH and 
have a fast response time while the latter is simpler and more readily corruptible 
(203,208,334,335). Although the prevailing influence of proton concentration in the redox peak 
shifts of riboflavin has been extensively studied, this is the first investigation where an 










Chemicals were purchased from Sigma Aldrich (UK), were of the highest grade available and 
used without further purification. Unless otherwise stated, measurements were completed 
with Britton-Robinson buffer, modified with the addition of concentrated sodium hydroxide 
until the required pH value is achieved. Toray carbon paper (TGPH-30, no wet proofing) was 
obtained from University of Surrey. Live kefir grains (10 g) were acquired from commercial 
sources and were inoculated with 500 mL cow’s milk at 22°C ± 2°C.  
 
Riboflavin was obtained from commercial sources whereas the phenol derivative was custom 
synthesised and was a gift from Dr Robert Smith, University of Central Lancashire. The 
synthesis of the flavin derivative, 10-(4-hydroxyphenyl)benzo[g]pteridine-2,4(3H,10H)-
dione, was accomplished via modifications to previous methods (336–338). The reaction 
summary is highlighted in Figure 5.2.1. In summary, p-anisidine (1) was reacted with 2-
fluoro-1-nitrobenezne (2) in the presence of potassium carbonate to yield 4-methoxy-2-
nitrodiphenylamine (3) which was isolated at the pump in 78% yield.  The crude material (3) 
was reduced using zinc dust under acidic conditions, and subsequently treated with alloxan 
monohydrate (4) in the presence of boric acid to yield the 10-(4-
methoxyphenyl)benzo[g]pteridine-2,4(3H,10H)-dione intermediate in 93% yield which was 
demethylated using hydrobromic acid you yield the final derivative (5) in 98% yield.  
 
 








5.2.2 Electrochemical Configuration 
 
All electrochemical measurements were conducted at room temperature (22 °C ± 2 °C) using 
a µAutolab Type III potentiostat (Eco-Chemie, Utrecht, Netherlands) with a standard three-
electrode system with either a glassy carbon or carbon fibre mesh as the working electrode. 
The circuit was completed with a conventional silver/silver chloride half cell reference 
electrode (3M KCl, BASi Technicol, UK) and a platinum wire serving as the counter electrode.  
 
5.2.3 Electrode Design and Modification 
 
Carbon fibre mesh was cut into suitable segments and were thermally sealed within a 
commercial polyester laminate (290), patterned with 4 x 4 mm window to establish a 
standardised area to enable comparisons before and after modification. The electrode was 
then electrochemically anodised (+2 V, 0.1 M NaOH, 300 s) which increases the exfoliation 
of the carbon fibre thus generating more edge plane sites and various oxygen functional 
groups, enhancing its electrochemical behaviour as discussed in Chapter 4. 
 
The electropolymerisation of the flavin phenol derivative (150 µM, pH 7 BR buffer/methanol) 
was completed through placing the electrode (glassy carbon or carbon fibre mesh) into an 
aqueous solution containing the flavin moiety and running repetitive cyclic voltammetry 
scans (+0.2 V ® -0.8 V ® +0.1 V, 50 mV/s). The solution was degassed with nitrogen prior to 
electrochemical experiments and were then carried out under nitrogen blanket. The flavin-
modified electrode was inserted in the kefir fermentation mixture and the pH of the 
microbial nidus was monitored in situ for up to 51 hours. 
 
5.2.4 NMR Analysis 
 
NMR spectra were recorded on a Bruker Fourier 300 (300 MHz) spectrometer. Chemical 
shifts are recorded in ppm relative to solvent residual (1H NMR d6-DMSO, 2.500 ppm and 
CDCl3 ppm, 7.26; 13C NMR d6-DMSO, 39.520 ppm and CDCl3, 77.16). Coupling constants are 
reported in Hertz (Hz) and are rounded to the nearest 0.5 Hz. Multiplicities are stated as 
singlets (s), doublets (d) and triplets (t) or a combination of these, peaks appeared broad are 
due to either H-bonding or restricted rotation are prefixed as broad (br). Low resolution mass 






(1800-800 cm-1) were recorded through a Perkin Elmer Spectrum RX 1 with a Specac Golden 
Gate™ ATR accessory and values are quoted in wavenumbers.  
 
5.3 Results and Discussion 
 
5.3.1 Characterisation of the Flavin-Phenol Moiety 
 
A comparison between the electrochemical properties and voltammetric responses of 
riboflavin and the engineered flavin-phenol moiety was completed and observed using a 
conventional glassy carbon electrode in pH 7 BR buffer, shown in Figure 5.3.1A. Evidently, 
the flavin centre’s redox process in both cases exhibit near reversible kinetics and displays 
well defined, distinct peaks. It can be seen that the reduction peak of the flavin-phenol 
compound occurs at a marginally less negative potential in comparison to riboflavin. This can 
be attributed to the latter containing methyl and sugar substituents which have a greater 
combined effect on the reduction potential required than that of the phenolic substituent 
altering its electron-releasing nature. Nevertheless, the primary difference between the 
voltammetric profiles is focused on the irreversible peak process observed at +0.81 V on the 
flavin-phenol moiety, which is noteworthily non-existent on the riboflavin scans. This 
irreversibility as well as the evident decrease of the peak height with increasing scan number 
(Figure 5.3.1B) is consistent with the phenol oxidation process. 
 
The magnitude of the redox peaks observed at -0.3 V of the phenolic derivative are also 
visibly increasing with consecutive scans. As the potential is swept more positively, the 
phenol component is oxidised which, in turn, induces the formation of oligomeric and 
polymeric deposits on to the electrode, as forecasted in Figure 5.1.1 (I ® III). At a narrower 
cyclic potential range (+0.2 V ® -0.8 V), the hydroxy functionality is not oxidised therefore 
no increase in the flavin current is observed. Thus, the increasing flavin peak magnitude is 
explained by the accumulation of deposited/polymerised flavin derivative on the electrode 
surface which only occurs via the oxidation of the phenol. Further investigation of the flavin’s 
cyclic voltammogram traces reveals that the initial peak height increase seen on the second 
scan slows after a few cycles and ultimately ceases. This is explained by the lack of available 
electrode surface to be coated, which eventually hinders further polymerisation and film 
growth. It should be noted that the flavin peak processes continue to be well-defined and 








Figure 5.3.1 A) Cyclic voltammograms comparing the response of a glassy carbon electrode towards riboflavin 
(red line) and the flavin-phenol derivative (black line) in pH 7 BR buffer. B)  Five consecutive cyclic 
voltammograms detailing the electropolymerisation of flavin-phenol derivative in pH 7 BR buffer. Scan rate: 50 
mV/s. 
 
To further prove the deposition of the polymer on the electrode surface, the electrode was 
thoroughly rinsed, placed in a fresh pH 7 BR buffer solution and cyclic voltammetry was again 
employed. Upon initial inspection, the characteristic flavin redox peaks remained, however, 
the slow transfer of counter ions into the flavin polymer significantly increases the film’s 








Figure 5.3.2 Cyclic voltammograms detailing the flavin-modified glassy carbon electrode response with 
increasing scan rate in fresh pH 7 BR buffer. 
 
The relationship between the peak height response of the immobilised film to increasing 
scan rate is displayed in Figure 5.3.3. The positive linear relationship between scan rate (10 
mVs-1 to 5 Vs-1) and peak height also corroborates the initial suggestion that the flavin was 
immobilised on the electrode surface, as described by the Randles-Ševčik equation (Chapter 
3.5.1, Eq. 3.5). The slope of the cathodic peak currents against scan rates allowed the 
calculation of the flavin polymer surface concentration on the glassy carbon electrode 









Figure 5.3.3 Variation of polyflavin peak heights with scan rate recorded on a glassy carbon electrode in pH 7 BR 
buffer.  
 
5.3.2 Evaluation of Flavin-Modified Carbon Fibre Mesh as a pH Sensor 
 
Upon the observed stability of the redox processes and their retainment after insertion in 
fresh BR buffer, the flavin was then electropolymerised on to the surface of a more flexible 
and scalable carbon fibre mesh electrode. It should be noted that the same 
electropolymerisation technique described in Section 5.2.3 was employed in this case and 
with the glassy carbon electrode. The same voltammetric profiles were also observed as in 
Figure 5.3.1B. As per previous method, after confining the flavin polymer on the electrode 
surface, the electrode was rinsed and then placed in consecutive pH BR buffers to determine 
the influence of pH on the peak responses. 
 
To minimise the effect of oxygen as well as to more accurately determine peak potentials, 
square wave voltammetry was employed. The scans were initiated at -0.8 V which is 
sufficiently negative to induce the reduction of the flavin centre and, as the potential is swept 
more positively, the core flavin is re-oxidised. Figure 5.3.4 displays the shifts in oxidation 
peak due to varying pH and its corresponding calibration/linear regression graph. Evidently, 
distinct sharp peaks are observed with each pH and the oxidation peak moves towards more 
negative/less positive potentials as the pH becomes more alkaline.  This relationship was 






(NpH = 7, Nscans/pH= 3,); R2 = 0.999), similar to that of a previous report by Roushani et al. (2014) 
on the use of riboflavin-graphene quantum dots (317).  
 
Figure 5.3.4 A) Square wave voltammograms and B) corresponding linear regression calibration graph exhibiting 
the shift in oxidation peaks of the flavin-modified anodised carbon fibre mesh in BR buffers of various pH. Each 
point is an average of three scans and mean standard deviation error bars are added but too small to be 
observed. 
 
The ability to periodically scan and monitor the pH of the local environment is a prerequisite 
in not only kefir-microbial reactors where a batch takes at least 24 hours to process, but also 
in catheter systems which are used in a daily basis. The robustness of the flavin-modified 
electrode was therefore evaluated through successive cycling of the electrode in a series of 
three successive sequences with each ranging from pH 2.55 to pH 8.12 (Figure 5.3.5). In each 
pH BR buffer, square wave voltammograms were recorded in triplicate and the process was 
repeated a further two times as detailed in Table 5.3.1. This was completed to examine the 






and back. The process of repetitive cycling could, in turn, lead to potential drifts caused by a 
possible compromise on the integrity the flavin centre. This is typically common in quinoid 
systems where the oxidised centre can be susceptible to hydroxyl ion attacks in moderately 
alkaline conditions. In this case however, the pH sensing capability of the polymerised flavin 
is unambiguously reversible with a potential drift of only 4 mV (0.07 pH unit based on a 55 
mV per pH shift) after 63 scans. Conversely, the peak height was observed to decrease in 
magnitude by around 20% over the repetitive scans.  
 
Table 5.3.1 Detailed raw data obtained from repetitive scanning of flavin-modified anodised carbon fibre mesh 





Figure 5.3.5 Influence of pH on the oxidation peak potential of flavin-modified anodised carbon fibre mesh over 
three cycles in BR buffers of varying pH. Each pH is analysed in triplicate, totalling 63 scans, with each point on 
the graph representing the third scan of each cycle. 
 























Series 1 Series 2 Series 3 
pH 1 2 3 4 5 6 7 8 9 
2.55 -0.076 -0.064 -0.062 -0.135 -0.072 -0.066 -0.088 -0.068 -0.066 -0.077 0.023 0.0077 
3.89 -0.130 -0.135 -0.137 -0.134 -0.135 -0.137 -0.126 -0.132 -0.135 -0.133 0.0036 0.0012 
4.77 -0.175 -0.179 -0.179 -0.175 -0.183 -0.183 -0.185 -0.185 -0.185 -0.181 0.0041 0.0014 
6.07 -0.237 -0.249 -0.253 -0.253 -0.257 -0.258 -0.243 -0.249 -0.253 -0.250 0.0067 0.0022 
7.27 -0.316 -0.320 -0.320 -0.316 -0.322 -0.322 -0.316 -0.320 -0.322 -0.319 0.0026 0.0009 
7.82 -0.334 -0.344 -0.350 -0.342 -0.352 -0.352 -0.346 -0.352  -0.352 -0.347 0.0063 0.0021 







5.3.3 Challenging the Electrode’s pH Sensitivity in a Microbial Reactor 
 
The pH sensing capabilities of the flavin film was further challenged by inserting the electrode 
in a kefir matrix. Kefir grains were inoculated with milk and was left to ferment over 51 hours. 
Figure 5.3.6 displays the comparison between square wave voltammograms of anodised 
carbon fibre electrodes with and without the polymeric flavin film, attained at the start of 
inoculation and at the end of the fermentation process. The small but distinct peaks (initially 
at -0.413 V and shifted to -0.231 V) exhibited by the electrode without the polymer are 
attributed to the presence of natural riboflavin in milk. In comparison, the flavin-modified 
electrode displays a relatively larger, distinguished peak which has similarly shifted from  -
0.281 V to -0.114 V as the reactor’s pH shifts from the initial pH of pH 6.18 to pH 3.68 at the 
end of production.  
 
 
Figure 5.3.6 Square wave voltammograms comparing the response of a bare anodised carbon fibre electrode 
and polyflavin-modified anodised carbon fibre electrode in kefir-inoculated milk at the start and end of the 
fermentation cycle. 
 
The calculated pH from the calibration curve was then compared to that recorded using a 
standard pH glass probe (Figure 5.3.7). The consequential pH measurements from the flavin-






agreement with the conventional pH sensor. It is evident however, that at both 21 and 47 
hours after inoculation, anomalies which significantly differ from that of the control pH probe 
are detected. It should be noted that these deviations occur only after the electrode has 
been dormant in the microbial reactor for a period of over 12 hours.  
 
 
Figure 5.3.7 Comparison of pH measured between the conventional glass pH probe and the flavin-modified 
anodised carbon fibre mesh electrode within the kefir mixture over a period of 51 hours. Each point is the 
average of 3 scans. 
 
During periods of no use, it is probable that the electrode is colonised by microbes present 
in the matrix which leads to the nonconformity and the pH measured is actually that of the 
local environment created by the biofilm at the electrode surface, not the bulk matrix pH. 
The former was confirmed via scanning electron microscopy photographs of the carbon fibre 
mesh after 51 hours of fermentation (Figure 5.3.8). It was envisaged that a significant 
increase in kefir biomass would be produced with time which would then foul the electrode. 
It could be envisaged that permselective barriers may be effective in inhibiting microbial 
attachment to the surface of the electrode which will sequentially minimise fouling. 
However, biofilm formation on the barrier may still lead to inconsistency in pH 
measurements between the bulk and internal void.  
 
Upon recommencing measurements after the two aforementioned time points, the flavin 
response soon returns to matching the pH data of the standard probe. In this case, the 






be ascribed to the redox transitions occurring at the surface which induces physical swelling 
through the flux of counter ions. Nonetheless, biofilm formation is obvious after a 
fermentation phase of 51 hours (Figure 5.3.8). This is arguably beyond the typical period 
used for kefir-based products but could be problematic when other microbial systems, 
including microbial fuel cells (340), are taken into consideration. 
 
 
Figure 5.3.8 Scanning electron micrographs of the carbon fibre network after incubation in kefir mixture 
(SU5000 FE-SEM, Hitachi, Japan). 
 
In principle, an anodised carbon fibre without further modification may be used as a way to 
directly measure riboflavin endogenous to the milk-kefir concoction and exploit the 
dependence of its oxidation process on H+ ion concentration as the basis of a pH sensor. As 
seen in Figure 5.3.6, riboflavin oxidation peaks shift with pH. However, this approach 
assumes that riboflavin will always be present in milk feedstock and will be at an easily 
detected concentration. But in cases where there may be less riboflavin, i.e. other milk 
sources like coconut or soy,  or more importantly where it is non-existent such as within the 






also reveals that although riboflavin has a separate, well-defined peak, its magnitude is 
similar to other kefir mixture constituents (broad peak at +0.25 V) which may further 
decrease the former’s peak intensity. Changes to the composition of the milk source, like the 
introduction of additives or flavouring, could also conceal the peak produced by the present 
riboflavin. In contrast, the film modifier is polymerised on to the electrode surface and the 
intensity of the engineered flavin’s oxidation peak is much greater than the constituents 
present in the kefir mixture. These characteristics should therefore overcome the 
aforementioned issues.  
 
As previously mentioned, there is an ever-increasing need for the development of new pH 
sensing methods and electrode modifiers capable of monitoring pH in challenging 
environments. As such, several researches have focused on developing such technology as 
summarised in Table 5.3.2. Although there is evidently a variety of modifiers, it is also clear 
that validation through real matrix application can be difficult. The flavin-modified carbon-
based system here exhibits near Nernstian behaviour and, in comparison to techniques 
whose underlying principles are similar to the aforementioned, the flavin-functionalised 
electrode was critically assessed within a microbial reactor which is a real, complex and 
changing medium. 
 





pH Range Test 
Medium 
Ref. 
      
CeTixOy P 89.8 2-12 N/A (342) 
RuO2/Nafion P 55.2 2-6 Beverages (343) 
IrOx/Pt P 64 1-13 Corrosion (344) 
ERGO Polyaniline/Nafion P 55 2-9 Fermentation (345) 
CuO nanorods C 0.64 µF/pH 5-8.5 N/A (346) 
Graphite/polyurethane P 11.13 5-9 Sweat (347) 
WO4/WO3 P 56 2-10 N/A (348) 
Graphene - Polyaniline A 139 µA/pH 1-5, 7-11 N/A (349) 
NiO P 63 1-13 N/A (350) 
ZnO/W P 46 2-9 CSF (351) 
Ni3(PO4)2·8H2O  P 34.8 4-7 Sweat (352) 
Carbon-quinone V 73 2-8 Saliva (211) 
Pt-IrOx P 56 4-9 Biofilm (353) 
Si EGFET P 56 2-12 N/A (354) 
ZnO P 43 2-9 Tumour Cells (303) 
Polyaniline V 50 4-10 Wound fluid (355) 
Poly Dopamine V 58 1-12 N/A (356) 




a where C = capacitance; P = potentiometric; V = voltammetric; A = amperometric;  








This chapter detailed the use of a scalable, inexpensive, anodised carbon mesh that was 
further functionalised by an engineered flavin-phenol redox polymer as a solid-state pH 
sensor. The oxidation peak of the flavin derivative was found to occur within a potential 
range devoid of any typical interferences that may affect other pH sensors. Additionally, the 
probe was tested in a chemically complex medium of a microbial reactor where it was 
evident that the system provides a clear, unambiguous signal which shifts with pH. The 
analytical peaks exhibit reversible characteristics over a physiologically relevant pH range 
without requiring the solution to be degassed - an essential quality for in situ applications 
such as in catheter systems.  
 
In spite of proving the reagentless system’s capability of measuring pH in the presence of 
bacteria and fungi, there is a need to examine its functionalities in a more biologically 






















The customised flavin-phenol moiety was electropolymerised onto a mechanically flexible 
carbon-loaded polyethylene film to produce an adaptable electroanalytical sensor capable 
of measuring pH. This material was initially assessed as an alternative to the more brittle 
structure of the carbon fibre. The reagentless flavin system again exhibits its Nernstian-like 
behaviour of 60 mV per pH shift over a physiologically relevant pH range of pH 2.55 to pH 
8.12. Its robustness was also assessed whilst under cyclic and/or constant perpendicular 
mechanical flexing and has proven to have less than 0.001 pH unit degree of error. Similarly, 
the stability, pH sensing capabilities and applicability of the proposed system was analytically 
evaluated by submerging the electrode in chemically complex human urine samples and 








Aspects of the work detailed in this chapter is published in: 
McLister A, Casimero C, McConville A, Taylor C, Lawrence C, Smith R et al. Design of a smart 
sensor mesh for the measurement of pH in ostomy applications. Journal of Materials Science. 
2019;54(14):10410-10419. 
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Following on from the last chapter, this section details the use of the same engineered novel 
phenolic-flavin derivative. Instead of polymerising the flavin on to carbon fibre however, an 
anodised and laser ablated carbon-loaded polyethylene (C-PE) film is used as the substrate 
of a pH sensitive probe. The use of carbon fibre mesh as an electrode substrate has potential 
drawbacks including its brittleness, cost and transferability limitations to large scale 
productions (357). It was envisaged that a potential solution to these challenges could be the 
employment of a polyethylene based composite film that is inherently mechanically flexible 
and which is more amenable to mass manufacturing through conventional polymer 
processing techniques. Given the simplicity of the substrate, it has an additional advantage 
of being relatively low cost which is a prerequisite in healthcare devices given that there is 
an ever present focus on spending reduction.  
 
In this case, the sensor is based on a polyethylene film infused with carbon particles to 
enhance the electrical conductivity of the film. It was anticipated that the electroanalytical 
properties of the carbon-polymer composite could be augmented through removing the 
outmost superficial polymeric layers, which in turn exposes more interfacial carbon (358).  It 
was anticipated that laser processing could be exploited at a level inadequate to break 
through the film but sufficient to generate etch tracks within the film, with pores produced 
where the tracks would intersect via rasterization through the X and Y planes. Subsequently, 
this would generate a porous, mesh-like structure as displayed in Figure 6.1.1. While 
exposing the underlying carbon would produce a conductive yet mechanically adaptable film 
as a basis of the sensor, it was envisioned that the carbon would not have any analytical 
selective/pH sensitive characteristic that is a prerequisite to the proposed application. Thus, 
the electrode would still require to be modified using the redox active flavin polymer (Figure 
6.1.2) as described in Chapter 5 (Figure 5.1.1).  
 
The flavin polymer-coated polyethylene probe was tested in a range of matrices but, at the 
time of the study, it was not possible to acquire authentic IV fluids. Therefore, to test the 
analytical efficacy of the system with a complex biological fluid, human urine extracted from 
healthy volunteers was used. The latter was significant as it could be expected that the latter 






concentrations that could interfere with the flavin response thus hindering the sensor’s 
ability to successfully sense pH. 
 
The development of electrochemical biosensors for the analysis of urine are well established 
(359–361) and can allow the diagnosis of various clinical conditions that include:  diabetes (362,363), 
cancer (364,365) and urinary tract infection (366,367) as well assessing urine pH (368,369). Urine 
samples are compositionally complex and are naturally heterogenous thus providing a 
challenging matrix suitable for assessing the pH-sensing capabilities and reproducibility of 
the proposed system. The aim of this chapter therefore is to provide a detailed analysis of a 
mechanically flexible carbon-loaded polyethylene film modified with polyflavin and its ability 
to act as a pH sensor within a chemically complex media, which could ultimately be 
integrated within a smart sensing catheter system. 
 
 









Figure 6.1.2 Redox transition of the flavin unit (I®II®I) and the electro-oxidation of the phenolic substituent 
leading to the production of a polyphenylene oxide polymer (I®III) on exposed carbon surfaces at the carbon-
polyethylene film interface. 
 




All chemicals were purchased from Sigma Aldrich (UK), were the highest grade available and 
were therefore used without further refinement. Unless otherwise stated, Britton-Robinson 
buffers were amended to the appropriate pH by adding drops of concentrated NaOH and 
were used in electrochemical assessments. Butyl-grafted polyethylene films filled with 
carbon-black (80 µm thick, 100 Wcm resistivity) were obtained from Goodfellow Research 
Materials (UK).  
 
6.2.2 Electrochemical Configuration 
 
Electrochemical measurements were executed using a VSP-300 Multichannel Potentiostat / 






electrode setup was employed, using either a glassy carbon or C-PE film, a conventional 
Ag/AgCl reference electrode (3M NaCl, BASi Technicol, UK) and platinum wire acting as the 
working, reference and counter electrode, respectively. All analytical assessments were 
carried out at 22 °C ± 2 °C. 
 
6.2.3 Preparation and Characterisation of Modified Film 
 
The carbon-polyethylene composite was laser patterned using a 30 W CO2, air-cooled, 
computer-controlled FB400 series laser cutter (CadCam Technology Ltd., UK). The ApS-Ethos 
propriety software was used to control the laser’s direction, raster/vector speed and output 
power, with a spatial resolution of 25 micron. The laser scanned along X and Y directions with 
a 2 mm distance between each pass. Dektak XT Stylus Profilometer (Bruker Corporation) was 
used to characterise the surface morphology and etch depth of the composite, with a single 
pass detailing 60 µm depth, as illustrated in Figure 6.2.1.  
 
 
Figure 6.2.1 Dektak surface profile of the laser-modified carbon-polyethylene film displaying the typical depth 
profile of areas receiving a single and double pass. Insert: photograph of the C-PE film after laser treatment. 
 
Macroscopic examination of the composite is able to clearly differentiate the permeable, 
mesh like structure of the film after laser procedures from the original non-porous and 
featureless film. The voids occur where the laser tracks perpendicularly intersect and are 






passes. Noteworthily, the polymeric film is only 80 µm thick and since one pass carves 60 
µm, the second pass would effectively etch another 60 µm and cuts through the material.  
 
Additionally, a scanning electron microscope (JSM-6010, Jeol Ltd., Japan) was employed to 
further characterise the surface of the mesh film as exhibited in Figure 6.2.2. The resulting 
images complement the visual investigation and further highlights the highly porous 
configuration produced through exposing residual carbon (Figure 6.2.2B) of the polyethylene 
polymer via laser etching, with Figure 6.2.2C displaying a point of intersection which further 
exhibits this permeable and porous structure as two laser passes occurred here. A 
comparison between untreated and laser-modified polyethylene in Figure 6.2.2B 
emphasizes the relatively featureless surface profile of the initial polymer, in which isolated 
accumulations of carbon particles are observed to penetrate through the film’s surface, as 
hypothesised in Figure 6.1.1. It evidently proves that laser etching significantly increases the 
concentration of exposed carbon particles which would consequently, across the laser-
treated tracks, enhance the electrochemical properties of the polymeric film.  
 
 
Figure 6.2.2 Scanning electron micrographs of the carbon-polyethylene mesh after laser processing. A) Low 
magnification highlighting the direction of the laser raster and creation of holes within the film. B) Comparison 
of the laser etched track and unmodified C-PE film. C & D) Removal of the polyethylene at the pore edge as a 






6.2.4 Electrode Design and Modification 
 
The laser modified C-PE film was sectioned and thermally enclosed in a polyester laminate 
with a fixed 4 mm x 4 mm window to enable comparative examination in a similar manner 
to that used with the carbon fibre in Chapter 4 and Chapter 5. As per Chapter 4, the benefits 
of electrode anodisation in enhancing the electrochemical properties were also exploited in 
this case using chronoamperometric techniques (+2 V, 0.1 M NaOH). The synthesis of the 
phenol-flavin derivative was as described in Chapter 5 (Figure 5.2.1). The moiety was 
polymerised onto the electrode surface via repetitive cyclic voltammetry scanning (+0.2 V ® 
-0.8 V ® +1 V, 50 mV s-1) in an aqueous solution containing the derivative (150 µM, pH 7). In 
cases where the solution was degassed, nitrogen was used prior to commencing the 
experiment and was then run under a nitrogen blanket.  
 
6.2.5 Ethics Approval and Compliance 
 
The proposed flavin-modified laser etched carbon-polyethylene sensors were critically 
assessed in human urine. The bodily fluid was simply used as a relevant, multifarious matrix 
to test and assess the robustness of the electrode under investigation and to determine if 
electrode surface biofouling and/or electrochemical by-product generation occurs over time. 
Urine samples were obtained from three healthy volunteers (2 males and 1 female) who had 
not consumed any form of medication in the 24 hours preceding the collection. After sample 
collection and anonymisation, the fluids were stored at 4 °C until required and immediately 
after study conclusion, were appropriately flushed to waste. Ethical approval to use human 
urine samples was sanctioned through Ulster University Ethics Committee (UREC Ref: 
REC/16/0073) prior to the study.  
 
6.3 Results and Discussion 
 
6.3.1 Electrochemical Evaluation of Flavin-Modified pH Sensitive 
Electrode 
 
The preceding chapter has successfully employed polyflavin onto carbon fibre mesh 






biofouling within a microbial reactor. In this case, it was necessary to assess and differentiate 
the electrochemical signature of the lasered carbon loaded polyethylene electrode in 
comparison to carbon fibre mesh electrodes. Despite improving the electroanalytical activity 
of the C-PE composite through the employment of laser etching, graphitic carbon would still 
be predominant and, as such, electrochemical anodisation in sodium hydroxide prior to 
commencing analytical experiments was carried out. Through this exfoliation process, more 
edge plane sites and oxygen functionalities are generated (Chapter 4) thus enhancing the 
electrode’s electron transfer kinetics.  
 
The same procedure detailed in Chapter 5 (Figure 5.3.1) was conducted to electropolymerise 
the novel redox flavin moiety onto the surface of the C-PE mesh (Figure 6.3.1). Although the 
voltammetric profile of polyflavin on the C-PE electrode is similar to that of carbon fibre 
mesh, it is evident that the redox peaks are significantly less defined and have a larger peak 
separation on the composite mesh compared to the latter. Nonetheless, the three pertinent 
processes found on the flavin-modified carbon mesh are still clearly visible on the cyclic 
voltammogram response of C-PE moiety. In this case, polyflavin’s increasing reduction and 
oxidation peaks (I ® II an II ® I, respectively, as highlighted in Figure 6.1.2) are observed at 
-0.65 V and -0.1 V, respectively, and the decreasing oxidation peak of the phenolic 
substituent can be seen at +0.81 V (I ® III), thus following a similar trace to that with carbon 
fibre-based electrodes.  
 
Figure 6.3.1 Cyclic voltammogram traces exhibiting the response of the anodised laser-modified carbon-
polyethylene composite electrode towards the flavin-phenol derivative in pH 7 Britton Robinson buffer. Scan 







Similar to that in the former chapter, the electrode was removed from the phenolic flavin 
solution, thoroughly rinsed and then placed in fresh solutions buffered at various pH to not 
only determine the encapsulation of the polyflavin on the surface of the C-PE mesh but also 
to assess its pH sensing capabilities. Figure 6.3.2 details the resulting square wave 
voltammograms comparable to carbon fibre-based electrodes with Nernstian behaviour of 
59.5 mV per pH shift (E / V = -0.0595 pH + 0.0961; Ntotal = 21 (NpH = 7, Nscans/pH= 3); R2 = 0.9973). 
It should be noted that each resultant point in the linear regression calibration graph (Figure 
6.3.3) is an average of three analytical scans and that error bars are present, however, they 
are so minute (average standard deviation = 1.80 mV; average standard error = 0.601 mV) 
that they are not clearly visible within the larger y-scale of the figure. Analogous to the 
preceding chapter, the flavin oxidation peaks are within the negative potential range and are 
therefore devoid of other competing processes. The peaks are also insensitive to the 
presence of oxygen thus negating the need for solution degassing - a critical prerequisite for 
the implementation within a smart catheter hub. 
   
 
Figure 6.3.2 Square wave voltammograms displaying the pH sensitive response of a flavin-modified anodised C-








Figure 6.3.3 Corresponding calibration plot detailing the linear response between pH and peak positions over a 
total of 21 scans, recorded using flavin-modified anodised C-PE electrode. Each point is an average of 3 scans. 
Mean standard deviation error bars are included but are too small to be observed. 
 
Subsequently, the robustness and reversibility of the sensor was examined through 
repetitive and sequential scanning in varying pH buffers. Simply put, the electrode was 
inserted into successive pH BR buffers, wherein the electrode completes three square wave 
voltammetric scans prior to being placed into the next BR buffer, and after completing the 
physiologically relevant pH series (pH 2.55 – pH 8.12), the whole sequence is repeated twice 
more, producing a total of 63 scans as detailed in Table 6.3.1. Figure 6.3.4A illustrates the 
corresponding pH vs peak position graphs while Figure 6.3.4C displays the linear calibration 
curve - both of which are acquired over the three consecutive sets, with each spot being an 
average of 3 and 9 scans respectively. Similar to the previous calibration graph, error bars 
were added for each data point but again are not visible due to their miniscule size (average 
standard deviation = 2.28 mV; average standard error = 0.253 mV) in relation to the graph 
scale.  A similar Nernstian behaviour of 60 mV/pH was detected over the three sets (E / V = 
-0.060 pH + 0.0972; Ntotal = 63 (NpH = 7, Nscans/pH/set = 3); R2 = 0.9977). Additionally, Figure 6.3.4B 







Table 6.3.1 Detailed raw data obtained from repetitive scanning of polyflavin-modified anodised C-PE electrode 



























Series 1 Series 2 Series 3 
pH 1 2 3 4 5 6 7 8 9 
2.55 -0.062 -0.066 -0.064 -0.062 -0.064 -0.062 -0.064 -0.064 -0.064 -0.064 0.0013 0.0004 
3.89 -0.132 -0.134 -0.135 -0.134 -0.135 -0.137 -0.135 -0.135 -0.137 -0.135 0.0015 0.0005 
4.77 -0.177 -0.179 -0.179 -0.181 -0.181 -0.183 -0.183 -0.183 -0.183 -0.181 0.0022 0.0007 
6.07 -0.258 -0.258 -0.255 -0.260 -0.258 -0.258 -0.260 -0.258 -0.260 -0.258 0.0016 0.0005 
7.27 -0.344 -0.342 -0.340 -0.340 -0.340 -0.344 -0.346 -0.346 -0.346 -0.343 0.0027 0.0009 
7.82 -0.368 -0.372 -0.374 -0.372 -0.374 -0.376 -0.379 -0.378 -0.378 -0.375 0.0036 0.0012 








Figure 6.3.4 A) Variation of peak potential with pH over three consecutive pH series with each point being an 
average of 3 scans, B) effect of repetitive pH series cycling on the oxidation peak magnitude and C) 
corresponding linear regression calibration graph displaying the average peak positions for each pH, all 
recorded at the flavin-modified anodised carbon-polyethylene mesh over 63 scans. Mean standard deviation 






By normalising the peak heights (using the magnitude of the first scan as the base) and 
plotting this against related scan number (Figure 6.3.4B), it is evident that repetitive scanning 
affected the peak height but the retention of an unambiguous and distinct peak throughout 
the scans confirms the stability of the flavin polymer coating of the carbon-doped 
polyethylene film. After the scanning from low to high pH and repeating this action twice 
more, garnering a total of 63 data points, the inherent flavin oxidation peak height only 
diminishes by 18%. This is a specifically critical factor that is imperative for applications 
where periodic monitoring of physiological fluids for a relatively long period of time are 
ideal/desired, i.e. smart catheter devices. 
 
6.3.2 Mechanical Flexibility Assessment 
 
The primary advantage of using a carbon-doped polyethylene film against carbon fibre mesh 
is its mechanical flexibility while the latter has a more brittle characteristic. This is notably 
important for systems such as those used in ostomy applications where conformation to skin 
morphology is vital. As such, the effect of bending on the electroanalytical sensitivity of the 
electrode was assessed. The flavin-phenol derivative was electropolymerised onto the film 
surface as per previous and was then subjected to physical bending pressure prior to 
commencing square wave voltammetry scanning.  
 
Electroanalytical responses of the anodised C-PE electrode functionalised with the redox 
flavin were conducted and recorded every fifth cycle of mechanical flexing at 90°, with a total 
of 50 bending cycles and 30 scans, as illustrated in Table 6.3.2. Subsequently, the same table 
summarises the film’s ability to produce a signal while fixedly bent at 90°. The corresponding 
square wave voltammograms for the two experiments are displayed in Figure 6.3.5. It should 














Table 6.3.2 Raw data highlighting the quantitative changes in peak positions of the polyflavin-modified anodised 
C-PE electrode resulting from mechanical flexing cycles and when electrode is fixed perpendicularly at 90°. 
 Potential / V Average Standard 
Deviation 
Standard 
Error Bend Cycle 
No. 
1 2 3 
0 -0.201 -0.199 -0.197 -0.199 0.00198 0.00115 
10 -0.197 -0.195 -0.195 -0.196 0.00115 0.00066 
15 -0.195 -0.195 -0.195 -0.195 0.00000 0.00000 
20 -0.195 -0.193 -0.197 -0.195 0.00198 0.00115 
25 -0.197 -0.195 -0.195 -0.196 0.00115 0.00066 
30 -0.195 -0.195 -0.197 -0.196 0.00115 0.00066 
35 -0.199 -0.199 -0.197 -0.198 0.00115 0.00066 
40 -0.195 -0.199 -0.199 -0.198 0.00229 0.00132 
45 -0.203 -0.195 -0.197 -0.198 0.00413 0.00238 
50 -0.197 -0.199 -0.195 -0.197 0.00198 0.00115 
Fixed at 90° -0.199 -0.199 -0.199 -0.199 0.00000 0.00000 
 
 
Figure 6.3.5 Square wave voltammograms detailing the effect of 90° mechanical flexing on the analytical 
response of the flavin-coated anodised C-PE electrode A) after repetitive cycling and B) after fixedly bent at 90°. 
Scatter graphs displaying the changes in the flavin oxidation C) peak potentials and D) peak heights, attributable 






It is evident from Figure 6.3.5 that there are differences between the initial scans and the 
subsequent scans. The principal change observed is the decrease in the oxidation peak height 
magnitude after both cases of cyclic bending and 90° fixed fold. The change in peak height is 
analogous to that highlighted in Figure 6.3.4B wherein repetitive scanning, conducted in the 
absence of mechanical bending, instigated the reduction of peak height magnitude - 
although at a slower rate. The former could be explained however by the possible loss of 
polyflavin from the electrode surface as the film is mechanically bent. Nevertheless, well-
defined and unambiguous oxidation peaks of the flavin redox centre are still distinctly clear 
in the voltammograms - indicating that no significantly disastrous failure occurred 
throughout both studies. The second investigation where the electrode is fixed at an angle 
additionally proves the characteristic conductivity of the carbon-polyethylene composite 
upon physical distortion.  Moreover, it is noteworthy that the oxidation peak position of the 
polyflavin remains constant with a relative standard deviation percentage of only 0.06% for 
both types of experiments, as detailed quantitatively in Table 6.3.2. The peak position 
determines the required electroanalytical signal and, as it has been proven to be unaffected 
by cyclic and set mechanical bending, is extensively important in several applications where 
flexibility is a primary need.  
 
6.3.3 Electroanalytical Capabilities within a Biofluid 
 
The functionality and accuracy of the flavin-modified anodised carbon polyethylene mesh 
was further assessed in human urine. The electrodes were submerged in the urine samples 
with each undergoing three consecutive square wave scans. The third square wave 
voltammograms of each urine specimen are presented in Figure 6.3.6. It is clear that the 
polymer composite electrodes retain their analytical characteristic in a more complex matrix. 
When the potential is swept towards less negative/more positive potentials, a second 
broader peak begins to develop (Figure 6.3.6 insert), which is instigated by the presence of 
other low weight components within urine – mostly likely attribute to excreted urate. The 
typical concentration of urate within urine ranges from 143 - 357 µM and 202 - 416 µM for 
a healthy female and male respectively (370). As discussed in the preceding chapter, the key 
asset of the polyflavin is that its oxidation peak occurs at a lower potential range where it is 








Figure 6.3.6 Square wave voltammograms presenting the analytical signals taken from flavin-modified anodised 
C-PE electrode in each human urine sample. Insert: representative square wave voltammogram highlighting the 
broad second peak observed if potential is swept towards a more positive range. 
 
The oxidation potentials from each sample were taken and the linear regression equation 
attained from calibration graph generated in Figure 6.3.4C was exploited to calculate the 
urine pH from the peak positions. Measurements obtained from the flavin C-PE composite 
were then compared to those acquired from a conventional glass pH probe as shown in Table 
6.3.3. This shows that the signals obtained from the manufactured electrode are only up to 
2.2% different from that taken with the conventional probe. Again, the peak potential 
remains constant after consecutive scans and no biofouling has occurred when immersed in 
a relevant biofluid – an imperative function required in systems that will be used for days at 
a time. At more negative potentials, fewer processes that could potentially passivate the 
surface of the electrode can occur, including oxidation of tyrosine and tryptophan (358), thus 
the polymeric flavin has a great advantage against other modifiers as described in Chapter 
5.3.3. 
Table 6.3.3 Peak potentials of the flavin-modified anodised C-PE mesh in human urine and their equivalent pH 
measurements against conventional pH probe. 







Error  Sample 1 2 3 
F1 -0.258 -0.258 -0.258 -0.258 5.92 5.98 0.06 
M1 -0.296 -0.296 -0.296 -0.296 6.55 6.48 0.07 








Electrochemical pH sensing using various modalities have already been explored, in this case 
however, a novel approach using a mechanically flexible anodised carbon-polyethylene film 
modified with polyflavin was investigated. The composite system was shown to provide a 
versatile sensor able to be employed in applications where flexibility, contouring and 
disposability are essential. The core redox flavin film clearly demonstrated its robustness 
upon continuous, repetitive scanning and is able to accurately determine pH even within a 
chemically complex urine biofluid.  As per previous discussion, the potential required to 
oxidise the flavin centre, and thus the quantification of the electroanalytical oxidation peak 
potential, occurs in a cathodic range whereby there is no need for solution degassing and 
where it is also devoid of any common interferences. The flavin-modified carbon-
polyethylene sensor described here evidently demonstrates its Nernst-like (60 mV/pH) 
behaviour that is robust and capable of performing under both constant and cyclic 
mechanical flexing as well as during normal measurements (without mechanical duress). The 
latter characteristic is advantageous in that it highlights only minute drifts in peak potential 
are observed under various types of pressure and with the degree of error being less than 
0.001 pH unit, by far proves to be better than potentiometric system where drift commonly 
limits the usage of the sensor in real-life applications.  
 
It is clear that the system could be used as an alternative to the carbon fibre detailed in 
Chapter 5 but it also possesses a range of advantageous characteristics that could be 
transferable to other sensing applications. Although there are various spectroscopic 
methods of measuring urine pH, these are costly, unscalable, methodically complex and are 
therefore unsuitable for direct incorporation to conventional systems such as those used in 
ostomy as well as catheter applications. The configuration investigated here is proven to be 
the opposite as it is a thin, conductive, reagentless system that can not only be easily 
integrated due to its mechanical flexibility but is also inexpensive and has an ability to be 
mass produced. The underlying electronics necessary to operate the voltammetric 
methodologies, and hence method to obtain the corresponding electroanalytical signals, are 
well-known and can significantly be scaled down which enhances the capability of the flavin-












Integration of Riboflavin-Modified Carbon Fibre and Screen Printed 







Riboflavin, vitamin B2, is a biocompatible chemical that possesses a redox active flavin core 
that is dependent on the presence of H+ concentration and thus could be an ideal component 
within the proposed smart catheter system. As such this chapter details an investigation into 
its exploitation as the basis of a pH sensitive sensor. The sensing rationale is based on a 
riboflavin-modified electrode system integrated within a modified 3D printed catheter 
needle free connector (bionector) hub which, in turn, can be readily integrated into existing 
catheter lines and which can measure changes in lumen pH arising from microbial 
contamination. Carbon fibre mesh was initially used as a conductive substrate which was 
then replaced by a more disposable, inexpensive carbon-based screen printed electrode. 
Both systems exhibit near Nernstian behaviour of 63 mV/pH unit and 62 mV/pH unit, 
respectively, and are capable of monitoring pH within chemically complex solutions. The 
release of hydrogen peroxide from riboflavin is also briefly discussed as a means of 











The primary reason for employing the engineered flavin-phenol compound in initial 
investigations was its ability to be electropolymerised directly onto the electrode surface 
whilst preserving its characteristic redox transitions which, in turn, was exploited to produce 
electroanalytically sensitive sensors. Although there was evident success in employing the 
custom phenolic flavin derivative in measuring pH, its major drawback and limitation in 
central venous catheter applications is the non-biocompatible nature of its 
monomers/oligomers. In instances where polymer leaching could potentially occur, there is 
a possibility that the use of polyflavin could result in cytotoxic adverse effects and this is 
especially problematic as the fragments would have direct access to the vascular/circulatory 
system if implemented in venous catheter systems. Therefore, this chapter aims to provide 
an alternative route where electropolymerisation is not needed and the commercially 
available riboflavin can be used to replace the flavin-phenol moiety.  
 
Needle free hub connectors (NFCs) were originally developed to reduce the risk of 
occupational injuries associated with needlestick events  and which could potentially lead to 
the transmission of blood borne diseases (65). These NFCs are essential extensions at the end 
of CVC lines which allows access for intravenous fluid in and/or out of the body (66). They are 
designed to be gatekeepers to reduce catheter contamination, however, studies have shown 
that these catheter hubs are the most common source of infection (3,45,66,69,371,372). This can be 
attributed to the presence of dead space in the core design between the septum seal and 
housing which proffers the perfect nidus for microorganism attachment, growth and 
proliferation thereby potentially leading to biofilm formation and eventually catheter-
related bloodstream infection. The use of aseptic techniques, specifically scrubbing the NFCs 
with 70% isopropyl alcohol for 30 seconds (109,373), is suggested to reduce the risk of infection 
however, as stated in Chapter 2, contamination can still occur with user compliance being 
one of the main contributors to its ineffectiveness. As such, the vision for this project was 
the employment of a smart hub whereby the conventional design is enhanced to be devoid 
of empty spaces and can monitor the line. Additionally, it was hoped that the same redox 
species responsible for conferring the indirect measurement of pH could be harnessed as an 
electrocatalyst for the generation of reactive oxygen species and therein have the potential 







Carbon loaded polyethylene was initially considered as an alternative substrate to replace 
the brittle carbon fibre mesh but the availability of screen printed electrodes (SPEs) in the 
course of the project opened up another avenue of investigation. These represent a cost-
effective solution given the ease with which they can be manufactured as evidenced by the 
commercial success of home glucose monitors. One possible limitation however would be 
whether or not they possessed the electrochemical characteristics necessary for facilitating 
the unambiguous identification of the riboflavin peak positions used as an indicator for pH.  
The employment of screen printed electrodes as an electrically conductive sensor has been 
widely used for several biomedical applications including detection of uric acid (374,375), 
salicylic acid (264), glucose (376,377) and hydrogen peroxide (378,379). Modifications of SPEs are also 
common with graphene oxide (374,380,381), Prussian blue (378,379,382,383) and other nanoparticles 
(384–386) as primary samples of usual modifiers. In the present case, carbon-SPEs were 
functionalised with the pH-sensitive riboflavin.  
 
The adsorption of riboflavin onto a conductive carbon-based electrode encased in a 
customised 3D-printed hub was the proposed development route. It was envisaged that the 
system would detect pH changes within the connector – the main site of contamination. 
Similar to the novel phenolic-flavin derivative, the redox transitions of the heterocyclic flavin 
core of riboflavin are highlighted in Figure 7.1.1 where it can undergo reduction (I ® II) and 
oxidation (II ® I) based on a two electron/two proton transfer. Additionally, it was 
anticipated that the electroactive riboflavin core would also be capable of redox cycling in 
the presence of oxygen. In its natural state, riboflavin is present in its oxidised form (I) but 
upon reduction (II), it is capable of electron transfer to molecular oxygen resulting in the 
production of reactive oxygen species such as superoxide anion and peroxide. A core 
assumption was that the generation of the ROS could help prevent the establishment of 
biofilm within the access line. Although several studies (186,387–389) have shown that a 
significant amount of ROS (typically in millimolar range, ≥ 0.2 mM of hydrogen peroxide 
(186,387–389)) is required to eradicate bacteria, it was anticipated that within the small volume 
of the NFC, ROS electrogenerated from the riboflavin could be a potent antimicrobial, 
sufficient enough to overcome bacterial defences (i.e. superoxide dismutase or various 
peroxidases). It was also envisaged that in travelling down the catheter line, the ROS would 







Figure 7.1.1 Reaction scheme detailing the electrochemical redox reactions of riboflavin at the electrode and 
the catalysis of oxygen reduction leading to the generation of peroxide. 
 
 
As discussed in Chapter 2, there are many risk factors associated with catheter related blood 
stream infection (i.e. duration of use, presence of underlying disease, etc.). In particular, 
patients receiving total parenteral nutrition (TPN), and other intravenous fluids, are at a 
higher risk of infection as these solutions provide necessary nutrients for the patient but 
which can similarly provide a growth medium that enhances the proliferation of CRBSI-
causing microorganisms (73,76,77). A typical composition of TPN is detailed in Table 7.1.1 
highlighting the diverse range of carbohydrates, trace elements and amino acids critical for 
maintaining nutritional health. Some 26% of increased risk was observed in patients 
requiring TPN compared to those who don’t and a study by Santarpia et al. (2016) highlights 
that, even with the lack of clinical symptoms, 50% of CVC tips used for TPN administration 
were infected (75). Intravenous solutions like TPN are chemically complex and thus would 
provide a suitably challenging milieu for electrochemical sensors that are intended for 
catheter applications. Herein, the proposed sensor relies on carbon-based electrode as the 
underlying conductive substrate and riboflavin as the pH sensitive electroactive agent. It is 
noteworthy that riboflavin’s oxidation peaks are observed at more negative potentials and 
as such, devoid of competing processes. In addition, this is of distinct advantage since the 
presence of amino acids such as tryptophan and tyrosine in TPN would mean that if the cyclic 
voltammetry or square wave sweep is too positive, these would be irreversibly oxidised 
leading to oligomeric/polymeric material that would potentially contaminate the electrode 






Table 7.1.1 Typical components of TPN solution. 
 
Total Calories 1210 KCal 
Glucose 1000 KCal 
Fat 0 KCal 
Nitrogen 9 gram 
Sodium 275 millimol 
Potassium 60 millimol 
Calcium 7.5 millimol 
Magnesium 10 millimol 
Non-Protein Calories 1000 KCal 
Phosphate (excluding Fat) 10 millimol 
Acetate 0 millimol 
Chloride 324.19 millimol 
Zinc 100 micromol 
Copper 20 micromol 
Selenium 400 nanomol 
Iron 20 micromol 
Water for Injection 2022.47 ml 
Glucose 50% 500 ml 
Magnesium Sulfate 50% 5 ml 
Sodium Glycerophosphate 21.6% 10 ml 
Additrace 10 ml 
• Ferric Chloride, 6H2O 20 micromol 
• Zinc Chloride 100 micromol 
• Manganese Chloride, 4H2O 5 micromol 
• Copper Chloride, 2H2O 20 micromol 
• Chromic Chloride, 6H2O 0.2 micromol 
• Sodium Selenite anhydrous 0.4 micromol 
• Sodium molybdate, 2H2O 0.2 micromol 
• Sodium fluoride 50 micromol 
• Potassium Iodide 1 micromol 
Cernevit (5ml WFI) 5 ml 
• Retinol palmitate corresponding to Retinol (Vitamin A) 3500 IU 
• Cholecalciferol (Vitamin D3) 200 IU 
• DL α-tocopherol 10.2 mg 
- corresponding to α-tocopherol (Vitamin E) 11.2 IU 
• Ascorbic Acid (Vitamin C) 125mg 
• Nicotinamide (Vitamin B3) 46 mg 
• Dexpanthenol 16.15 g 
-  corresponding to pantothenic acid (Vitamin B5) 17.25 mg 
• Pyridoxine Hydrochloride 5.5 mg 
- corresponding to pyridoxine (Vitamin B6) 4.53 mg 
• Riboflavin sodium phosphate 5.67 mg 
- Corresponding to riboflavin (Vitamin B2) 4.14 mg 
• Cocarboxylase tetrahydrate 5.8 mg 
- Corresponding to thiamine (Vitamin B1) 3.51 mg 
• Folic Acid 414 mcg 
• D-Biotin 60 mcg 
• Cyanocobalamin (Vitamin B12) 5.5 mcg 
Aminoven 25 350.19 ml 
• Isoleucine 1.82 g 
• Leucine 3.12 g 
• Lysine Acetate 5.48 g 
• = Lysine 3.89 g 
• Methionine 1.33 g 
• Phenylalanine 1.93 g 
• Threonine 3.01 g 
• Tryptophan 0.56 g 
• Valine 1.93 g 
• Arginine 7.00 g 
• Histidine 2.56 g 
• Alanine 8.75 g 
• Glycine 6.48 g 
• Proline 5.95 g 
• Serine 3.36 g 
• Tyrosine 0.14 g 
• Taurine 0.70 g 
Calcium Chloride 1 mMol/mL 7.5 ml 
Sodium Chloride 30% 49.84 ml 
Potassium Chloride 15% 30 ml 











Chemicals were obtained from Sigma Aldrich (UK), were the highest grade available and were 
used without further purification. Toray carbon paper (TGP-H-60, 19 x 19 cm) and riboflavin 
were both purchased from Alfa Aesar (Thermo Fisher Scientific, UK). Similar to previous 
chapters, drops of concentrated NaOH was added to Britton-Robinson buffer until the 
appropriate pH unit was attained and the resultant buffers were used throughout the 
experiments unless otherwise stated.  
 
7.2.2 Electrochemical Configuration and Electrode Modification 
 
Electrochemical analysis was carried out using a µAutolab Type III potentiostat with a 
standard three-electrode configuration with a carbon fibre mesh (2.5 mm x 2.5 mm window) 
or a carbon screen printed electrode acting as the working electrode. These were modified 
via pre-anodisation (300 seconds and 180 seconds in 0.1 M NaOH, respectively) and were 
further functionalised through adsorption of riboflavin, completed through submersing the 
electrode in solution containing the latter (250 µM, pH 7, unless otherwise stated). Platinum 
wire served as the counter electrode and a conventional silver/silver chloride (3 M KCl, BASi 
Technicol, UK) reference electrode completed the set-up.  All measurements were 
conducted at 22oC ± 2oC.   
 
7.2.3 Screen Printed Electrode Manufacture 
 
Carbon screen printed electrodes (SPEs) were fabricated using a DEK 240 Manual Screen 
Printer, a stainless-steel screen mesh and graphite ink (Gwent Electronic Materials, UK). The 
electrode was printed onto a Valox™ substrate which was heat cured at 70 °C for 90 minutes 
and the print had a typical height/thickness of 20 µm (264). The electrode area of the carbon 










7.2.4 Counter and Reference Electrode in 3D Printed Hub 
 
Experiments involving the carbon fibre electrodes and 3D-printed catheter hub extension 
used a two-electrode system whereby a carbon mesh (8 x 4.5 mm window) modified with 
electrodeposited silver acted as both the reference and counter electrode. Silver 
electrodeposition was completed through chronoamperometric method employing -0.1 V 
for 300 seconds in 10 mM AgNO3 in 0.1 M HNO3. Subsequently, the electrodes were 
chlorodised through cyclic voltammetry (-1 V ® 0.6 V ® -1 V) in 0.1 M KCl electrolyte.  
 
In experiments involving screen printed electrodes, the three-electrode configuration used 
within the hub is diagrammatically shown in Figure 7.2.1, where silver ink was added on to 
the third electrode to serve as the reference electrode. It should be noted that the working 
area was defined using a similar technique to that used with carbon fibre mesh where a 
polyester laminate was cut, and the electrode was thermally sealed.  
 
 
Figure 7.2.1 Three screen printed electrode configuration used within the customised catheter hub. 
 
The stability of the produced reference electrodes was assessed using zero current 
potentiometry in logarithmically increasing concentrations (0.001 M to 1 M) of KCl for 180 
seconds and recording the last 10 seconds for each concentration, as exhibited in Figure 









Figure 7.2.2 Representative A) potentiometric trace and B) linear regression calibration curve (Nelectrodes = 3) 
detailing the stability of the Ag/AgCl-modified carbon screen printed reference electrodes. Error bars represent 
mean standard deviation. 
 
7.2.5 Needle Free Hub Design 
 
 
The initial design of the suggested catheter hub system is presented in Figure 7.2.3 wherein 
the 3D printed connector can be easily integrated into existing central venous lines. This was 
later enhanced (Figure 7.2.4) so that the solution flows through the two-electrode carbon 
fibre mesh sensor (Figure 7.2.5) to ensure that intravenous fluid is further filtered as reactive 
oxygen species are generated, and any changes in pH, as a consequence of the presence of 
microorganisms, could be detected to alert the patient or healthcare practitioner. Figure 
7.2.4D highlights the flow through network inside the suggested hub. As discussed in Chapter 
2, the design of the hub must remain simplistic and devoid of dead space in order to minimise 
the risk of the needle free connector becoming a pathogen nidus and ultimately the source 
of CRBSI. This was therefore taken into consideration and explains the straightforward 
nature of the design chosen. Luer connector ends were included to ensure that it can be 






that it is easy to rapid prototype such a device and, it could be envisaged that the end results 




Figure 7.2.3 Initial design of the catheter hub extension showcasing its capability to be readily integrated with 














Figure 7.2.5 Two carbon mesh electrode system assembly. 
 
7.3 Results and Discussion – Carbon Fibre Mesh System 
 
7.3.1 Electroanalytical Evaluation of Riboflavin-Modified Carbon Fibre 
Electrode 
 
Representative cyclic voltammogram traces of riboflavin (3.19 µM, pH 6.21) with and without 
solution degassing are highlighted in Figure 7.3.1. The oxygen peak observed at -0.722 V in 
the riboflavin CV trace is clearly absent when the solution is degassed. This is attributable to 
the presence of nitrogen which removes the oxygen in the solution. It can be seen however 
that both redox peaks of riboflavin are visibly distinct without the intervention of the latter 
and thus useful for in situ applications. Similar to the polymeric flavin, the peak potentials of 









Figure 7.3.1 Cyclic voltammetry traces comparing the riboflavin (3.19 µM, pH 6.21) redox reaction at an 
anodised carbon fibre mesh electrode with and without solution degassing. Scan rate: 50 mV/s. 
 
In contrast to previous chapters where the flavin component was electropolymerised onto 
the carbon substrate through the oxidation of the phenol component, in this case the 
electrode was modified by simple physisorption. The simple submersion of the carbon 
electrode into a solution containing the riboflavin (250 µM, pH 7) was sufficient to induce 
the adsorption of the flavin. Subsequent rinsing of the electrode with fresh electrolyte (or BR 
buffer) did not perturb the adsorbed species and the electrochemical properties were of little 
difference to those recorded with the riboflavin in solution (Figure 7.3.1). In order to test the 
efficacy of this simple modification procedure, the physisorbed riboflavin electrode was 
assessed in varying pH BR buffers. However, in this case, a two-carbon fibre mesh electrode 
system was employed directly within the 3D-printed catheter extension (detailed previously 
in Figure 7.2.4D). Figure 7.3.2 showcases the shift of physisorbed riboflavin’s oxidation peak 
towards less negative potentials with the presence of increasing H+ concentrations. Square 
wave voltammetry was used to provide a more accurate measurement of peak potential as 
well as reduce the effect of oxygen. As with the phenolic flavin moiety (Chapters 5 and 6), 
the scan was initiated at a negative potential of -0.8 V which is enough to induce the 
reduction of riboflavin and is then swept towards more positive potentials to initiate its re-
oxidation. The system is shown to have a near-Nernstian behaviour of 63 mV/pH unit (E / V 
= -0.0629 pH – 0.1189; Ntotal = 18 (NpH = 6, Nscans/pH= 3); R2 = 0.9933) which is broadly consistent 








Figure 7.3.2 A) Representative square wave voltammetry scans of the physisorbed riboflavin-modified anodised 
carbon fibre electrode within the 3D printed hub to BR buffers of varying pH. B) Corresponding linear regression 
calibration line with each point of the calibration curve being an average of 5 scans and error bars represent the 
mean standard deviation. 
 
Needle-free connectors are recommended by the CDC to be replaced no more than every 72 
hours to reduce the risk of catheter related bloodstream infection (58,390). As such, the smart 
hub system proposed here must be robust and able to perform multiple scans that could 
cover this period. As with the flavin-phenol film investigations, the physisorbed riboflavin-
modified electrode was submerged in successive pH BR buffers (covering pH 3.10 to pH 8.07) 
and the series was repeated three times as shown in Table 7.3.1. The near Nernstian 
characteristic remained with a 57.8 mV/pH unit shift recorded (Figure 7.3.3C) (E / V = -0.0578 
pH – 0.0221; Ntotal = 54 (NpH buffers = 6, Nscans/pH/set = 3,); R2 = 0.9989). The corresponding 
variation in peak potentials and changes in peak magnitude are displayed in Figure 7.3.3. An 






and a 42% difference in peak current magnitude was calculated at the end of 54 scans. 
Minimal drift as well as minute change in peak magnitude are imperative to applications 
where repetitive/continuous scanning is required such as in smart catheter bionector 
systems. Critically, there was relatively little loss of the physisorbed riboflavin despite the 
repetitive scan and frequent changes in pH (and associate rinses). The system presented here 
is therefore suitable for periodic scanning. Assuming that 12 scans are required per day 
(based on differential period of central line culture versus peripheral culture is ≥ 2hrs (5,9)), 
the proposed system would be viable for at least 4.5 days which is beyond the typical lifetime 
of needle free connectors of 3 days (58,390,391). 
 
Table 7.3.1 Detailed raw data obtained from repetitive square wave voltammetric series scanning of the 
physisorbed riboflavin-modified anodised carbon fibre electrode in Britton Robinson buffers of varying pH; 
Nscans = 54. 
 
 























Series 1 Series 2 Series 3 
pH 1 2 3 4 5 6 7 8 9 
3.10 -0.196 -0.196 -0.196 -0.196 -0.196 -0.194 -0.220 -0.228 -0.232 -0.206 0.0158 0.0053 
4.11 -0.252 -0.252 -0.252 -0.250 -0.250 -0.250 -0.264 -0.266 -0.268 -0.256 0.0076 0.0025 
5.37 -0.328 -0.328 -0.328 -0.324 -0.324 -0.326 -0.332 -0.334 -0.334 -0.329 0.0039 0.0013 
6.19 -0.376 -0.376 -0.378 -0.374 -0.376 -0.376 -0.380 -0.382 -0.382 -0.378 0.0029 0.0010 
7.08 -0.436 -0.436 -0.436 -0.430 -0.430 -0.432 -0.434 -0.434 -0.434 -0.434 0.0024 0.0008 








Figure 7.3.3 Changes in A) peak potential and B) current magnitude of the physisorbed riboflavin-modified 
anodised carbon fibre electrode as a result of serial scanning in BR buffers of varying pH. C) Calibration curve 
displaying the average peak potential for each pH (Ntotal = 54). Error bars represent mean standard deviation. 
 
7.3.2 Assessment in TPN and Laked Horse Blood 
 
It must be acknowledged that the simple Britton-Robinson buffers offer little challenge to 
the proposed system and, as such, relevant matrices that proffer a more complex milieu 
were used to assess the pH sensitive capabilities of the riboflavin-modified electrode. Total 
parental nutrition and laked horse blood both contain components that could be expected 






determine if they would affect the redox activities (or indeed the stability) of the physisorbed 
riboflavin. Moreover, TPN is used as an intravenous fluid while laked horse blood was used 
as a more immediately accessible substitute for human blood. As noted in Chapter 2, reflux 
of blood into the NFC hub can occur and hence an investigation of its effect is of relevance 
for the purpose of this project. As in Chapter 5, kefir grains were used to alter the pH of both 
matrices and resulting square wave voltammograms are presented in Figure 7.3.4 and Figure 
7.3.5, respectively. It is clear that kefir inoculation had a greater effect in altering the pH of 
TPN compared to laked horse blood which could be attributed to the fact that the former 
would contain greater concentrations of available nutrients (i.e. glucose) that would 
significantly enhance the proliferation of the bacteria and yeast found in kefir grains.   
 
 
Figure 7.3.4 Square wave voltammograms showcasing the changes in peak potential using physisorbed 
riboflavin-modified anodised carbon fibre electrode: A) continuously kept in kefir-inoculated TPN, B) 
continuously submerged in TPN without kefir, C) periodically inserted in kefir-inoculated TPN and D) periodically 








Figure 7.3.5 Square wave voltammograms showcasing the changes in peak potential using physisorbed 
riboflavin-modified anodised carbon fibre electrode: A) continuously kept in kefir-inoculated laked horse blood, 
B) continuously submerged in laked horse blood without kefir, C) periodically inserted in kefir-inoculated laked 
horse blood and D) periodically placed in laked horse blood without kefir. 
 
Both figures show that the peak potential significantly changed only in the presence of kefir 
grains which continuously ferment throughout the experimental period, producing lactic and 
acetic acid, thus changing the pH to become more acidic (331,332,392,393). This is analogous to 
the shifts found when BR pH buffers were used and by using the linear regression equation 
calculated from the calibration curve (Figure 7.3.3C), the pH of the TPN and laked horse 
blood cultured with kefir was determined as per Table 7.3.2. The difference between the 
results taken from the physisorbed riboflavin electrode continuously submerged in the 
solution and ones that were only inserted at each time period could be possibly explained by 
the biofouling of kefir, and thus biofilm formation on the former electrode surface is more 
viable than the latter. However, it is evident that data from both electrode protocols slightly 
deviated from the pH measured using the commercial pH probe. The maximum percentage 
difference was calculated to be less than 10% which was a result of the physisorbed 
riboflavin-electrode, inserted in the kefir-culturing TPN throughout the duration of the 
experiment, after a period of inactivity. This is somewhat similar to that found in Chapter 5 






overnight and more frequent scanning reduced the discrepancy. It is also important to note 
that average peak potential is the mean of 3 consecutive scans and a total of 12 scans was 
completed for each riboflavin-functionalised electrode. This along with the peak magnitude 
shown in Figure 7.3.4 and Figure 7.3.5, further suggests that the system is robust and useful 
for in situ applications.  
 
Table 7.3.2 Raw data obtained from the physisorbed riboflavin-modified carbon fibre electrode: A) continuously 
submerged in kefir-cultured TPN, B) periodically inserted in kefir-cultured TPN, C) continuously submerged in 
kefir-cultured laked horse blood and D) periodically inserted in kefir-cultured laked horse blood. 
 
7.4 Results and Discussion – Screen Printed Electrode System 
 
7.4.1 Preliminary Electrochemical Characterisation 
 
The ease of deployment and replacement of the physisorbed riboflavin-carbon fibre system 
could be considered to be economically viable when considering the costs associated with 
CRBSI treatment (Chapter 2). Nevertheless, the translation of the proposed riboflavin 
technology to screen printed systems is recommended as the latter is easier to mass produce 
and offers a more inexpensive, disposable approach for employment in smart catheter 
systems. Therefore, a carbon-based screen printed electrode modified through the 
physisorption of riboflavin was investigated. 
 
Similar to the previous technique used with the carbon fibre network, riboflavin (250 µM, pH 
7) was adsorbed on to the screen printed electrode and its electrochemical response was 




































































0 hr 5.65 -0.363 5.89 0.24 
 
0 hr 5.65 -0.369 6.01 0.36 
4 hr 4.29 -0.259 4.10 0.19 
 
4 hr 4.29 -0.277 4.42 0.13 
23 hr 3.78 -0.220 3.42 0.36  23 hr 3.78 -0.229 3.58 0.20 
24 hr 3.74 -0.230 3.60 0.14 
 
24 hr 3.74 -0.229 3.58 0.16 
 
C 
     
D 
    
0 hr 7.52 -0.455 7.49 0.03 
 
0 hr 7.52 -0.493 8.15 0.63 
3 hr 7.21 -0.421 6.90 0.31 
 
3 hr 7.21 -0.416 6.81 0.40 
22 hr 7.15 -0.415 6.80 0.35  22 hr 7.15 -0.461 7.59 0.44 
24 hr 7.28 -0.416 6.81 0.47 
 






riboflavin and showcases the effect of scan rate on the riboflavin-modified anodised SPE. The 
redox peak separation increases with scan rate attributable to the decreasing transfer rate 
of counter ions. The peak visible at +0.06 V could be explained by the possible contamination 
of silver on the screen printed electrode surface. 
 
 
Figure 7.4.1 Cyclic voltammograms detailing the influence of scan rate on the redox processes of a physisorbed 
riboflavin-modified anodised screen printed electrode in pH 7 Britton Robinson buffer.  
 
Likewise, Figure 7.4.2 details the change in riboflavin peak height as a function of scan rate. 
The positive linear relationship between peak height and scan rate ascertains the 
confinement of the electroactive species on the surface of the electrode. To further assess 
the adsorption of riboflavin, the electrode was placed into fresh pH BR buffer after 
modification and square wave voltammetry was performed. As per the preceding section, 
the riboflavin oxidation peak remained present and shifts with pH as shown in Figure 7.4.3. 
The system shows a near Nernstian behaviour of 62 mV shift per pH (E / V = -0.0616 pH – 








Figure 7.4.2 Variation of riboflavin peak heights as a function of scan rate recorded using physisorbed 





Figure 7.4.3 A) Square wave voltammograms of a physisorbed riboflavin-modified anodised carbon screen 
printed electrode in Britton Robinson buffers of varying pH. B) Corresponding calibration curve (each point is an 
average of three scans) showing the effect of pH on peak potential. Mean standard deviation error bars are 






Additionally, X-ray photoelectron spectroscopy was also used to ensure riboflavin had been 
adsorbed. Table 7.4.1 displays the average atomic concentration percentage of carbon, 
oxygen and nitrogen in an unmodified and physisorbed riboflavin-modified SPE. High 
resolution and wide energy survey scans both showed an increase of nitrogen in the 
physisorbed riboflavin-modified SPE compared to non-modified electrode - 2.48 and 2.21 
times more, respectively. This increase is explained by the presence of nitrogen in riboflavin’s 
chemical structure. It is assumed that although the carbon-graphite ink contains nitrogen, 
the adsorption of riboflavin significantly increased the atomic concentration percentage of 
nitrogen. 
 
Table 7.4.1 Average atomic concentration percentages of unmodified and physisorbed riboflavin-modified SPE 
using XPS. 
Average atomic concentration percentage (High resolution scans) 
Element Non-modified SPE Riboflavin-modified SPE 
O 1s 9.26 13.77 
N 1s 0.81 2.01 
C 1s 89.93 84.22 
 
Average atomic concentration percentage (Wide energy survey scans) 
Element Non-modified SPE Riboflavin-modified SPE 
O 1s 9.53 10.83 
N 1s 0.81 1.79 
C 1s 81.93 79.47 
Cl 2p 7.74 7.91 
 
7.4.2 Integration within 3D Printed Catheter Hub 
 
The influence of pH on the oxidation peak of the physisorbed riboflavin-modified SPE system 
was further assessed using various pH BR buffer solutions flushed into the 3D-printed 
catheter extension. The hub was modified to contain a slot for the screen printed electrode 
system instead of the two-electrode carbon fibre mesh configuration. As per previous 
investigations, square wave voltammetry was employed starting at a negative potential 
sweeping towards a more positive potential, which allows riboflavin to initially be reduced 
then re-oxidised. Figure 7.4.4A displays the distinct oxidation peaks obtained from the 
voltammetric scans. As the pH decreases, riboflavin’s oxidation peak shifts towards a less 






slope of 61 mV/pH unit (E / V = -0.061 pH - 0.085; Ntotal = 18 (NpH = 6, Nscans/pH = 3); R2 = 0.9979) 
- analogous to previous result. 
 
As previously mentioned, needleless components of catheters are typically changed every 
72 hours (58,390). This means that the electrode system must be robust enough to go through 
periodic scanning for up to three days. Robustness was therefore assessed by cycling the 
electrode system through a series of pH sequences with each sequence starting from a low 
of pH 3.07 to a high of pH 7.96. Square wave voltammograms of each pH BR buffer was 
completed in triplicates and the whole process was repeated three times (Figure 7.4.4B). An 
average drift of 31 mV (0.51 pH unit based on a 61 mV per pH shift) was found to have 
occurred after 54 scans which could possibly be due to hydroxyl ions attacking the oxidised 
riboflavin which, in turn, showcases a slightly irreversible characteristic. Equally, this could 
be due to the instability/degradation of the reference electrode. However, it should be noted 









Figure 7.4.4 A) Square wave voltammograms displaying the response of the physisorbed riboflavin-modified 
anodised SPE system in Britton Robinson buffers of varying pH and B) influence of pH on the oxidation peak 
potential over three cycles (total of 54 scans with each point representing an average of 3 scans). 
 
Figure 7.4.5 exhibits the representative cyclic voltammograms comparing the response of 
physisorbed riboflavin-modified SPE against a non-modified electrode in TPN. Analogous to 
previous chapters, it is also evident that the screen printed electrode is capable of 
electroanalytical measurements within a chemically complex media. Riboflavin is present in 
TPN (0.00138 mg/mL) thus explaining the small oxidation peak found using the unmodified 
SPE. It can be argued that a bare screen printed electrode can be used instead, however, it 
is evident that the modified riboflavin has a far greater peak response due to the riboflavin 
already adsorbed on the electrode. It must also be noted that the aim here is for the 
development of a sensing system that could be used across a range of applications and it is 
unlikely that riboflavin would be present in every infusion fluid. Hence modifying the 








Figure 7.4.5 Square wave voltammograms representing the response of physisorbed riboflavin-modified SPE 
and unmodified SPE in TPN (20th scan). 
 
Upon repetitive cycling (20 scans) in TPN, the peak potential remained steady (-0.356 V) with 
only a 4 mV potential drift (0.07 pH units based on the 61 mV/pH unit shift), however the 
magnitude of the oxidation peak decreased by 23% (Figure 7.4.6). Additionally, the modified 
three-SPE system was also assessed using TPN injected in the catheter extension after 
triplicate scans in each physiologically relevant pH BR buffer (pH 3.08 to pH 7.43; NpH = 6; 
Ntotal = 18). The calculated pH was found to be pH 6.14 using the calibration graph from Figure 
7.4.3B which is in good agreement with the actual TPN pH (pH 5.96). It must be noted that 
the peak current reduced significantly to only 42% of the original magnitude which does 
provide a query over the relative stability of the signal/strength of adsorption to the SPE 
graphite surfaces or the presence of components with the TPN that act to displace the 
riboflavin – competition for adsorption sites from other components.   
 
Further experiments in ensuring a stronger adsorption of riboflavin is clearly necessary prior 
to clinical application though it should be recognised that the leaching of riboflavin from the 
surface would present no risk to the patient and stands in marked contrast to the flavin-
phenol system investigated in previous chapters.  The use of membranes that would hinder 
the diffusion of riboflavin out of the electrode could be a solution to the decreasing peak 








Figure 7.4.6 Variation of A) magnitude and B) potential of the oxidation peak of the physisorbed riboflavin-
modified anodised SPE as a result of repetitive square wave scans in TPN (Nscans = 20). 
 
With this in mind, the ion permeable Nafion™ membrane was utilised to impede the flow of 
riboflavin. The polymeric solution was cast on to the riboflavin-modified electrode by 
dropping a volume (30 µL) enough to cover the surface of the electrode and was left to dry. 
The resultant electrode was then inserted into TPN and underwent 40 square wave scans. It 
was noticed that the potential of the first 17 scans continued to fluctuate which may be 
explained by the fact that the polymer coating was still equilibrating to the pH of TPN. After 
this however, Figure 7.4.7 demonstrates that the oxidation peak potential remained 
constant at around -0.383 mV and the peak height difference had a maximum 5% change 
with an average magnitude of 2.41 µA after the remaining 23 scans. This would therefore 
enhance the possibility of using inexpensive and disposable SPEs in existing catheter hub 
systems to monitor the condition of the line. As per Figure 7.2.2B, the slight shift in TPN peak 
potential could be attributable to the different Ag/AgCl SPE reference electrode used which 







Figure 7.4.7 The effect of repetitive square wave voltammetry scanning in TPN on peak A) height and B) 
position of the Nafion-coated riboflavin-modified anodised screen printed electrode. 
 
 
7.5 Hydrogen Peroxide  
 
As mentioned in the introduction to the chapter, riboflavin has the ability to produce reactive 
oxygen species (superoxide anion, hydrogen peroxide) through catalysing the reduction of 
dissolved oxygen (Figure 7.1.1). Preliminary investigations examining the production of 
hydrogen peroxide through applying a suitable potential (-0.450 V) to reduce riboflavin (250 
µM, pH 7) physisorbed onto a carbon fibre mesh electrode were conducted. A peroxide assay 
kit (Sigma Aldrich, UK) was used to validate the quantity of peroxide produced via the 
electrochemical processes. The latter relied on the Fe3+-xylenol orange chromogenic reaction 
where a purple resultant is produced as Fe2+ is oxidised to Fe3+ due to the presence of 
peroxide in the sample (Figure 7.5.1) and, as such, the resulting colour intensity is directly 
proportional to the concentration of the latter (394). Figure 7.5.2 and Table 7.5.1 showcases 
the calibration curve and subsequent calculated peroxide concentrations produced from the 
electrochemical reduction of riboflavin over varying electrolysis time periods. Each point was 









Figure 7.5.1 Simplified Fe3+-xylenol orange reaction scheme in the presence of peroxide. 
 
 
Figure 7.5.2 Linear relationship between hydrogen peroxide concentration and Fe(II)/Fe(III) assay absorbance 
(lmax = 585 nm) value. Each point is an average of 2 scans and the error bars represent mean standard 
deviation. 
 
Table 7.5.1 Average absorbance value (lmax = 585 nm) and calculated peroxide concentration following on from 
electrochemical riboflavin reduction (-0.450 V) physisorbed on anodised carbon fibre mesh electrodes at different 
time periods. 






0 0.983 0 0 
1 1.053 0.070 1.099 
3 1.094 0.111 2.298 
5 1.657 0.674 18.760 
30 1.599 0.616 17.064 
 
As highlighted in Table 7.5.1, there is a positive relationship between scan duration and 
peroxide concentration however it is noteworthy that the system plateaus essentially after 






employing chronoamperometry reduces riboflavin thus increasing the production of 
hydrogen peroxide. It is clear that the data presented here is preliminary however time 
constraints and complications due to the pandemic did not allow further work to be 
completed. The absorbance data however highlights that the production of hydrogen 
peroxide is promising. Evidently, further investigations are required to complete the study 
including, but not limited to, ROS generation within the customised 3D printed hub, its 
influence on CRBSI-causing microorganisms, the stability of the electrode substrate and the 
employment of miniaturised potentiostat/electronics, suitable for in situ use, to complete 




An inexpensive and disposable pH system, based on carbon fibre mesh and/or screen printed 
electrode, through the adsorption and manipulation of riboflavin has been described. The 
use of riboflavin solves the biocompatibility issues of earlier flavin polymer system, as 
vitamin B2 and its monomers are already present in the body. As observed with the phenolic 
flavin modifier, the oxidation peak of riboflavin provides an unambiguous signal free from 
typical interferences that could hinder conventional voltammetric pH measurements (i.e. 
those employing quinone based systems). Additionally, the system is capable of undergoing 
repetitive square wave voltammetry cycling in more chemically complex solutions 
(TPN/laked horse blood) whilst retaining its near Nernstian behaviour. The translation from 
carbon fibre mesh to screen printed electrodes is a critical advance as the latter would 
provide a cheaper, more disposable solution where mass production would be easier to 
achieve.  
 
The proposed systems were also successfully integrated within a custom designed 3D printed 
needle free connector which in turn can be used as a smart extension that could be readily 
incorporated into existing CVC lines. The ability of riboflavin to generate hydrogen peroxide 
was also briefly assessed which suggests that riboflavin-modified carbon electrodes could 
not only monitor the condition of the line (detect contamination), but also has the potential 
in eradicating pathogen contamination through the release of reactive oxygen species.  
Therefore, the smart sensor could ultimately provide a novel, sustainable and efficient 













































The design, development and deployment of catheters for intravenous therapy can be 
considered as one of the key milestones that underpin modern healthcare. Catheters provide 
a bedrock and invaluable pathways for most medical treatments in modern medicine and 
are responsible for saving countless of patients suffering from various morbidities including 
but not limited to cancer, kidney failure and intestinal failure. Despite their indispensable 
benefits, catheters are prone to complications and can act as the gateway for life threatening 
infections. It is therefore necessary to ensure that the benefits outweigh the limitations prior 
to inserting an indwelling catheter. The most common drawback is the significant risk of 
catheter related bloodstream infection which is one of the most ubiquitous nosocomial 
infection. Currently, the onset of fever and presence of rigors are the primary diagnosis for 
CRBSI which remains to be highly unspecific, insensitive and unreliable.  
 
Due to various reasons (limited insertion sites, presence of comorbidities, cost, etc.), 
catheter removal and replacement, although greatly effective, is not the preferred solution 
to this problem and, as such, a myriad of preventative measures have been researched and 
implemented throughout the years.  The introduction of lock solutions, aseptic/disinfection 
techniques, barrier caps as well as thorough research on antiseptic impregnation and 
extensive developments on catheter material have all valuably aided in minimising CRBSI 
cases yet, they do not represent an infallible route to the effective eradication of the problem 
as infection, despite many decades of attention, still remains problematic. Some of these 
techniques provide protection only for a limited period and do not eliminate all 
contaminating microorganisms. It should also be noted that the use of antibiotics adds on to 
the ever-increasing risk of pathogen resistance, thus is not a suitable long-term solution.  
There is therefore a pressing need for the development of a smart sensor system that can be 
easily integrated into existing catheter lines which can ultimately detect and eradicate 
pathogen invasion before health-jeopardizing infection occurs. Thus, the suggested smart 
catheter system described here was developed as a response to that need. Rather than 
relying on subjective factors and prolonged waiting for clinical results, it is envisaged that 
employing a sensitive electrochemical sensor could provide a faster diagnostic alternative as 
well as a more efficient and effective method to eradicate contaminants which would 
ultimately prevent CRBSI. Furthermore, such system could be used as a conduit for routine 







Carbon is the most common electrode material used in electroanalysis and its modification 
through electrochemical oxidation is recognised to enhance its ability to perform in various 
applications. Chapter 4 detailed the effect of the co-application of ultrasound during 
anodisation towards the generation of surface functionalities and ultimately its influence on 
carbon electrode performance. As with silent anodisation alone, ultrasound-aided 
anodisation increased the electron transfer kinetics of the carbon fibre mesh electrode and 
has improved its response towards ferrocyanide, effectively altering the irreversible 
behaviour of an unmodified carbon electrode to a reversible one. Through solely comparing 
cyclic voltammogram traces of silently anodised and sonoanodised electrode towards 
ferrocyanide, it was observed that ultrasound simply accelerated the process to which 
reversibility is achieved and that via the examination on the influence of prolonged 
anodisation periods (beyond 300 seconds), the latter provided only minimal improvement in 
the voltammetric response in comparison to the former, thus suggesting ultrasound had a 
kinetic effect rather than a structural influence. This was then corroborated with the data 
obtained from Raman spectroscopy which highlighted that the lattice disorder 
characteristics of sonoanodised electrode was analogous to that of its conventionally 
anodised counterpart.  
 
However, sonoanodisation significantly enhanced electrode surface hydrophilicity and, 
through SEM assessments, had a clear influence on the morphology of the carbon fibre, 
resulting in markedly greater physical deterioration compared to silent oxidation which 
stands in contrast to the Raman spectra. Additionally, deconvoluted carbon functionality XPS 
analyses on the C1s and O1s spectra of both normal and ultrasound-aided anodisation 
revealed that there were major distinct disparities in the population of the C=C/C-C and C-O 
functional groups between the two conditions, and only diminutive differences were found 
in the percentage contribution of carboxyl functionalities even with prolonged anodisation. 
In spite of these discoveries, and with regards to the purpose of this project, sonoanodisation 
simply sped up the electrochemical processes which occur through silent anodisation alone 
and, as such, only the latter was used for the rest of the experimental work.  
 
Subsequently, anodised carbon fibre mesh was used as a substrate for a scalable and 
disposable pH sensitive electrode in Chapter 5. A novel flavin-phenol moiety was custom 






concentration dependent redox reactions were then exploited as the basis of an 
electrochemical sensor. Unlike riboflavin, the phenolic flavin derivative can undergo 
electropolymerisation without damaging the core pH-sensitive flavin group as the presence 
of the phenol ring allows polymerisation to occur through a radical cation process attacking 
the phenolic substituent instead. When assessed in physiologically relevant pH BR buffers 
(pH 2.55 – pH 8.12), the oxidation peaks of the polymer occurred and shifted within the 
potential range where no other competing signals are present – a prerequisite for 
electrochemical sensors. The system exhibited a near Nernstian behaviour of 55 mV/pH with 
minimal drift of only 4 mV upon repetitive cycling. The sensor’s ability to detect pH changes 
was further tested via insertion within a demanding milieu of a kefir-based microbial reactor. 
The shift in oxidation peak after 51 hours was in correlation with that observed in the less 
challenging pH BR buffers which suggests its applicability in microbial systems. However, in 
dormant periods, the presence of biofilm on the electrode surface was evident in the SEM 
images as well as the nonconformity of the calculated pH against the actual pH measured 
with a conventional pH probe, which could be problematic in other microbial systems and 
should therefore be thoroughly considered. However, upon continuous cycling with shorter 
periods of rest, the peak oxidation potentials soon returned to complement actual pH values.  
 
Carbon loaded polyethylene film was then used as the base of a conductive yet mechanically 
flexible pH probe in Chapter 6. Through raster mode laser ablation, mesh like interfacial 
carbon pores were exposed where the tracks intersected. The redox active phenolic flavin 
was again polymerised as the pH sensitive layer and the reagentless system provided 
unambiguous signals which indirectly measure pH without the need for solution degassing. 
As with the previous chapter, a near Nernstian behaviour of 60 mV per pH shift was observed 
over the physiologically relevant pH range of pH 2.55 to pH 8.12. Upon repetitive 90° 
mechanical bending, it was observed that the oxidation peak height decreased but the signal 
remained unambiguous and more importantly, the peak potential was constant and 
unaffected by repetitive bends as well as when the sensor was fixed at a 90° bend. The 
decrease in signal amplitude was analogous to results obtained from repetitive scanning 
without flexing and may be explained by the possible loss of the flavin polymer from the 
electrode surface. The ability to detect pH was further assessed in chemically complex urine 
samples. With only a maximum pH difference of 0.07 pH units from results achieved via a 
conventional pH probe, the system proved to be useful in detecting biofluid pH changes 






observed remained advantageous in this case as it is barren of other competing signals that 
would be present in biofluids such as tryptophan and tyrosine. 
 
Although there is evident success in employing the novel engineered flavin phenol derivative 
as the core remit of a pH sensitive sensor, its primary disadvantage in catheter application is 
the non-biocompatibility of its oligomers. Adverse cytotoxic events could occur upon the 
event of polymer leaching and, if implemented within a catheter system, this would have a 
direct route towards the vascular system. Riboflavin, vitamin B2, was therefore used as an 
alternative in Chapter 7. The primary reason for not using the latter initially was its inability 
to be electropolymerised without affecting the core redox flavin group however, it was 
observed that upon submersion of electrode into a riboflavin solution (250 µM, pH 7), the 
vitamin strongly adsorbed onto the electrode surface. The system was then inserted in a 
custom designed needle free connector hub and a two-electrode configuration was 
implemented. Riboflavin-modified carbon mesh was employed as the working electrode 
while a silver coated carbon fibre mesh served as the counter and reference electrode. 
Oxidation peaks shifted with pH and a near Nernstian behaviour of 58 mV/pH was observed 
upon repetitive cyclic scanning with a maximum standard error of only 0.005 was calculated. 
The system was further assessed in kefir inoculated TPN and laked horse blood and distinct, 
unambiguous riboflavin oxidation peaks were observed in both cases even after 24 hours of 
electrode immersion in respective solutions. The calculated shifts in pH had minimal 
discrepancy to those obtained from a commercial probe.  
 
The system was successively translated to a more disposable, inexpensive and easily mass-
produced screen printed electrodes. Analogous to previous, a 62 mV per pH shift was 
observed when integrated within the hub thus again displaying a near Nernstian 
characteristic. However, upon repetitive cycling, the oxidation peak magnitude decreased 
significantly and as such the ion permeable Nafion membrane was employed to minimise 
signal deterioration - only a 5% height decrease was observed after the implementation. 
Subsequently, chronoamperometry was employed to induce the reduction of riboflavin to 
release hydrogen peroxide. Prolonged reduction meant that a greater concentration of 
reactive oxygen species was produced. This mechanism could potentially be exploited to 
eliminate catheter contaminating pathogens and ultimately, significantly minimise the risk 
of catheter-related bloodstream infection. However, it is important to recognise the 






the efficacy of the methodology. Nevertheless, the dual capability of detecting the presence 
of pathogens as well as eradicating them suggests the system’s marked advantages over 
existing preventative measures.  
 
8.2 Recommendations for Future Work 
 
The main scope of this work was to develop a smart sensor that can be readily integrated 
within existing catheter systems for the prevention of catheter related bloodstream 
infection. However, the simplicity, scalability and disposability of the suggested system can 
be easily transferred to other applications including smart bandages, ostomy applications 
and other invasive/indwelling medical devices requiring the detection and eradication of 
pathogens. The next key viable step would be the development of a miniscule, portable 
potentiostat that would allow autonomous, periodic monitoring of the line condition. The 
addition and implementation of such a device would minimise intervention beyond the initial 
placement and ultimately alert the relevant medical personnel if a shift in local pH, due to 
the onset of biofilm formation, is detected. It is envisaged that early intervention would 
significantly minimise the risk of bloodstream infection, reduce economic burden relating to 
CRBSI and more importantly, improve patient outcome. Although the work investigated here 
focused on the development of the sensor rather than the development and implementation 
of a miniature potentiostat, it is necessary for the latter to be investigated. In view of the 
ever-growing advancements in miniaturised electrical components as well as the pressing 
need for portable smart systems, the production of such a device is undoubtedly anticipated.  
 
Further modification on the suggested catheter hub could also be studied where the focus 
would be on the elimination of gaps and dead spaces as well as the use of other 
manufacturing methods that could improve the final design of the hub. The flow of pertinent 
solutions including total parenteral nutrition and lock solutions through the hub and smart 
electrode configuration should also be thoroughly investigated. Eddie currents and retention 
of fluid (i.e. blood) that could encourage pathogen growth should be avoided and, as such, 
hub modifications may be necessary. 
 
Surface fouling is an inevitable challenge for devices developed to function within complex 
biological fluids as it could eventually significantly decrease the accuracy and lifespan of the 
sensor. In this application however, central venous catheter hubs are expected to be 






cycling of up to 63 scans from pH 3 to pH 8, remained to produce reproducible, sensitive and 
distinct signals with minimal potential drift. It is therefore envisaged that such configuration 
could last beyond the conventional lifetime of a needle free connector thus avoiding further 
manipulation. However, amendments through the addition of size sensitive polymers could 
be further assessed to prevent polymer leaking specifically for the physisorbed riboflavin 
systems where the loss of redox core could occur at a faster rate.  
 
Moreover, the sensor’s ability to detect pathogen growth through pH changes should be 
further challenged via investigations involving microbiological methods. By culturing 
common CRBSI-causing microorganisms (S. epidermidis, S. aureus, P. aeruginosa, etc.) in 
normal catheter solutions and detecting pH changes using the suggested sensor 
configuration, the applicability of the device in real life situations could be assessed. 
Additionally, this could further assess the correlation between shift in pH and the presence 
of pathogens in needle free catheter hubs. In depth evaluation of the release of reactive 
oxygen species from riboflavin and its ability to eradicate aforementioned microbes could 
offer significant advantages and are potential directions for future development of the 
system described here. Nonetheless, the applicability of the pH sensitive sensor has been 
clearly demonstrated through assessments within suitable complex solutions of TPN and 
laked horse blood. Evidently, the sensing rationale could act as a vital stepping stone towards 
the development and manufacture of novel technologies that could be regularly used in 
clinical practice. The materials used here are disposable, inexpensive, readily adaptable for 
mass manufacturing and are therefore economically viable for implementation within the 
cost-conscious healthcare industry. Despite the considerable advances in miniaturised pH 
sensitive probes over recent years, this work provides invaluable research which stands at 
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